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ABSTRACT
EXPLORATION OF THE COMPLEX RELATIONSHIP AMONG MULTILEVEL PREDICTORS OF PREP USE
AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
By
Kristina Rodriguez

Advisor: Elizabeth Kelvin, PhD

Background: Men who have sex with men (MSM) remain the group most heavily affected by HIV
in the United States (US), with MSM of color further disproportionately represented. In July 2012,
the US Food and Drug Administration (FDA) approved the use of tenofovir disoproxil fumarate plus
emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis (PrEP) in HIV-negative adults
who are at high-risk of HIV infection. Despite its effectiveness, PrEP prescriptions are reaching only
a small proportion of those who could benefit from the drug and prescription rates vary both by
race and geographic region. The goal of this dissertation was to explore the complex relationship
among multilevel predictors of PrEP use in a geographically diverse sample of MSM in the US.

Methods: Data from a cross-sectional survey of MSM residing in all 50 US states was used to test
a series of hypotheses regarding PrEP use. Using the framework of the social-ecological model
and multi-level logistic and linear regression we explored if (a) variables at the individual- (i.e.
iii

demographics, identity), social- (MP factors and social behaviors), and state-levels (state equality,
HIV prevalence, socio-economic factors) influenced the outcome (Aim 1 and 2: PrEP use and Aim
3: Patient Trust in Physician) among MSM with a focus on the equality of the state (LBGTQ+ and
racial equality); we further extended this hypothesis to examine if our state equality measures
modified the association between individual identity-level variables (sexual and racial/ethnic
identity) and our outcome (PrEP use or PTP scores), and (b) if the association between state-level
(LGBTQ+ and racial equality) and individual-level (sexual and race/ethnic identity) variables and
PrEP use was mediated through patient trust in physician (PTP). We examined these hypotheses
among all participants, and then conducted a sub-analysis looking at the first hypothesis, among
only MSM of color, as this group currently has the highest HIV incidence in the US and we felt
warranted a closer look in an attempt to tease out reasons for this high risk.

Results: Aim 1 included 4,165 HIV-negative MSM of whom 13.4% (N = 560) were taking PrEP at
the time of the survey. In Aim 2, there were 1,465 HIV-negative MSM of color, of whom 13.6% (N
= 199) were taking PrEP. In the analyses for both aims, we found that age, several main partner
(MP) factors, number of sexual partners, STI history, and the LGBTQ+ equality of the state where
the participant resides were all significantly associated with higher odds of using PrEP, while sexual
identity and other main partner (MP) factors were associated with lower use. In aim 1 alone, higher
education and a mid-level HIV prevalence were also associated with higher PrEP use. Lastly, only
in aim 2, race/ethnicity was shown to be associated with PrEP use, with Hispanic and Asian MSM
being less likely to use PrEP.
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In aim 3, of the 2,750 HIV-negative participants who reported having a primary care provider,
there were several individual- and social-level factors associated with PTP scores. Geographic
region, sexual identity, and individual drug use were shown to be associated with lower PTP scores,
while participants who reported PrEP use were shown to have higher PTP scores. The interaction
analysis suggested that racial/ethnic identity influenced PTP differently depending on the racism
level at the state-level. After stratifying on the racism/racial equality variable of the state, the
results suggest, that with the exception of black participants, compared to whites, all other races
had higher PTP scores in high racial equality states (less racism) than in low racial equality states
(more racism).

Conclusions: This is one of the first studies that explored several multi-level predictors of PrEP use,
and given our large sample, it also offered a unique opportunity for us to examine the influence
of state-level factors on PrEP use, as both a main effect and as an effect modifier. The results of
our work suggests that individual-, social-, and state-level variables, specifically the LGBTQ+
equality of the state of residence, are associated with PrEP use. The findings of this study suggest
that policies that increase inequality may have an impact on HIV prevention interventions.
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CHAPTER 1: INTRODUCTION
BACKGROUND
The aim of this dissertation was to explore the relationship among multilevel predictors of
Pre-Exposure Prophylaxis (PrEP) use among men who have sex with men (MSM) in the United
States (US), who continue to be disproportionately affected by HIV. Using the social ecological
model (SEM) as a backdrop, we aimed to contextualize how factors working at and interacting
across multiple levels of organization may explain why some groups are more likely to use PrEP
than other groups. PrEP is one of the newest HIV prevention tools, but for it to be effective, those
at highest risk need to understand the benefits of the medication and use it as prescribed.
HIV and MSM
The incidence of HIV in the US is approximately 50,000 cases per year, with MSM
disproportionately affected.1 The Centers for Disease Control and Prevention (CDC) estimated that
in 2017, MSM represented about four percent of the male population,2 yet accounted for
approximately 70% (27,000) of the 38,739 new HIV diagnoses in the United States (US), with 1 in
6 unaware that they were infected.1
Biological, behavioral, and structural factors make the dynamics of the epidemic in the US
complex.3 Most studies exploring associations with HIV among MSM have largely focused on
individual-level factors, with many of those studies showing that individual-level factors alone are
insufficient in the explanation of high transmission in this population.4 Individual- (race, age, SES,
behavioral factors), social- (partner characteristics for both main and casual partner, provider care
relationships), and structural- (state policies, access to health care, equality issues) level factors
1

have been shown to be associated with risk of HIV infection.3 MSM have the additional burden of
homophobia, stigma and discrimination solely related to their sexual identity, which may further
increase their risk of HIV acquisition.5-7 Stigma and homophobia have been shown to be negatively
associated with the physical and mental health of MSM, affecting their overall health and their
capacity to seek and access healthcare services as well as potentially shape the quality of the
services that they receive (i.e. type or quality of primary care providers).7-9 However, individuallevel identity, sexual and race/ethnic identity, may influence how MSM react to stigma and
discrimination in their efforts to prevent HIV through mechanisms such as PrEP uptake.
HIV and MSM of Color
MSM of color are the most impacted by HIV, and differences in acquisition among MSM
by race has varied, and in some groups increased over time.10 From 2005 to 2014, HIV diagnoses
in white MSM declined 18% overall, whereas among Hispanic/Latino and African American MSM,
diagnoses rose by 24% and 22% respectively.10 Among young African American MSM (13-24 year
of age) the increase in HIV diagnosis was 87% during this period.10 MSM of color likely identify with
multiple minority identities (sexual and race/ethnicity) and their experiences may differ from that
of those with no or only a single minority identity (e.g. heterosexual ethnic minorities or white
LGBT individuals).11 Research has described that there may be a greater impact on one’s health
behavior of having multiple minority identities than the sum of the impact of each identity
alone.12,13 Compared to white MSM, these differences may influence the way MSM of color reveal
their sexual identity to family and friends as well as healthcare providers, the nature of their
relationships, and how they access HIV-related care.14 Homophobia and same-sex
stigma/discrimination (both internal and external) have been said to be a contributing factor in an
2

individual’s decision to disclose and previous research has found that MSM of color are less likely
than white MSM to identify as gay or disclose same-sex behaviors to others.15 MSM who do not
identify as gay may not be as connected to the LGBTQ+ community, where HIV prevention may
occur. Moreover, providers who often rely on a patient’s self-reported sexual identity may not
accurately assess the risk for STDs and HIV of a non-disclosing patient. Examining MSM of color
and how their intersecting identities are impacted by both racial and sexual minority
discrimination, especially in the places where they reside, may be crucial to understanding their
HIV-risk and protective behaviors, including prevention interventions such as PrEP use.
PrEP and MSM
In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir
disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis
(PrEP) in HIV-negative adults who are at high-risk of HIV infection.16 While PrEP has been found
effective in preventing HIV infection, its impact on the epidemic is contingent on uptake among
those at highest risk. The CDC guidelines recommend that PrEP be offered to people who are HIVnegative and at substantial risk for HIV.17 Specifically for MSM, the CDC recommends PrEP use for
those not in a mutually monogamous relationship with a partner who recently tested HIVnegative, those who are a gay or bisexual man and who have had anal sex without a condom or
been diagnosed with a sexually transmitted infection (STI) in the past 6 month and/or who are in
a HIV-discordant relationship.17 Initial reports regarding PrEP suggest that knowledge of PrEP as
a form of prevention has been limited and the uptake of the drug was initially slow. 18-21 A report
by Gilead Sciences (Truvada’s manufacturer), found that, in the US between January 2012 and
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September 2016, almost 100,000 people started taking PrEP.22 Based on filled prescriptions for
PrEP, the majority of those taking the drug were Caucasian (74%) 23 and men (87%).21,24
Geographically, four states (CA, NY, TX, FL) account for 50.5% of PrEP initiations, with New
York (15.9%) and California (16.7%) accounting for the majority, 24 despite the fact that both Texas
and Florida have higher numbers of new HIV diagnoses.25 Overall, the data suggests that while the
use of PrEP is increasing in the US, uptake is not proportionally aligned with the groups or the
geographic regions where HIV incidence is highest.23,24
Provider challenges
Although increased healthcare access may enhance PrEP uptake, there are still structural
challenges to PrEP use even for those who have access to healthcare. Some studies have shown
issues with provider knowledge of PrEP, while others have focused on the concerns of a provider’s
willingness to prescribe PrEP as a prevention tool,26,27 with the willingness of provision often
varying by race.28 Furthermore, there have been contradictory views about which types of
providers should prescribe PrEP, a condition coined the “purview paradox.” This event occurs
when infectious disease specialists believe that primary care providers are more likely to have
contact with high risk HIV negative patients while primary care providers believe that antiretroviral prescription is in the purview of the infectious disease doctors and may not feel
equipped to discuss sexual behavior.29-32 In any event, this ‘paradox’ leads to fewer providers
informing about PrEP or providing it to patients. Although we believe concerns regarding
behavioral disinhibition to be erroneous and inflated, providers have expressed this concern as
well as concerns about patient adherence and challenges in identifying individuals who would
benefit from the drug.26,31,33 Some providers feel it is only appropriate to prescribe PrEP to
4

serodiscordant couples,26,34 and although this is one recommended group, partners of virally
suppressed individuals may not be the group at highest risk.32,35 Moving forward, it is imperative
that all doctors ask about sexual history and conduct regular HIV/ STI screening while providing
sexual health information in an accurate and nonjudgmental manner.

OVERVIEW AND GAPS IN THE LITERATURE
In order to design effective PrEP programs, it is important to not only understand what
predicts uptake but to also identify barriers to its use among the populations that need it the most.
Previous PrEP studies have often focused on one ecological level or another (i.e. individual or
community) or they have explored predictors on only one level (e.g., individual-level) while making
recommendations on another (e.g., social-, or structural-level).36 Yet, similar to other behaviors
related to disease prevention, it is likely that in addition to individual-level factors, social- and
structural-level factors and the interactions within and between each level may also impact the
use of PrEP.37 Moreover, some factors may be acting as effect modifiers or as mediators in the
associations.
Individual-level factors: In the literature, individual-level factors, including age

38-41,

race/ethnicity 42-44 sexual behavior 42,45,46, and education 42,47, have been explored as predictors of
PrEP acceptability. While some studies found these individual-level factors were associated with
PrEP acceptability, the associations were not consistent across studies and no clear patterns
regarding predictors of acceptability emerged. Similarly, a number of studies explored behavioral
factors such as condomless sex 19,20,45, STI history 42,48 and high number of sexual partners 42,48 as
predictors of PrEP acceptability, again not finding any clear pattern across studies. The
5

contradictions between studies could be attributed to the timing of when the study was conducted
(i.e. pre-or post the release of the efficacy results),19 differences in the population sampled, or the
impact of higher-level contextual factors, such as regional differences in equality for sexual and
other minority groups.49
Social-level factors: In several HIV studies, an individual’s social network has been shown
to influence health and health behaviors to reduce HIV risk behaviors among high-risk, hard-toreach populations, including MSM and MSM of color.50 A number of studies have looked at
relationships between serodiscordant partners, yet there have been limited PrEP studies on MSM
in seroconcordant negative relationships, with both casual or main partners.51 One study found
no difference in the intent to use PrEP among MSM with a main partner compared to those
without partners.52 Another study found that HIV-negative MSM reported an interest in taking
PrEP to protect themselves from an HIV-positive primary partner, regardless of type of relationship
(i.e. monogamous vs. open).53 Despite the increase in interest in PrEP, exploring partner
relationships and the factors that may motivate a person to use PrEP is important, as intimate
relationships may be a key determinant in the decision making.51
Another social factor potentially associated with PrEP use is the doctor-patient
relationship. PrEP requires a prescription, designating providers the gate keepers to PrEP access.
A positive relationship between a doctor and a patient can reinforce a patient’s self-efficacy and
motivate them to decrease risky behavior and increase protective behaviors.54 In a study exploring
the experiences of MSM with healthcare, participants reported that they separate their sexual
healthcare from their primary healthcare due to distrust of providers, fear of judgment and/or
embarrassment.55-57 Any reluctance to disclose sexual identity or discuss sexual behaviors with
6

PCP may discourage and delay care.56,58,59 What is more, the relationship between a doctor and a
patient may also be influenced by structural-level factors, including a state where a person resides.
MSM of color may be particularly distrustful given the history in the US, studies including the
Tuskegee experiments and other harms of black patients by health professionals. These
maltreatments have come to symbolize ethical misconduct and could be contributors to the
mistrust and the disparities in healthcare provision we see today as well as explain why MSM of
color have higher rates of HIV as they are less likely to be provided PrEP.60,61
Structural-level Factors: Environmental and structural-level factors can impact PrEP use
through a number of mechanisms, including the HIV prevalence of a location, income, healthcare
accessibility, and through legislation that discourages equality (i.e. homophobia, racism and
stigma). Inequality may impact individual health seeking behavior 62 as well as other social-level
factors, such as access to appropriate healthcare.52 The impact of these structural-level factors
may be direct and/or indirect and mediated or modified through secondary factors, such as
individual- and social-level factors including relationships with healthcare providers.
Understanding the potential impact state policies and environments have on patient-provider
relationships may help us understand decisions to use PrEP. Furthermore, the relationship
between a doctor and a patient may be influenced by the geographic region, such as the state one
practices/lives in, and the culture and policies of that region. One study found that distrust in
physicians in the US varied by race/ethnicity, with minorities having a higher distrust of physicians
than whites, and by region of residence.63

7

Additional state-level factors, including HIV prevalence, income, health care access, and
cost, are potentially associated with PrEP use and can vary by state. The prevalence of HIV in a
state is a risk factor for HIV transmission as it impacts the likelihood of exposure,10 and this may
impact risk perception and therefore PrEP uptake. In the US, the burden of HIV is not dispersed
evenly across states/regions nor racially/ethnically. In most areas, HIV is concentrated in urban
areas. However, in Southern states, which account for approximately 44% of all people living with
HIV, diagnosis is higher in smaller metropolitan and nonmetropolitan areas.25 Blacks and Latinos
disproportionately reside in the South and are significantly affected by HIV in that area.64,65 There
are a number of factors likely influencing the high HIV prevalence in the Southern states, including
socioeconomic factors such as income inequality, access to healthcare and generally poorer health
outcomes.25,66
Lack of healthcare access can prevent those infected with HIV from being diagnosed, and
when diagnosed, from accessing treatment and controlling their viral load with medication and
those at risk who are HIV-negative from receiving counseling and prescriptions for prevention care
such as PrEP. HIV-positive MSM of color have been are less likely to have access care, be on ARVs
and to have an undetectable viral load than white MSM.67,68 This uncontrolled HIV in the sexual
networks of MSM of color may be another reason for increased risk of acquisition. Furthermore,
state policies may also have an impact on factors that influence HIV prevalence.66 The CDC reports
that southern states have not widely accepted new HIV prevention advances (i.e. newer HIV
testing kits) which could delay the detection of acute HIV diagnosis.66 Delaying diagnosis would
subsequently delay the treatment and increases the likelihood of transmission to others. A high
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HIV prevalence in a region may impact PrEP use by influencing an individual’s HIV risk perception,
as well as influencing the healthcare provider’s opinion on the importance of prescribing the drug.
Healthcare access and ability to pay for PrEP are likely a direct barrier to PrEP uptake.69
People need to be able to see a healthcare provider, to obtain a prescription, and to pay the cost
of the drug. The cost of the drug alone for those without insurance is approximately $17,000 per
year, with additional fees for doctor visits and any ancillary services required. 70 While there are
PrEP assistance programs (both from the state and the pharmaceutical company) they often do
not cover all costs. Some insurance plans, including Medicaid, provide coverage of PrEP. 70
Medicaid expansion at the state-level increased access to healthcare and lowered drug costs for
many,71 however, not all states participated in the expansion. In 2015, 21 states had opted out of
the ACA Medicaid expansion, potentially limiting the access and availability of PrEP in those
states.71 Some of those states are where HIV incidence is at its highest, such as Georgia and Florida,
opted out of the ACA Medicaid expansion.10,71
Lastly, state-level equality policies toward sexual and racial minorities may impact PrEP use
through their influence on minority stress. Minority stress has been shown to be associated with
HIV risk behavior and health seeking behavior overall.72-74 In the US, there are 32 states without
fully inclusive protections for sexual minorities,75 with over 50% of the LGBTQ+ population living
in states with low to negative LGBTQ+ friendly policy scores.76 The systemic discrimination of
LGBTQ+ groups can hinder a person’s motivation or even their ability to get tested for HIV, and
prevent PLWHA from seeking the care and treatment needed to manage their disease and prevent
transmission. State-level inequality may impact PrEP use directly, with the impact likely being
greater on those with dual minority identities. For example, racial inequality may differentially
9

impact racial minorities, while sexual minority inequality may act differently depending on the
sexual identity of an individual. Individuals with both racial and sexual minority identities may be
impacted even more than those with a single minority identity. Thus, state-level equality policies
may modify the association of individual-level factors, such as sexual and racial/ethnic identity, on
PrEP use, underscoring the limitations and potentially severe consequences of considering
individual-level interventions in isolation from larger systemic factors.

OVERVIEW OF THE DISSERTATION
Theoretical Framework – Social Ecological Model
As suggested by the Social Ecological Model (SEM), the motivation, decisions, and
behaviors regarding PrEP use are likely developed through socially structured interactions among
the individual, their social network, and the environment within which they live.77 Individual-level
factors are often shaped by broader structural factors and there has been increasing recognition
of the importance of the social and structural drivers that may motivate someone to use a
prevention intervention, such as PrEP.78 The social theory recognizes that although individuals are
responsible for their own health, an individual’s ability to assume this responsibility may be
influenced by factors on multiple levels. Using the SEM as a backdrop, this dissertation considered
how factors working at and interacting across multiple levels of organization may explain
predictors of why some groups are more likely to use PrEP than other groups. Figure 1 illustrates
how we applied the SEM to PrEP use and how it guided the statistical methodology (i.e. multi-level
modeling) and subsequent analysis.
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Using the SEM, we contextualized individuals’ behaviors

using dimensions made up of the individual- (i.e. demographics and identity), the social- (i.e.
10

behaviors, persons trust in physician, partner factors), and environmental/structural-level (i.e. HIV
prevalence, local, state policies or national statutes) to provide a framework for describing the
impact of factors at different levels and their interactions between levels.50 The overlapping rings
illustrate the porous nature between each level of organization, depicting how they may interact.
Based on the literature and consistent with the SEM, we hypothesized that state-level
characteristics may both be directly and indirectly (i.e. mediation) associated with the use of PrEP.
The specific aims of the dissertation were as follows:

Aims
Aim 1: Examine the predictors of PrEP use at the individual-(sexual identity, racial/ethnic identity,
etc.) and state- (sexual minority equality measures, racism measure, income equality, HIV
prevalence, etc.) levels
•

Sub aim 1a: Assess the extent to which variability in PrEP use by state is due to state- vs.
individual-level factors.

•

Sub aim 1b: Examine the association of individual-level and state-level factors with PrEP
use.

•

Sub aim 1c: Assess interaction among state-level sexual and racial discrimination/equality
measures and individual-level sexual and racial/ethnic identity in predicting PrEP use.

AIM 2: Examine the predictors of PrEP use at individual- and state-levels among only MSM of color
•

Sub aim 2a: Assess the extent to which variability in PrEP use by state is due to state- vs.
individual-level factors.
11

•

Sub aim 2b: Examine the association of individual-level and state-level factors with PrEP
use.

•

Sub aim 2c: Assess interaction among sexual identity and state-level sexual minority
equality in predicting PrEP use.

AIM 3: Examine the relationship among individual- and state-level factors and patient trust in their
physician (PTP) in predicting PrEP use
•

Sub aim 3a: Assess the extent to which variability in PTP by state is due to state vs
individual-level factors.

•

Sub aim 3b: Examine the association of individual-level and state-level factors with PTP.

•

Sub aim 3c: Assess interaction among state-level sexual and racial discrimination/equality
measures and individual-level sexual and racial/ethnic identity in predicting PTP

•

Sub aim 3d: Explore PTP as a mediator of the association between individual- and statelevel factors and PrEP use.

To our knowledge, this is the first study looking at the complex inter-relationship among
factors organized at multiple levels in predicting PrEP use.
CONCLUSION
A thorough exploration of the complicated relationship among the individual-,
interpersonal-, and contextual-level factors and how they may impact PrEP use within the SEM
framework may shed some light on the divergent findings in previous PrEP literature.
Furthermore, the impact that effect modification or mediation may partially explain the
inconsistencies in the predictors of PrEP studies seen in the literature and explain the suboptimal
12

uptake of PrEP. Understanding the multi-levels associated with PrEP use may provide vital
information about the facilitators and barriers to PrEP use so that programs can effectively develop
tailored interventions to address specific populations and ensure that we get the maximum benefit
from this biomedical HIV prevention tool. The aim of this dissertation was to explore the complex
relationship among the described multilevel predictors of PrEP use in a geographically diverse
sample of MSM in the US. Further aims were to identify direct predictors at the individual and
state-level and to assess whether structural characteristics of state of residence, specifically sexual
minority friendly policies and racism measures, modify the association between individual sexual
and racial identity characteristic and PrEP use. Lastly, we wanted to examine whether some of the
associations of these structural-level factors on PrEP use might be mediated through trust in
healthcare provider.
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CHAPTER 2: EXPLORATION OF THE COMPLEX RELATIONSHIP AMONG
MULTILEVEL PREDICTORS OF PREP USE AMONG MEN WHO HAVE SEX
WITH MEN IN THE UNITED STATES
ABSTRACT
Background: Men who have sex with men (MSM) continue to be disproportionately affected by
HIV, however, there is wide variation in HIV incidence in the United States (US). More than half of
new cases occur in MSM of color and in MSM who reside in the southern states. Despite increasing
awareness, pre-exposure prophylaxis (PrEP) use remains low in the US. Studies have explored
associations of individual level factors and PrEP use with inconsistent results. However, there has
been less work evaluating higher-level predictors, such as contextual factors (HIV prevalence,
racial/ethnic and sexual minority equality policies), nor has cross-level interaction been explored
as a possible explanation for the contradictory results.
Methods: Between May 2015-March 2016, a cross-sectional survey was conducted among a
geographically-diverse sample of 4,165 HIV-negative MSM. Participant survey data was linked to
publicly-available state-level data based on participant’s residential zip code. Guided by the socialecological model, multivariable multilevel logistic regression was used to explore the association
of individual-(demographics/behavioral), social-(main partner [MP]), and contextual-(state level
LBGT and racial inequality, HIV prevalence, poverty and insurance coverage) level factors and PrEP
use.
Results: Overall, 13.4% of participants were taking PrEP at time of study. Participants who did not
self-identify as gay had lower odds of PrEP use ([OR=0.489,CI(0.356, 0.672)]. Those with a MP who
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was HIV-positive [OR=4.5,CI(2.880,6.886)] or taking PrEP [OR=16.5,CI(9.670,28.205)] had higher
odds, while participants with HIV-negative MPs not on PrEP [OR=0.5,CI(0.350 0.623) or of
unknown HIV-status [OR=0.3,CI(0.191,0.620)] had lower odds of PrEP use compared to those
without a MP. Participants residing in states with higher LGBTQ equality score had higher odds of
taking PrEP [OR=1.6,CI(1.134,2.215)]. No cross-level interaction was seen.
Conclusions: The LGBTQ equality of a state may be a marker for a more progressive environment
implying that states with more inequality may have structural barriers specific to LGBTQ
populations. Moreover, individual level variables, such as MP social relationships, may be a point
of intervention to improve PrEP use.
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INTRODUCTION
Men who have sex with men (MSM) accounted for approximately 2–3% of the United
States (US) population in 2016, but accounted for 67% (26,844) of the 40,324 new HIV diagnoses.1
In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir disoproxil
fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis (PrEP) in HIVnegative adults who are at high-risk of HIV infection.2 Although PrEP effectively prevents HIV
infection, its impact on the epidemic is contingent on uptake among those at highest risk.

Despite the availability of PrEP, knowledge of it as a form of prevention has been limited,
and uptake has been low and unequally distributed by population subgroups and geographic
region.3-7 The majority of PrEP users in the US are male (95.3%), white (68.7%) and from the
Western part of the US (29.7%).8 However, in 2016, African-American (10,226; 38%) and Latino
(7,689; 29%) MSM accounted for the majority (67%)9 of all new HIV diagnoses, and the Southern
US states experienced the greatest burden of HIV incidence, illness, and deaths compared to other
US regions.10,11 In fact, from 2008 to 2013, nine southern US states have had the highest HIV and
AIDS diagnosis rates in the country.10,12
A number of individual-level factors, including age,13,14 race/ethnicity,15-18 sexual
behavior,13,17,19 and education14,19 have been found to be associated with PrEP use, however, the
associations were inconsistent across studies and no clear patterns emerged. The contradictions
between studies could be due to the impact of higher-level contextual factors working as
confounders or modifiers of the individual-level associations.20 Few studies have looked at equality
of the state and its association with PrEP use. One study explored structural stigma of states in the
22

US, which included an LGBTQ inequality variable in their composite score. This study reported that
state-level LGBTQ structural stigma does impact HIV prevention efforts, including PrEP use, citing
that individuals living in states with lower levels of structural stigma were associated with
increased odd of having heard and of having used PrEP.21
The Social Ecological Model (SEM) suggests that health behavior is influenced by social
interactions between individuals, their social networks, and their environment.22 While individuallevel factors like demographics may impact health seeking behaviors, the impact of these
individual-level predictors could be context specific and may function differently depending on
environmental factors. Thus, it is possible that the impact of individual-level factors may vary by
region in terms of stigma and discrimination against sexual and racial/ethnic minorities, income,
and healthcare access. Examining the factors that influence PrEP use at both the individual- and
state-level, may help explain why uptake is still lagging among those at highest risk. Insight into
the reasons for low PrEP uptake is urgently needed in order to direct resources toward the
populations where PrEP use could have the greatest impact on reducing HIV incidence.
The aim of this study is to explore the complex relationship among individual(demographics), social- (partner characteristics), and contextual- (characteristics of state of
residence) level factors of PrEP use and to assess interaction among selected state-level and
individual-level factors. Few studies have explored the relationship between both the LGBTQ and
the racial equality of the state and PrEP use among MSM and to our knowledge no studies have
explored interactions between multi-level predictors. To address this gap we examined the
complex inter-relationship among factors organized at multiple levels to explore PrEP use with a
specific focus on characteristics of the state in which a person resides.
23

METHODS
Dataset, study population, and data collection
The data for these analyses come from a cross-sectional survey of a geographically-diverse
sample of MSM in the US that was conducted from May 2015 to March 2016. The study methods
have been described elsewhere,23 but the design is briefly presented here. Participants were
eligible for participation in the survey if they were age 18 years or older, cisgender male, and
reported sex with other men in the past 5 years. For this analysis, participants who identified as
HIV-positive were excluded as they would not be eligible for PrEP use.
Participants were recruited in a number of different ways. (1) Online via a sexual
networking website, where a banner was hosted advertising the survey for 30 days; (2) Online via
various internet gay porn sites, where the same banner was used for a period of 39 days; (3)
Mobile devices via a geo-social sexual networking app popular with men-for-men connections,
where we had a pop-up message that was displayed to participants when they opened the app for
the first time during a given 12-hour window; (4) Online via a social networking site popular with
the general public (not primarily oriented toward MSM or about facilitating sexual relationships),
where we ran an advertisement for 11 days; (5) street intercept outside of locations in New York
City frequented by MSM, (6) invitation to participants in a an ongoing panel study of 1,071 HIVnegative MSM identified by a marketing firm. All participants completed a brief self-administered
survey of approximately twenty minutes. Those recruited via street intercept completed the
survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software, and all others
did so online via a personal computer or phone app. The survey included questions about
24

demographic characteristics, including zip code of residence, HIV risk/protective behaviors,
partner characteristics (e.g. main/casual, HIV status, PrEP use, etc.) as well as participant’s use of
PrEP.
Measures
Outcome Variable
The outcome for these analyses was self-reported, current PrEP use at time of survey and
was determined using responses to the question: “What is your HIV status?“ Response options
were: (1) HIV-positive and undetectable, (2) HIV-positive, but detectable, (3) HIV-negative, on
PrEP, (4) HIV-negative, not on PrEP, (5) Don’t know/unsure. Participants who reported they were
HIV-positive were excluded. Participants who reported don’t know/unsure of HIV status were
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP
versus not on PrEP.
Predictor variables- Individual-level factors included demographic and HIV-related behavior
Participant age was self-reported and was examined both as a continuous and a categorical
variable (18-29, 30-39, 40-49 and 50+ years), with categories based on the distribution of the data
to ensure sufficient frequencies in each category. Race and ethnicity were categorized into 5
distinct groups (Hispanic, non-Hispanic Black, non-Hispanic White, non-Hispanic Asian and other).
The ‘other’ category included American Indian, Alaska Native, Native Hawaiian, Pacific Islander and
other and was collapsed due to the small sample sizes in each of these groups. Level of education
was categorized into 3 categories (High school diploma, GED or less; some college, currently
enrolled in college and/or associates degree; 4-year college degree or more). Sexual identity was
examined as four categories in the descriptive analysis (gay, bisexual, heterosexual and other) and
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due to the low numbers within the heterosexual and other groups the variable was collapsed into
an indicator for gay identity versus did not identity as gay for the regression analysis.
Participants were asked about the number of sex partners they had had in the last 3
months, which was categorized into 4 groups (0 partners, 1 partner, 2-5 partners and >5 partners)
based on the distribution of the data. Participants were provided with a list of sexually transmitted
infections (STIs) and asked to indicate which infections they had been diagnosed within the last six
months. The variable was collapsed into an indicator for having been diagnosed with any STI in the
past six months. Similarly for drug use, participants were provided with a list of recreational drugs
(including non-prescribed and prescription drugs) and asked which they had used them in the past
six months and then collapsed into an indicator for any drug use.
Social Factors related to a Main Partner - All participants were asked if they had a main
partner (MP) with whom they were in a committed relationship and if so, their knowledge of their
main partner's HIV and PrEP status. For these analyses we included a 5 category variable for main
partner (MP) status with the following categories: (1) no MP, (2) MP is HIV+, (3) MP and I don't
know their status, (4) MP and they are HIV-negative and on PrEP (5) MP and they are HIV-negative
and not on PrEP.
State-level Characteristics - All state-level measures of HIV prevalence, healthcare access, equality
for sexual and racial/ethnic minorities, and state income were explored for the year 2015.
State HIV prevalence was ascertained from the CDC annual HIV Surveillance Report among
adults and adolescents and was categorized using the CDC ranking.24 Healthcare access was
assessed based on the percent uninsured (via private or government insurance) in each state. Data
was obtained from the Kaiser Family Foundation and modeled as a continuous variable. 25
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The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) equality measure came
from the Human Rights Campaign (HRC) state scorecard which is a report on statewide laws and
policies that affect LGBTQ people and their families.26 The HRC categorizes these scores into four
groups: 1) High Priority to Achieve Basic Equality, 2) Building Equality, 3) Solidifying Equality and
4) Working Toward Innovative Equality. We dichotomized the variable into low (categories 1 and
2) and high (categories 3 and 4) LGBTQ equality states.
To asses state-level structural racism, a measure was used that ranks states by the
proportion of the state’s non-black residents who regard blacks more negatively than the national
median.27 Elmendorf and Spencer et al. created the variable using multilevel regression with poststratification, a statistical technique that has shown to yield estimates of state-level public opinion.
Using their results, each state was ranked from 1-50 with 1 representing the state with the highest
proportion of nonblack residents who are ‘prejudiced overall’.27
State-level poverty was defined using the US Census Bureau's American Community Survey
Briefs for poverty in 2014 and 2015. The poverty rate measures the percentage of people whose
household income fell below their state’s assigned poverty threshold. Poverty thresholds are
assigned to individuals or families based on family size and composition.28
Statistical analysis
Descriptive statistics (means/standard deviations and percentages) were calculated to
describe the individual-, social-, and state-level characteristics of the sample overall and stratified
by PrEP use. To assess bivariate associations with PrEP use, chi-squared (Fishers exact when the
expected cell count is <5) or Wilcoxon rank sum tests were used.
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To examine the association of individual-, social- and state-level characteristics with PrEP
use, we developed crude and multivariable logistic regression models with random intercepts to
calculate odds ratios (ORs) and 95% confidence intervals (CIs) of interest. The level-1 unit was the
participant and the level-2 unit was the state.
Pseudo intraclass correlation coefficients (ICC, or pseudo-ICC) and median odds ratios
(MOR) were calculated in order to assess the extent that variability in PrEP use was due to statevs. individual-level factors. Model 1 was an ‘empty’ model which assessed the extent that the
variability in PrEP use was due to state- vs. individual- level factors (ICC and/or MOR). Model 2
included demographic characteristics (age, race, education, sexual identity), Model 3 included
social factors (number of partners, STIs, main partner’s status). Models 2-3 allowed for the
assessment of the impact of the set of individual-level factors on PrEP use. Model 4, included all
state-level characteristics to examine the association of state-level characteristics with PrEP use.
Model 5 was extended to include all variables into a final model.
To explore whether the intersection of individual sexual and race/ethnic identity with
state-level stigma shapes the use of PrEP, we examined whether there was interaction among
state-level equality measures (LGBTQ and racial scores) and individual-level variables (sexual and
racial/ethnic identity) in predicting PrEP use. The initial analysis explored a 4-way interaction with
all four variables., all possible product terms, including all 2-way, 3-way and 4-way product terms
for all possible combinations of the 4 variables were added to the adjusted model.29 This model
was then compared to 3 other models: 1-the main effects model, 2- model with only all 2-way
interactions and 3-the model with 2- and 3- way interactions. The nested models were evaluated
using p-values at 0.10 level of the interaction terms and AIC values to identify the best fitting
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model.30 Analyses were undertaken using SAS 9.4 with the GLIMMIX macros for binary outcomes
(SAS, Cary, NC, USA).

RESULTS
Description of the sample overall
There were 4,165 HIV-negative participants with 560 (13.4%) participants who reported
taking PrEP at the time of the survey. More than one-third were between 18-29 years old (35.1%)
with the average age being 38.3 years old. More than half of the participants were white (64.8%)
and had a college degree or more (51.6%) and identified as gay (81.8%). The greatest percentage
resided in the South (32.6%). (Table 1)
Less than half (40.5%) of participants reported having a main partner. Of those with a main
partner, 7.6% reported knowledge that their partner was HIV-positive and 6.4% reported
knowledge that their main partner was HIV-negative and taking PrEP. More than half of
participants (64.3%) reported having more than two sexual partners in the past three months and
using drugs in the last three months (69.4%). Over 15% of the participants reported having been
diagnosed with an STI within the last six months. (Table 1)
More than half of the participants lived in states in the two lowest LGBTQ equality
categories (58.5%), in the lowest structural racism category (62.1%) and in the second to lowest
HIV prevalence range (10.0-19.9%) (52.1%). Of the participants in the study, the mean percentage
living in poverty was 14.7% (SD 2.2) and the mean percent uninsured was 9.1% (SD 3.4). (Table 1)
PrEP users
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PrEP use was highest among those age 30-39 (16.6%) compared to 12.8% among those
aged 18-29, 14.5% among 40-49, and 10.7% among those older than 50 years (p=<0.001).
Participants residing in the Northeast (17.3%) were more likely to be taking PrEP as compared to
those from the West (15.0%), South (11.2%), and the Midwest (10.8%) (p=<0.001). Participants
who reported having a 4-year degree or more (17.2%) were more likely to be taking PrEP than
participants who had some college or equivalent (9.9%) or a high school degree, GED or less (8.0%)
(p=<0.001). Participants who identified as gay (14.7%) were more likely to use PrEP as compared
to those who identified as bisexual, straight or other (8.0% vs 0.0% vs. 12.5% p=<0.001).
Participants who had a MP who was currently taking PrEP (75.3%) were more likely to be taking
PrEP than those who had a MP who was HIV-positive (40.3%), those with a MP who was HIVnegative and not on PrEP (6.1%), those who had a MP with an unknown/uncertain HIV status
(5.8%), and those who had no MP (14.2%, p=<0.001). Of the participants who reported having
more than 5 partners in last 6 months, 25.9% were taking PrEP compared to only 13.3% who had
2-5 partners, 4.7% who only had 1 partner and those 3.2% with 0 partners (p=<0.001). Participants
who used drugs in the last 3 months (15.1%) and those who had been diagnosed with an STI
(32.7%) were more likely to take PrEP than their counterparts (9.6% and 11.0%, respectively,
p=<0.001). Of the participants who resided in the states with the second highest LGBTQ equality,
18.4% were taking PrEP compared to those who lived in the highest tiered equality states (16.4%)
and those who lived in the two lowest equality states,10.6% and 10.7%, respectively, (p=<0.001).
Lastly, those who lived in the state with the highest HIV prevalence (20.3%) were more likely to be
taking PrEP as compared to all other groups.
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Multilevel mixed effects model with random effects
Table 2 shows the assessment of variance for each model. Model 1 (empty model/pseudoICC), suggests that 2.4% of the total variance in PrEP use is due to between state differences
whereas 97.6% is explained by individual differences. Models 2 (individual level variables) and 4
(state level variables) suggest that, after adjusting for these respective variables, less than 1% of
variance is due to differences in characteristics between the states while the remaining is due to
unmeasured differences between individual- and state -level characteristics. In contrast, model 3,
which explored social and behavioral characteristics of the individual, showed the greatest
variation. Model 3 suggests that 1.8% of the residual variation in PrEP use that persists is due to
the systematic differences between states while 98.2% is due to individual differences. There is no
ICC nor MOR for Model 5 (full model), as expected, there was not enough variation in the response
to attribute any variation to state or individual effects, controlling for everything else in the
model.31
Crude logistic regression model results
In the univariate models, the odds of taking PrEP among those 30-39 years old were
significantly higher than among those 18-29 [OR=1.33, CI(1.053, 1.685)]. Education was positivelyassociated with PrEP use in a dose response pattern, although the association was significant only
for those with a 4-year degree or more compared to high school diploma, GED or less [OR=2.31,
CI(1.640, 3.242)]. (Table 3)
Participants who had an HIV-positive MP [OR=4.63, CI(3.025, 7.085)] or who’s MP was
taking PrEP [OR=16.30, CI(9.648, 27.525)] had significantly higher odds of PrEP use while
participants with a MP whose HIV status was unknown [OR=0.36, CI(0.208, 0.633)] or whose MP
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was HIV-negative but not taking PrEP [OR=0.40, CI(0.305, 0.516)] had significantly lower odds of
PrEP use compared to those who did not have a MP. PrEP use was positively associated with
number of partners in the past three months, [2-5 partners (OR=3.51, CI(2.260,5.456)] and had >5
partners (OR=7.90 CI5.113, 1.196, versus no partners)]. Similarly, participants who reported drug
use in the last three months [OR=1.64, CI(1.314, 2.037)] or had been diagnosed with an STI in the
last six months [OR=3.97, CI(3.193, 4.935)] had a higher odds of PrEP use. (Table 3)
Participants who lived in a state with more LGBTQ equality [OR=1.71, CI(1.372, 2.139)] and
lived in the states with the highest HIV-prevalence [OR=2.00, CI(1.120, 3.558)] had significantly
higher odds of taking PrEP than those who lived in state with less equality or had an HIV prevalence
less than 10.0%, respectively. (Table 3)
Multivariate logistic regression models results
Table 3 displays five models with covariate-adjusted multilevel logistic regression results
(OR’s and 95% CI’s) for individual-, social-, and/or state- level predictors of PrEP use. In model 2
(Table 3, column 3), the adjusted association of individual-level demographic characteristics with
PrEP use was explored finding significant associations with age, region, race, education, and sexual
identity. The odds of taking PrEP decreased as age increased, with significance only seen among
the oldest group [OR= 0.77, CI (0.586, 1.00)] compared to those 18-29 years old. Participants who
reported that they did not identity as gay were less likely to take PrEP as compared to those who
identified as gay [OR=0.55, CI (0.413, 0.740)]. PrEP use was positively-associated with residence in
the Northeast [OR=1.41, CI(1.025, 1.936)] and the West [OR=1.38, CI(1.014, 1.864) compared to
the South. Those who were Black [OR=1.410, CI(1.024, 1.941)], and who had a 4-year degree
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[OR=2.29, CI(1.617, 3.235)] had higher odds of PrEP use compared to those who were White, and
had a high school diploma or less, respectively.
In model 3 (Table 3, column 4) the association of social behaviors with PrEP use was
explored. Those who had an MP who was HIV-positive [OR=4.6, CI(3.025, 7.085)] and who’s
partner was on PrEP [OR=16.3, CI(9.648, 27.525)] had a higher odds of taking PrEP compared to
those who did not have a main partner at all. Furthermore, those with a MP whose HIV status was
unknown [OR=0.3; CI(0.191, 0.605)] and whose MP was HIV-negative and not on PrEP [OR=0.5;
CI(0.346, 0.607)] had lower odds of taking PrEP compared to participants with no MP. A linear
association with PrEP use was seen with the number of sexual partners in the past three months.
Participants who reported 2-5 partners [OR=3.3 CI(2.083, 5.153)] and greater than 5 partners
[OR=6.7 CI(4.256, 10.388)] had a higher odds of PrEP use compared to those with no partners.
Additionally, participants who reported having used drugs in the last 3 months [OR=1.3; CI(1.044,
1.693)] and who had been diagnosed with an STI in the last 6 months [OR=3.3 CI(2.550, 4.143)]
had a higher odds of taking PrEP compared to those who had not used drugs or been diagnosed
with an STI.
Model 4 (Table 3, column 5) shows the adjusted association of state level characteristics
with PrEP use. Residents of states with the high LGBTQ equality score [OR=1.7, CI(1.316, 2.297)]
and of states with the highest HIV prevalence [OR=1.7, CI(1.047, 2.906)] had higher odds of PrEP
use compared to residents of states with low LGBTQ equality scores and with the lowest HIVprevalence (less than 10.0%), respectively.
Finally, Model 5 (Table 3, column 6) shows the results from the full model with all
individual-, social-, and state-level variables included. Model 5 was similar to the earlier models
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with the exceptions of age, drug use, and prevalence. In model 2, which only included participant
demographics, participants who were >50 years of age had lower odds of taking PrEP than those
18-29 years of age. Conversely, in the adjusted model, participants who were 30-39 [OR=1.3,
CI(1.021, 1.752)] and those who were 40-49 [OR=1.4; CI(1004, 1.834)] were now seen to have
higher odds of using PrEP compared to the youngest group (18-29 years) and older participants
were no longer statistically significant. In regards to the social-level characteristics, all variables
stayed the same as in model 3, with the exception of drug use which was no longer significant in
the final model. Lastly, comparable to model 4, the LGBT equality scored remained significant,
where participants who resided in states with higher LGBTQ equality scores [OR=1.6, CI(1.134,
2.215)] had a higher odds of taking PrEP as compared to those with lower equality scores,
however, states with the second lowest HIV prevalence scores became significant. In the adjusted
model, participants between 10.0-19.9 [OR=0.7, CI(0.451, 0.982)] had lower odds of taking PrEP
compared to states with the lowest HIV-prevalence (less than 10.0), while the higher odds of PrEP
use associated with residing in a state with the highest prevalence rate was no longer statistically
significant in the final adjusted model.
Lastly, all possible four-, three-, and two-way, interactions were tested. Interactions that
were not significant were removed and models were refitted. In the 2-way interaction, the product
term #5 (Sexual identity * Racial equal) was significant at our a priori alpha of 0.1 (p-value =0.0801).
Using the principle of parsimony, the significant 2-way interaction between Sexual identity * Racial
equality was added to the final adjusted model (model 5). The interaction between sexual identity
and racial equality was no longer significant in the absence of the other interaction terms
(p=0.222) and therefore we did not run a stratified analysis.
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DISCUSSION
Applying the concepts from the SEM, the findings from this analysis suggest that there is a
complicated relationship among and between the individual-, social-, and the contextual-level
factors and how they impact who and where in the US PrEP is being used.
Importantly, our findings suggest that contextual-level factors at the state level, specifically
the equality for LGBTQ residents of a state, may be a marker for multiple causal factors or even
play a direct and targeted role in influencing PrEP use among MSM. Characteristics that make a
state more or less equal may be institutionalized through legislation that discourages equality,
impacting sexual minorities risk and health seeking behavior21 as well as hindering access to
appropriate healthcare.32 Such barriers could decrease the awareness or availability of HIV
prevention strategies, such as PrEP, for individuals at highest risk for HIV acquisition.
Previous research has noted that sexual minorities living in states without legal protections
(e.g., same-sex marriage) were more likely to report symptoms of depression, anxiety, and alcohol
use which could lead to adverse health outcomes.33-35 Furthermore, studies that specifically
explored structural stigma and PrEP use have shown that individuals who lived in high structural
stigma states were less likely to have taken PrEP.21 Oldenburg et.al. suggested that states with
higher structural stigma may have reduced awareness about the modalities of PrEP, as well as lack
of access to providers who prescribe the drug.21 The study by Oldenburg and colleagues measured
structural stigma using a composite score addressing a number of dimensions of state prejudicial
social environments which included LGBTQ state policies. Our analysis used a score that focused
specifically on statewide LGBTQ equality laws and policies that affect LGBTQ people and their
families, however, we also included state level characteristics that may influence HIV prevention
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within sexual minority populations to sift through state characteristics and determine if one was
more strongly associated with PrEP use than others. Throughout the analysis, the state-level
LGBTQ equality variable remained strongly associated with PrEP use even after controlling for
multiple factors at the individual- (age, race/ethnicity, educational attainment, and sexual
identity), social- (main-partner status and behavioral factors) and state- (structural racism, HIV
prevalence, poverty rate and percent uninsured) level. The combination of these factors suggests
that equality, or inclusivity of the LGBTQ community in a state may be a particularly important
contributor to the current dynamics of PrEP use. It is possible that MSM who live in more inclusive
states, are more likely to experience better social support through their community and
subsequently may have better physical and mental health outcomes.33,36 In addition, states with
more inclusivity of the LGBTQ community may also have more access to healthcare, specifically
healthcare that focuses on gender/sex specific health. While we adjusted for access to healthcare
via the percent uninsured in the state, a state which is more inclusive to the LGBTQ community
may provide a more open environment for people to disclose their sexual identity and behavior to
their provider increasing the likelihood that someone is more likely to have heard about PrEP, feel
comfortable asking about it, and potentially motivating someone to take it. In the future more
research could look at geographic distance from a participant’s zip code to a PrEP clinic as a
measure of access.
Structural racism is a system which permits privileges associated with “whiteness” and
perpetuates disadvantages associated with “color.”37 It has been conceptualized as state-level
disparities across domains that directly influence mobility in society and/or healthcare and other
resources available for a given racial group.34 There has been a considerable amount of research
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showing that MSM of color often feel isolated from the broader LGBTQ communities or have
experienced racism and discrimination within them.38,39 Our findings showed that the structural
racism score was not significantly associated with PrEP use. While race and racism may play a
strong part of who is taking PrEP, racism of a state is difficult to measure in a single variable and
may not have been captured with the variable used in this analysis.
Overall, social and behavioral variables were strongly associated with PrEP use. Participants
with a MP who was HIV-positive or who was currently taking PrEP were more likely to be taking
PrEP themselves. Our results are consistent with other research conducted among serodiscordant
couples where it was shown that HIV-specific social support within couples was associated with
fewer reported HIV risk behaviors,40 and may suggest that intimate relationships can foster
improved risk reduction behaviors.41 We hypothesize that there potentially may be increased
communication, awareness, and education about HIV and HIV prevention between partners
where one is either taking ART or using PrEP. In addition, participants who reported more sexual
partners or who had received an STI diagnosis in the last 6 months were more likely to have been
taking PrEP at the time of the study. Among PrEP users, high rates of STIs have been reported and
concerns have been raised that PrEP use may be linked with an increase in STI incidence due to
risk compensation.42 In this context, risk compensation is defined as the PrEP users’ perception of
decreased risk of acquiring HIV which may lead to engagement in riskier sexual behavior and
subsequently increasing the likelihood of acquiring an STI.42 Other studies have cited that PrEP
does not necessarily lead to increases in risky behavior, but rather that PrEP brings into care a
population of MSM who are already at high risk for HIV and STIs.43 While our analysis is unable to
determine if the STI occurred before or after the initiation of PrEP, if PrEP is associated with an
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increase in STI rates or higher partner numbers, this would suggest the need to increase risk
reduction counseling when prescribing PrEP.
Overall, social/behavioral variables were strongly associated with PrEP use. Participants
with MP’s who were HIV-positive or were currently taking PrEP were more likely to be taking PrEP
themselves. This may be related to HIV-specific social support within couples. Johnson et al. found
that among serodiscordant couples, HIV-specific support within the couple was associated with
fewer HIV-risk behaviors and greater self-reported ART adherence.41 Interestingly, participants
who had HIV-negative MPs not taking PrEP or who were unaware of their MPs HIV-status were
less likely to be taking PrEP than people with no MP. These findings build on others who have
found that intimacy motivations may play a role in PrEP adoption for MSM couples 44 and suggest
that understanding the impact of intimate relationship characteristics on sexual risk prevention
decision making is an avenue for further exploration.
Participants who reported a recent STI diagnosis, were more likely to have been taking
PrEP. We are unable to deduce whether the STI was the impetus to begin using PrEP or whether
those on PrEP were more likely to be screened for an STI as part of their PrEP care. However,
among PrEP users, high rates of STIs have been reported and concerns have been raised that PrEP
use may be linked with an increase in STI incidence due to increased unprotected sex. 42 Other
studies have found that PrEP does not necessarily lead to increases in risky behavior, but rather
that PrEP brings a population already at high-risk for HIV and STIs into more intensive care where
STIs are more routinely screened for and treated.42 Nevertheless, the results suggest the need to
increase risk-reduction counseling when prescribing PrEP.
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Lastly, US region, race, education, and sexual identity were all associated with PrEP use in
the first models. However, when both social and contextual factors were added to the model, only
age, education and identity remained significant. Participants between 30-50 years old and with a
college degree were more likely to be taking PrEP than those who were in the youngest group (less
than 30) and those with a high school diploma or less, respectively. Moreover, men who reported
that they did not identity as gay were shown to be less likely to be taking PrEP as compared to
those who reported that they were gay. We posit that all three variables may be linked to exposure
to the LGBTQ community and moreover exposure to PrEP and information about its efficacy. Older
and more educated MSM may have more increased knowledge of HIV and HIV risk, improved
access to healthcare and may be more likely to feel at ease disclosing their sexual identity and
their sexual behavior to their providers facilitating improved knowledge and access to PrEP. On
the other hand, participants who did not identify as gay may not be as integrated into the LGBTQ
community and therefore may not receive information regarding HIV risk and prevention
interventions, such as PrEP. In addition, this group may be less comfortable disclosing their risk
behavior to providers and therefore less likely to be prescribed PrEP.
Limitations
There are a number of potential limitations that should be mentioned. First the data is
from a cross-sectional study. Analyses from cross-sectional studies are often not able to determine
causal relationships as it is impossible to establish a temporal relationship between the exposure
and the outcome. For example, a participant could have lived in a state with high equality and
initiated PrEP and then moved to a state with low equality and continued taking PrEP, making a
causal relationship impossible to be determined in this type of analysis. Another limitation is social
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desirability bias. Taking PrEP has been associated with the stigma of being related to HIV-risk and
has been given the reputation of enabling promiscuity, inconsistent condom use, and unsafe sex.45
Therefore the sensitive nature of some of the questions regarding drug use, partner number, or
even the outcome, PrEP use, may lead some respondents to answer incorrectly. Furthermore, the
outcome, PrEP use, could also potentially be a source of outcome misclassification. The outcome
variable asked if the participant was currently taking PrEP, with no information on whether the
participant had taken the drug in the past. Both of these limitations could result in potential
misclassification or underreporting of PrEP use. Another limitation is that the study relied on selfreported data, once again potentially leading to misclassification due to recall error,
misunderstanding of the questions, or error in entering the response and the reported information
cannot be verified. However, given that the surveys were self-administered, false reporting is likely
to be minimal. There may also be some error in the state-level variables. Many of the constructs
in the analysis do not have an accepted definition or validated measurement and we relied on
measures that may include some misclassification of our exposure or have issues with construct
validity. Importantly, while the analysis recruited participants from all 50 states, recruitment was
mainly conducted online and are not representative of all MSM in the US. Lastly, the statistics used
to quantify fitness (i.e. deviance statistics, AIC, BIC and pseudo-R2) of a MLM with a dichotomous
outcome are often difficult to interpret. However, while there are other statistical models which
will account for clustering of data, our interest in this study was to identify level II units (LGBTQ
equality and structural racism of a state) that are associated with PrEP use and not just a
population average. At this time, MLM is the best statistical method that can accomplish both.
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CONCLUSION
Previous studies on PrEP use were often limited to participants in clinical trials and
demonstration projects and mostly focused on high-risk populations.46 This study is one of very
few which have looked at the impact of contextual (state-level) equality on PrEP use in a ‘real’
world setting in which PrEP is generally available. Our findings suggest that LGBTQ+ equality of the
state may influence PrEP use. The equality landscape in the US varies greatly by state, and while
recent laws had been moving towards increased equality country wide, in the current political
environment, many LGBTQ+ rights are being rolled back at the federal and state levels. 47 The
findings of this study suggest that increasing inequality for LGBTQ+ people may have a negative
impact on PrEP use and could limit our ability to meet the goals put forward by the US President
to end the HIV epidemic in the US.48
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TABLES AND FIGURES
Table 2 - 1. Description of individual-, social-, and state-level characteristics overall and by PrEP
use.
non-PrEP
PrEP user
Characteristics
Total
Total
users
p-Value
560 (13.4%)
3605 (86.6%)
Individual
level
characteristics
Age
4165
Mean (SD)
38.3 (13.8)
38.39 (14.0)
37.64 (12.2) <0.001*
Median (Range)
35.0 (65.0)
Age, n (%)
4165
18-29
1461 (35.1)
1274 (87.2)
187 (12.8)
0.001
30-39
929 (22.3)
775 (83.4)
154 (16.6)
40-49
750 (18.0)
641 (85.5)
109 (14.5)
>50
1025 (24.6)
915 (89.3)
110 (10.7)
Recruitment, n (%) site
4165
Sexual networking website
724 (17.4)
650 (89.8)
74 (10.2)
<0.001
general social networking
372 (8.9)
326 (87.6)
46 (12.4)
website
Street intercept
266 (6.4)
200 (75.2)
66 (24.8)
Geo-social sexual
networking
1594 (38.3)
1362 (85.4)
232 (14.6)
phone app
Online Gay Porn sites
378 (9.1)
340 (89.9)
38 (10.1)
panel study participants
831 (20.0)
727 (87.5)
104 (12.5)
US Region of residence, n
(%)
4165
Northeast
996 (23.9)
824 (82.7)
172 (17.3)
<0.001
Midwest
827 (19.9)
738 (89.2)
89 (10,8)
South
1359 (32.6)
1207 (88.8)
152 (11.2)
West
983 (23.6)
836 (85.0)
147 (15.0)
Race/ethnicity, n (%)
4164
Native American / Alaskan
/ Hawaiian / Pacific
214 (5.1)
186 (86.9)
28 (13.1)
0.266
Islander / Other
Black
336 (8.1)
278 (82.7)
58 (17.3)
Hispanic
748 (18.0)
656 (87.7)
92 (12.3)
Asian
167 (4.0)
146 (87.4)
21 (12.6)
White
2699 (64.8)
2339 (86.7)
360 (13.3)
Education, n (%)
4165
45

Characteristics

Total

High School Diploma, GED,
or less
Some College, Associates
Degree, or currently
enrolled in college
4-Year College Degree or
more
Sexual Identity, n (%)
4165
Gay
Bisexual
Straight
Other
Social-level Characteristics
Main Partner Status, n (%)
4165
No Main Partner (MP)
MP is HIV-positive
MP HIV status unknown or
uncertain
MP HIV negative and on
PrEP
MP HIV negative and not
on PrEP
Number of partners in past
4165
3 months, n (%)
0
1
2-5
>5
Drug use in the last 3
4165
months, n (%)
No
Yes
STD in past 6 months, n (%)
3487
No
Yes
State-level Characteristics
Equality , n (%)
Human Rights Campaign
4165
State Equality Index1

Total

non-PrEP
users
3605 (86.6%)

PrEP user
560 (13.4%)

p-Value

528 (12.7)

486 (92.0)

42 (8.0)

<0.001

1476 (35.4)

1330 (92.1)

146 (9.9)

2161 (51.9)

1789 (82.8)

372 (17.2)

3407 (81.8)
671 (16.1)
29 (0.9)
48 (1.2)

2907 (85.3)
617 (92.0)
39 (100.0)
42 (87.5)

500 (14.7)
54 (8.0)
0 (0.0)
6 (12.5)

<0.001

2479 (59.5)
124 (3.0)

2128 (85.8)
74 (59.7)

351 (14.2)
50 (40.3)

<0.001

244 (5.9)

230 (94.3)

14 (5.8)

93 (2.2)

23 (24.7)

70 (75.3)

1225 (29.4)

1150 (93.9)

75 (6.1)

574 (13.8)
995 (23.9)
1459 (35.0)
1137 (27.3)

550 (95.8)
948 (95.3)
1265 (86.7)
842 (74.1)

24 (4.2)
47 (4.7)
194 (13.3)
295 (25.9)

<0.001

1273 (30.6)
2892 (69.4)

1151 (90.4)
2454 (84.9)

122 (9.6)
438 (15.1)

<0.001

2958 (84.8)
529 (15.2)

2632 (89.0)
356 (67.3)

326 (11.0)
173 (32.7)

<0.001
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Characteristics

Total

Total

non-PrEP
users
3605 (86.6%)

PrEP user
560 (13.4%)

Working Toward
955 (22.9)
798 (83.6)
157 (16.4)
Innovative Equality
Solidifying Equality
773 (18.6)
630 (81.5)
143 (18.5)
Building Equality
376 (9.0)
336 (89.4)
40 (10.6)
High Priority to Achieve
2061 (49.5)
1841 (89.3)
220 (10.7)
Basic Equality
Structural Racism1, n (%)
4165
Low equality
2586 (62.1)
2255 (87.2)
331 (12.8)
High equality
1579 (37.9)
1350 (85.5)
229 (14.5)
Prevalence, n (%)
<10.0%
4165
1094 (26.3)
961 (87.8)
133 (12.2)
10.0% - 19.9%
2170 (52.1)
1852 (85.4)
318 (14.7)
20.0% - 29.9%
738 (17.7)
662 (89.7)
76 (10.3)
>/=30%
163 (3.9)
130 (79.8)
33 (20.3)
2
Poverty Rate
4165
Mean (SD)
14.7 (2.2)
14.7 (2.2)
14.8 (2.0)
Median (Range)
15.3 (13.8)
15.3 (13.8)
15.4 (13.8)
Percent Uninsured3
4165
Mean (SD)
9.1 (3.4)
9.2 (3.5)
8.7 (3.3)
Median (Range)
8.6 (14.3)
8.6 (14.3)
7.1 (14.3)
*Wilcoxon rank sum test p-value
1Human Rights Campaign (HRC) state scorecared
2Elmendorf and Spencer variable
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population 80

p-Value
<0.001

0.118

0.0007

0.349*

0.005*
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Table 2 - 2. Results of multilevel logistic regression models with random intercept with variables
entered in blocks by level
Model Summary
Ʈ2 of random
effects
VPC or ICC
MOR
PCV
Fit Statistics
AICC
BIC

Model1

Model 2

Model 3

Model 4

Model 5

0.0803

0.0160

0.0593

0.00496

0

0.024
1.31

0.005
1.13
80.1

0.018
1.26
26.1

0.002
1.07
93.8

0
1

3221.9
3272.34

3192.54
3223.76

2658.99
2680.17

3255.27
3272.61

2595.47
2652.97

PCV: proportional change of the variance, VPC: variance partition coefficient, ICC: intra class
coefficient, MOR: median odds ratio
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Table 2 - 3. Crude and covariate adjusted associations between individual, interpersonal, and structural level variables and PrEP use.
Mod
Variables
Bivariate
Model 2
Model 3
Model 4
Model 5
el1
OR (CI)
OR (CI)
OR (CI)
OR (CI)
OR (CI)
ICC
P-value
P-value
P-value
P-value
P-value
Individual-level Characteristics
Age
18-29
30-39
40-49
>50
US Region of
residence
South
Northeast
Midwest
West

REF
1.3 (1.053, 1.685)
0.017
1.2 (0.933, 1.566)
0.150
0.9 (0.665, 1.108)
0.238

REF
1.2 (0.927, 1.498)
0.178
1.1 (0.838, 1.425)
0.58
0.8 (0.586, 1.000)
0.050

REF
1.3 (1.021, 1.753)
0.003
1.34 (1.004, 1.834)
0.047
0.9 (0.694, 1.282)
0.705

REF
1.4 (0.992, 2.032)
0.055
0.9 (0.661, 1.317)
0.686
1.3 (0.934, 1.838)
0.1152

REF
1.4 (1.025, 1.936)
0.036
1.0 (0.721, 1.355)
0.940
1.4 (1.014, 1.864)
0.041

REF
1.3 (0.822, 2.138)
0.240
1.0 (0.640, 1.641)
0.917
1.1 (0.645, 1.725)
0.829

REF
1.4 (0.932, 1.740)
0.128

REF
1.4 (1.024, 1.941)
0.035

REF
1.4 (0.992, 2.048)
0.554

Race/ethnicity
White
Black

49

Hispanic
Asian
Native
American /
Alaskan /
Hawaiian /
Pacific
Islander /
Other
Education
High School
Diploma, GED,
or less
Some
College,
Associates
Degree, or
currently
enrolled in
college
4-Year
College Degree
or more
Sexual Identity
Gay
Did not
identify as gay

0.9 (0.662, 1.101)
0.221
0.8 (0.515, 1.349)
0.456

0.9 (0.708, 1.198)
0.537
0.7 (0.421, 1.115)
0.127

1.0 (0.726, 1.306)
0.859
0.7 (0.430, 1.268)
0.269

1.0 (0.640, 1.481)
0.900

1.0 (0.658, 1.543)
0.971

1.1 (0.677, 1.730)
0.740

REF

REF

REF

1.3 (0.876, 1.815)
0.210

1.2 (0.850, 1.769)
0.273

1.0 (0.686, 1.518)
0.920

2.3 (1.640, 3.242)
<0.001

2.3 (1.617, 3.235)
<0.001

1.8 (1.208, 2.560)
0.004

REF
0.5 (0.388, 0.692)
<0.001

REF
0.6 (0.413, 0.740)
<0.001

REF
0.5 (0.356, 0.672)
<0.001

Interpersonal-level Characteristics
50

Main Partner
Status
No Main
Partner (MP)
MP is HIVpositive
MP HIV
status
unknown or
uncertain
MP HIV
negative and
on PrEP
MP HIV
negative and
not on PrEP
Number of
partners in
past 3 months
0
1
2-5
>5
Drug use in the
last 3 months
No
Yes

REF

REF

REF

4.1 (2.781, 5.999)
<0.001

4.6 (3.025, 7.085)
<0.001

4.5 (2.879, 6.882)
<0.001

0.4 (0.208, 0.633)
<0.001

0.3 (0.191, 0.605)
<0.001

0.3 (0.191, 0.621)
<0.001

19.0 (11.562, 31.130)
<0.001

16.3 (9.648, 27.525)
<0.001

16.5 (9.661, 28.188)
<0.001

0.4 (0.305, 0.516)
<0.001

0.5 (0.346, 0.607)
<0.001

0.47 (0.350, 0.623)
<0.001

REF
1.1 (0.675, 1.866)
0.654
3.5 (2.260, 5.456)
<0.001
7.9 (5.113, 12.196)
<0.001

REF
1.3 (0.756, 2.240)
0.340
3.3 (2.083, 5.153)
<0.001
6.7 (4.256, 10.388)
<0.001

REF
1.7 (0.669, 2.007)
0.597
3.2 (1.994, 4.974)
<0.001
6.7 (4.275, 10.529)
<0.001

REF
1.6 (1.314, 2.037)
<0.001

REF
1.3 (1.044, 1.693)
0.022

REF
1.2 (0.922, 1.637)
0.058
51

STD in past 6
months
No

REF
Yes
4.0 (3.193, 4.935)
<0.001
State-level Characteristics
Equality
HRC state
Equality Index1
Low equality
High equality
State Racism2
High state
racism
Low state
racism
HIV Prevalence
Rate per
100,000, n (%)
<10.0
10.0% - 19.9
20.0% - 29.9
≥30
Poverty Rate3

REF
3.3 (2.550, 4.143)
<0.001

REF
3.2 (2.461, 4.055)
<0.001

REF
1.7 (1.372, 2.139)
<0.001

REF
1.6 (1.216, 2.108)
0.001

REF
1.6 (1.119, 2.203)
0.010

REF

REF

REF

1.4 (1.117, 1.860)
0.006

1.3 (0.978, 1.651)
0.072

1.0 (0.726, 1.473)
0.085

REF
1.0 (0.777, 1.430)
0.729
0.8 (0.540, 1.249)
0.349
2.0 (1.120, 3.558)
0.020
1.0 (0.938, 1.010)
0.743

REF
1.0 (0.758, 1.289)
0.930
1.0 (0.6559, 1.542)
0.969
1.8 (1.107, 2.963)
0.019
1.0 (0.965, 1.072)
0.522

REF
0.7 (0.511, 0.991)
0.045
0.8 (0.432, 1.303)
0.299
1.4 (0.731, 2.624)
0.309
1.0 (0.977, 1.1099)
0.230
52

Percent
Uninsured4

1.0 (0.930, 1.010)
0.132

Ʈ2 *

Mod
el1
0.080

VPC or ICC
MOR

2.4
1.31

Model Summary

PCV
Fit Statistic
AICC

1.0 (0.957, 1.053)
0.872

1.0 (0.962, 1.086)
0.472

Model 2

Model 3

Model 4

Model 5

0.016

0.059

0.005

0

0.485
1.13

1.77
1.26

0.15
1.07

0
1

80.1

26.1

93.8

0

3221.
3192.54
2658.99
3255.27
2595.47
9
BIC
3272.
3223.76
2680.17
3272.61
2652.97
34
1Human Rights Campaign (HRC) state scorecard
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population
*Estimated variance of random effect
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CHAPTER 3: EXPLORATION OF MULTILEVEL PREDICTORS OF PREP USE
AMONG MEN WHO HAVE SEX WITH MEN OF COLOR IN THE UNITED
STATES
ABSTRACT
Background: HIV incidence in the United States (US) is highest among MSM of color. However,
Black and Latinos receive fewer PrEP prescriptions than Whites. Studies to date have focused on
individual- and social-factors driving this inequity, but structural racism and anti-LBGT+ stigma may
also play a role.
Methods: Data from a 2015-2016 cross-sectional survey conducted among a geographicallydiverse sample of HIV-negative MSM in the US was linked to publicly-available state-level data on
zip code of residence. Multivariable multilevel logistic regression was used to explore the
association between PrEP use and individual-, social-, and state-level factors among MSM of color.
Results: Of the 1,465 HIV-negative MSM of color, 13.6% were currently taking PrEP. In the final
regression model, residents of states with high LGBTQ+ equality had significantly higher odds
[OR=2.0, CI(1.058, 3.720)] of PrEP use compared to residents of states with low equality even after
adjusting for individual- and social-level characteristics of participants.
Conclusions: State-level LGBTQ+ inequality may operate as a barrier to PrEP use in MSM of color.
Reducing institutionalized LBGT+ inequality coul be an important initiative to help the US achieve
its goal to end the HIV epidemic.
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INTRODUCTION
Black and Latino men who have sex with men (MSM) are the group most affected by HIV
in the United States (US).1 It is estimated that in their lifetime, one-in-two Black and one-in-four
Latino MSM will be diagnosed with HIV, compared to one-in-eleven White MSM.2 In 2012, the use
of the medication tenofovir disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) was
approved as pre-exposure prophylaxis (PrEP) in HIV-negative adults who are at high-risk of HIV
infection.3 Despite its effectiveness, reports have found that PrEP prescriptions are reaching only
a small proportion of those who could benefit from the drug and prescription rates among those
eligible vary both by race and geographic region.4
In 2016, Black and Latinos accounted for the smallest percentage of PrEP prescriptions to
date and although the South had 52% of new HIV diagnoses, only 27% of PrEP users were from
the South.5 Structural barriers such as racism, anti-immigration sentiment, homophobia, and
socio-economic factors can prevent MSM of color from either seeking or accessing needed
healthcare and/or treatment.6 Furthermore, these barriers may be working together
synergistically to hinder engagement in HIV prevention strategies, such as PrEP. Given the cultural,
political and legal diversity by state in the US, some of the barriers faced by MSM of color may vary
depending on the geographic region of residence.7,8 One study in the southern US found that
compared to Black and White persons, Latinos were more likely to enter into HIV care late in the
course of their infection with a majority of those presenting with several AIDS-defining
events/conditions.9
MSM of color, likely identify with multiple minority identities (i.e. sexual, racial, ethnic) and
the barriers and stigma they experience may differ from that of those with a single minority
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identity (i.e. heterosexual ethnic minorities or White LGBT individuals).10 This concept has been
coined ‘intersectional stigma,’ and recent studies have shown that there is a greater impact on
health with persons with multiple minority identities than the sum of the impact of each identity
alone.11-13 A study among HIV-positive young Black MSM explored the interplay between sexual
health and two forms of stigmas-HIV and sexual minority stigma. The study found participants
were at risk for experiencing multiple domains of stigma related to both their HIV status and their
sexual identity, moreover, those who reported higher levels of stigma also reported more
unprotected sex while under the influence of drugs or alcohol.14
Factors that may contribute to the geographic epidemic in the South, specifically among
MSM of color, include pervasive and multi-layered HIV-related stigma, poverty, high levels of
sexually-transmitted infections (STI) including HIV, racial and ethnic discrimination, poor access to
health and social services, and laws that further HIV-related stigma and fear, such as HIV
criminalization.15 Examining how the intersecting identities of MSM of color are impacted by both
racial and sexual minority discrimination in the places where they reside may be crucial to
understanding barriers to PrEP use for those who need it the most.
There are few studies that have explored the impact of both state-level LGBTQ and racial
equality and PrEP use among MSM of color, and to our knowledge, none have assessed interaction
among measures of state-level stigma and individual-level factors. To address this gap, we
examined the complex inter-relationship among factors organized at the state-, social-, and
individual-levels on PrEP use among MSM of color in the US.
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METHODS
Study sample and data collection
The data for these analyses come from a cross-sectional survey of a geographically-diverse
sample of MSM in the US that was conducted from May 2015 to March 2016. The study methods
have been described elsewhere16 but the design is briefly presented here. Participants were
eligible if they were age 18 years or older, cisgender male, and reported sex with other men in the
past 5 years. As this paper focuses on predictors of PrEP use among MSM of color, participants
who identified as White and who indicated that they were HIV-positive were excluded from this
analysis.
Participants were recruited via six different methods: (1) Online via a sexual networking
website, where a banner was hosted advertising the survey for 30 days; (2) Online via various gay
porn internet sites, where the same banner was used for a period of 39 days; (3) Mobile devices
via a geo-social sexual networking app popular with men-for-men connections, where we had a
pop-up message that was displayed to participants when they opened the app for the first time
during a given 12-hour window; (4) Online via a social networking site popular with the general
public, where we ran an advertisement for 11 days; (5) Street intercept outside of locations in New
York City frequented by MSM; (6) An invitation to participants in a an ongoing panel study of 1,071
HIV-negative MSM identified by a marketing firm. All eligible participants completed a brief selfadministered survey that took approximately twenty minutes. Those recruited via street intercept
completed the survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software,
and all others did so online via a personal computer or phone app. The survey included questions
about demographic characteristics, including zip code of residence, HIV risk/protective behaviors
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including current PrEP use, and partner characteristics (e.g. main/casual, HIV status, PrEP use,
etc.).
Measures
Outcome
The outcome for these analyses was self-reported, current PrEP use at time of survey and
was determined using responses to the question: “What is your HIV status?“ Response options
were: (1) HIV-positive and undetectable, (2) HIV-positive, but detectable, (3) HIV-negative, on
PrEP, (4) HIV-negative, not on PrEP, (5) Don’t know/unsure. Participants who reported they were
HIV-positive were excluded. Participants who reported don’t know/unsure of HIV status were
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP
versus not on PrEP.
Predictor variables -Individual-level factors included demographic and HIV-related behavior
Participant age was self-reported and was examined both as a continuous and a 4 category
variable (18-29, 30-39, 40-49 and 50+ years), with categories based on the distribution of the data
to ensure a sufficient number in each category. Race and ethnicity were categorized into 4 distinct
groups (Black, Hispanic, Asian, and other). The ‘other’ category included American Indian, Alaska
Native, Native Hawaiian, Pacific Islander and other, which were combined due to the small sample
sizes in each of these groups. Level of education was examined in 3 categories (High school
diploma, GED or less; some college, currently enrolled in college and/or associates degree; 4-year
college degree or more). Sexual identity was examined as three categories in the descriptive
analysis (gay, bisexual, and other) and due to the low numbers, the variable was dichotomized into
an indicator for gay identity versus did not identity as gay for the regression analysis.
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Behavioral characteristics included the number of sex partners and drug use in the last
three months as well as diagnosis with any sexually transmitted infection (STI) in the last six
months. The number of sex partners was categorized into 4 groups (0 partners, 1 partner, 2-5
partners and >5 partners) based on the distribution of the data. To assess STIs and drug history,
participants were provided a list of STIs and recreational drugs (including non-prescription and
prescription) and were asked to indicate which infection they had been diagnosed with and which
drugs they had used in the respective time period. STIs and drug use were both dichotomized into
an indicator for any STI or drug use.
Social Factors related to a Main Partner
All participants were asked if they had a main partner (MP) with whom they were in a
committed relationship and if so, their knowledge of their MPs HIV and PrEP status. For these
analyses we included a five category variable for MP status with the following categories: (1) no
MP, (2) MP is HIV+, (3) MP and I don't know their status, (4) MP and they are HIV-negative and on
PrEP (5) MP and they are HIV-negative and not on PrEP.
State-level Characteristics - All state-level measures used were from 2015.
State HIV prevalence - State HIV prevalence was ascertained from the CDC annual HIV
Surveillance Report among adults and adolescents and was categorized using the CDC ranking.17
Healthcare access - In 2012, the Supreme Court's ruling on the Affordable Care Act (ACA) allowed
states to opt out of the law's Medicaid expansion mandate. Healthcare access was assessed based
on whether in 2015, the state had adopted the Medicaid expansion

mandate and was

dichotomized to yes or no.18
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LGBTQ+ equality - The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ)
equality measure came from the Human Rights Campaign (HRC) state scorecard. The HRC assigns
a score based on statewide laws and policies that affect LGBTQ people and their families. 19 The
HRC categorizes these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building
Equality, 3) Solidifying Equality and 4) Working Toward Innovative Equality. We dichotomized the
variable into low (categories 1 and 2) and high (categories 3 and 4) LGBTQ equality states.
Racism - To asses state-level racism, a measure was used by Elmendorf and Spencer and
colleagues that ranks states by the proportion of the state’s non-Black residents who regard Blacks
more negatively than the national median.20 They created a using multilevel regression with poststratification, a statistical technique that has shown to yield estimates of state-level public opinion.
With their results, each state was ranked from 1-50 with 1 representing the state with the highest
proportion of non-Black residents who are ‘prejudiced overall’.20
State-level poverty – State level poverty was defined using the US Census Bureau's
American Community Survey Briefs for poverty in 2014-2015. The poverty rate measures the
percentage of people whose household income fell below their state’s assigned poverty threshold.
Poverty thresholds are assigned to individuals or families based on family size and composition.21
Statistical analysis
Descriptive statistics (means/standard deviations and percentages) were calculated to
describe the individual-, social-, and state-level characteristics of the sample overall and stratified
by PrEP use. To assess the statistical significance of differences in PrEP use, chi-squared or
Wilcoxon rank sum tests were used.
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We then developed crude and multivariable multilevel logistic regression models with
random intercepts to calculate crude and adjusted odds ratio (OR and AOR) and 95% confidence
intervals (CIs) for the association of each independent variable with the outcome of current PrEP
use. The level-1 unit was the participant and the level-2 unit was the state.
Pseudo intraclass correlation coefficients (ICC, or pseudo-ICC) and median odds ratios
(MOR) were calculated in order to assess the extent that variability in PrEP use was due to statevs. individual-level factors. Model 1 was an ‘empty’ model. Model 2 included demographic
characteristics (age, race, education, sexual identity), Model 3 included interpersonal/social
factors (number of partners, STIs, main partner’s status). Models 2 - 3 allowed for the assessment
of the impact of the set of individual- and social level factors on PrEP use. Model 4, included all
state-level characteristics to examine the association of state-level characteristics with PrEP use.
Model 5 was extended to include all variables into a final model.
To explore whether the intersection of individual sexual and race/ethnic identity interacts
with state-level stigma to shape PrEP uptake, we examined whether there was interaction among
state-level equality measures (LGBTQ and racial scores) and individual-level variables (sexual and
racial/ethnic identity) in predicting PrEP use. The initial analysis explored a 4-way interaction with
all four variables by adding all possible product terms, including all 2-way, 3-way and 4-way
product terms for all possible combinations of the 4 variables, to the adjusted model.22 This model
was then compared to 3 other models: 1-the main effects model, 2- model with only all 2-way
interactions and 3-the model with 2- and 3- way interactions. The significance of interaction was
assessed at alpha=0.10 due to the reduced power when testing for interaction.23 All main effects
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were tested at alpha=0.05. Analyses were undertaken using SAS 9.4 and PROC GLIMMIX for binary
outcomes (SAS, Cary, NC).

RESULTS
Description of the sample overall
Out of 1,465 HIV-negative MSM of color included in the analysis, 199 (13.6%) reported
taking PrEP at the time of the survey. Almost half of the participants were between 18-29 years
old (49.3%) with the average age being 32.9 years old. More than half of the participants were
Hispanic (51.1%) and identified as gay (81.2%). The greatest percentage resided in the South
(32.6%) and reported having a college degree or more (44.4%). (Table 1)
More than half of the participants reported not having a MP (63.8%). Of those with a MP
(N=530, 36.2%), the majority reported having a MP who was HIV-negative and not on PrEP (N=377,
71.1%), while 7.4% (N=39) reported knowledge that their partner was HIV-positive and 4.5%
(N=24) reported knowledge that their MP was HIV-negative and taking PrEP. More than half of
participants reported having more than one sexual partner (62.2%) and using drugs (67.7%) in the
past three months. Over 15% of the participants reported having been diagnosed with an STI
within the last six months. (Table 1)
Over half of the participants lived in states with the lowest LGBTQ+ equality (50.4%), the
lowest structural racism (56.3%), in the second to lowest HIV prevalence range of 10.0-19.9 per
100,000 (56.7%), and lived in the states which participated in Medicaid expansion offered by the
ACA (65.7%). The mean poverty rate of the states in which participants lived was 14.9% (SD=2.0),
just above the 2015 national average of 13.5%, and the mean state-level percent uninsured for
participants was 9.6% (SD=3.4),21 which was similar to the national average in 2015.24
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PrEP users
PrEP use was highest among those age 30-39 (17.2%) compared to 11.5% among those
aged 18-29, 16.1% among 40-49, and 11.3% among those older than 50 years (p = 0.035).
Participants residing in the North (19.2%) reported the highest use of PrEP as compared to those
from the West (13.5%), Midwest (12.9%), and the South (9.7%) (p<0.001). Participants who
reported having a 4-year degree or more (18.0%) were more likely to be users of PrEP than
participants who had some college or equivalent (10.6%) or a high school degree, GED or less
(8.6%, p < 0.0001). Participants who reported that their MP was currently taking PrEP (62.5%)
reported more use of PrEP, followed by those who had HIV-positive partners (43.6%) as compared
to those whose MP HIV status was unknown (8.9%), or negative and not on PrEP (6.4%), and those
with no MP (14.4%, p < 0.0001). Of the participants who reported having more than 5 partners in
the past 3 months, 23.5% were taking PrEP compared to only 14.4% who had 2-5 partners, 6.6%
who only had 1 partner and 4.1% who reported 0 partners (p < 0.0001). Participants who had
recently used drugs (15.4%) and been diagnosed with an STI (27.4%) reported more use of PrEP
than their counterparts (9.7%, p = 0.003 and 11.1, p < 0.0001, respectively).
PrEP use was highest amongst participants who lived in the highest LGBTQ+ equality states
(17.4%) as compared to those in low equality states (9.9%; p < 0.0001). Similarly, PrEP use was
more common among participants who lived in states with lower state racism (15.9% vs 10.6%; p
< 0.004) and who lived in states that had approved of the Medicaid expansion (15.4% vs. 10.2%; p
= 0.006) (Table 1)
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Multivariate logistic regression
Table 2 shows the assessment of variance for each model. Model 1 (empty model/pseudoICC), suggests that 4.2% of the total variance in PrEP use is due to between state differences
whereas 95.8% is explained by individual differences. Model 3, which explored social/behavioral
characteristics of the individual, showed the greatest variation, with 2.7% of the residual variation
in PrEP use persisting due to systematic differences between states. Model 4 (state-level variables)
suggest that after adjusting for the state-level variables, less than 1% of variance is due to
differences in characteristics between the states while the remaining variance is due to
unmeasured differences between individual- and state-level characteristics. The ICC and MOR
were 0, 1 respectively for Models 2 and 5, as there was not enough variation in the response to
attribute any variation to state- or individual-level effects, controlling for all variables in the
model.25
Crude logistic regression model results
In the univariate models, the odds of taking PrEP were significantly higher among those
30-39 years old (OR=1.56, 95% CI: 1.084, 2.252), from the Northeast (OR=2.22, 95% CI: 1.478,
3.344), and those who had a 4-year degree or more (OR=2.25, 95% CI: 1.344, 3.754) than among
those 18-29, from the South, and with those with a high school diploma, GED or less, respectively.
Participants who did not identify as gay had a significantly lower odds of taking PrEP as compared
to those who identified as gay (OR=0.63, 95% CI: 0.401, 0.993). (Table 3)
Participants who had an HIV-positive MP (OR=4.64, 95% CI 2.344, 9.194) or who’s MP was
taking PrEP (OR=9.78, 95% CI: 4.043, 23.650) had significantly higher odds of PrEP use while
participants whose MP was HIV-negative but not taking PrEP (OR=0.40, 95% CI: 0.254, 0.638) had
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significantly lower odds of PrEP use compared to those who did not have a MP. PrEP use was
positively associated with number of partners in the past three months, [2-5 partners (OR=3.95,
95% CI: 1.916,8.134) and >5 partners (OR=7.0, 95% CI: 3.419, 14.337)], compared to no partners,
with those who reported drug use in the last three months (OR=1.69, 95% CI: 1.171, 2.429) or had
been diagnosed with an STI in the last six months (OR=2.9, 95% CI: 2.017, 4.158). (Table 3)
Participants who lived in a state with more LGBTQ equality (OR=1.84, 95% CI: 1.258, 2.702)
had significantly higher odds of taking PrEP than those who lived in state with less equality. (Table
3)
Table 3 displays five models with covariate-adjusted multilevel logistic regression results
(OR’s and 95% CI’s) for individual-, social-, and/or state- level predictors of PrEP use. Model 2
(Table 3, column 3), the adjusted association of individual-level demographic characteristics with
PrEP use showed there was a positive association between PrEP use and residence in the
Northeast [adjusted odds ratio (aOR=2.09, 95% CI: 1.377, 3.168) and the West (aOR=1.57, 95% CI:
1.020, 2.426) compared to the South and having a 4-year degree or more (aOR=2.21, 95% CI:
1.303, 3.730) versus a high school degree or less. Participants who were Hispanic (aOR=0.68, 95%
CI: 0.467, 0.996) or Asian (aOR=0.51, 95% CI: 0.286, 0.892) had lower odds of using PrEP as
compared to those who identified as Black.
In model 3 (Table 3, column 4), the association of PrEP use with social-factors was explored.
Those who had an MP who was HIV-positive (aOR=4.02, 95% CI: 1.939, 8.315) and who’s partner
was HIV-negative and on PrEP (aOR=10.91, 95% CI: 4.355, 27.344) had higher odds of taking PrEP
compared to those who did not have a main partner at all. Furthermore, participants with an HIVnegative MP who was not on PrEP (aOR=0.43; 95% CI: 0.261, 0.709) had lower odds of taking PrEP
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compared to participants with no MP. A dose-response association with PrEP use was seen with
the number of sexual partners in the past three months. Participants who reported 2-5 partners
(aOR=3.75, 95% CI: 1.795, 7.842) and greater than 5 partners (aOR=6.02, 95% CI: 2.900, 12.496)
had a higher odds of PrEP use compared to those with no partners. Lastly, participants who had
been diagnosed with an STI in the last 6 months (aOR=2.63, 95% CI: 1.782, 3.886) had a higher
odds of taking PrEP compared to those who had not been diagnosed with an STI.
Model 4 (Table 3, column 5) shows the adjusted association of state level characteristics
with PrEP use. Residents of states with the high LGBTQ+ equality score (aOR=1.93, 95% CI: 1.107,
3.350) had higher odds of PrEP use compared to residents of states with low LGBTQ+ equality
scores.
Finally, Model 5 (Table 3, column 6) shows the results from the full model with all
individual-, social-, and state-level variables included. All variables statistically significant in the
earlier models remained significant in the final model, with the exception US region of residence.
In addition, although not significant in model 1, in the final model, participants who did not identify
as gay (aOR=0.52, 95% CI: 0.317, 0.850) had lower odds of using PrEP compared to those who
identified as gay.
Lastly, all possible four-, three-, and two-way, interactions were tested among state-level
LGBT equality, state-level racial equality, and both the individual variables, sexual identity and
race/ethnic identity. There was no significant interaction and therefore we did not run a stratified
analysis.

DISCUSSION
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PrEP research has often focused on individual-level factors, such as demographics and
behavioral characteristics, however, structural-level factors, such as the structural stigma of a
state, may also play a role. Our findings show that MSM of color who resided in states with more
LGBTQ+ equality had a higher odds of using PrEP even after controlling for individual, social, and
structural level factors. The strong association suggests that equality, or inclusivity, of the LGBTQ+
community is an important contributor to the use of PrEP. States with more inclusivity of the
LGBTQ+ community may have either the ability or the resources to reach MSM of color and
provide more access to healthcare, specifically healthcare that focuses on minority health.
Moreover, these states with increased equality may have progressive social policies where
behaviors and identities that are often stigmatized in other areas may be enacted with less fear
and more aid. Parker and Aggleton described how stigma can manifest itself at the structural level
via discriminatory legislation and policies and can occur when such policies disinvest in research
or prevention interventions, more so if those disinvestments target minority populations. 26
Perhaps, one example of where more progressive policies could be useful is in the
Southern part of the US, where eight of the ten states with the highest rates of new HIV diagnoses
are located.27 The conservative environment of the South has been implicated in fostering the
spread of HIV and HIV-stigma.28 A number of states in the South only provide abstinence-based
sex education and/or have laws that criminalize behavior related to HIV exposure or transmission,
which can lead to shame or could discourage individuals from seeking HIV prevention, care, or
treatment.28 Several studies have shown the negative impacts of stigma on population health,
including increasing the likelihood of engaging in high-risk behavior and adverse mental health
conditions.29,30 One study focused on structural stigma and HIV prevention in the US and showed
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that residents of states with high-level structural stigma were less likely to have heard of or used
PrEP and suggested that it may be a function of reduced awareness of PrEP, as well as lack of
access to providers who prescribe the drug.30 Their analysis used a composite score addressing
four dimensions of state LBGTQ+ prejudicial components with one of the dimensions including a
focus on four LGBTQ+ state policies.30 Our analysis extended this work by using a more
comprehensive measure of LGBTQ+ equality consisting of more than seventeen state laws and
policies that affect not only the individual but also laws that affect their families. In addition, our
analysis included and adjusted for other state-level characteristics that may interact with and/or
compound LGBTQ+ state stigma.
Together with stigma, variables such as racism, HIV-prevalence, poverty, and healthcare
access could be confounders to PrEP use. To reach the populations at most need of PrEP, it will be
important to disentangle the effects of stigma experienced by MSM of color and its barriers with
PrEP use. Although much of the current stigma literature focuses on the consequences of only one
form of stigma, MSM of color will likely experience the additional stress of multiple minority
stigmas which are often correlated and interrelated and their combined effects may not just be
additive.31 There has been research showing that MSM of color not only are disproportionately
affected by HIV but that they often feel isolated from the broader LGBTQ+ communities and/or
have experienced racism and discrimination within them.6,32 A study by Han and colleagues found
that a large majority of MSM of color reported racism from within the gay community, and that
the racism experienced was a significant source of stress which led to an increased likelihood of
engaging in high-risk sexual behaviors.33
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The analysis presented here, explored the intersectionality of multiple minority identities
interacting with multiple forms of inequality and subsequently its impact on PrEP use. The findings
of this study did not find a significant association between PrEP use and the state racism score,
nor did we find any evidence of interaction among minority identities and state-level equality
measures. To a degree, our lack of significance could be due to the racism experienced within the
gay community rather than at the state level, as we did not have this measure in our study. This
could suggest that the racism experienced at the community-level is important in the healthseeking behaviors of MSM of color. Alternatively, it could be that state-level racism is highly
variable within the state and/or that level of racism is difficult to measure, and our variable may
not have captured this construct adequately. Although our measure of state racism was not
predictive, we did find variation in the odds of PrEP use by individual race/ethnic identity.
Participants in our study who identified as either Latinos or Asians had lower odds of taking PrEP
compared to Black participants, suggesting that PrEP use is both suboptimal among MSM of color
and differential by race/ethnicity, even after controlling for individual level factors. MSM of color
should not be treated as a panethnicity, and that each group, as well as other factors including
sexual identity and nativity, need to be considered and addressed with specific culturally
appropriate HIV prevention strategies.
Social/behavioral variables were strongly associated with PrEP use. Participants with MPs
who were HIV-positive or were currently taking PrEP were more likely to be taking PrEP
themselves. This is consistent with other studies which suggested that when positive relationship
dynamics exist and partners provide emotional, informational, and instrumental support to each
other, their relationship may lead to better anti-retroviral treatment adherence via improved
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mental health, increased knowledge about HIV, and increased accountability.34,35 Participants who
had HIV-negative MPs that were not taking PrEP were less likely to be taking PrEP than people
with no MP. This finding requires further investigation and should focus on identifying effective
PrEP messaging that targets MSM in relationships and explores the intimate aspects of
relationships and sexual decision-making.36
In this study, participants with more sexual partners or a recent STI diagnosis, were more
likely to be taking PrEP. Studies have reported high rates of STIs among PrEP users and concerns
have been raised that PrEP use may be linked to decreases in condom use, while other studies
have found that PrEP might not lead to behavior change but that it may be bringing a population
at risk into the healthcare system.37 PrEP use guidelines recommend frequent testing for STIs,
typically at quarterly intervals.38 Therefore, the findings that participants who are using PrEP have
a higher odds of an STI diagnosis could be partially explained by the likelihood of having been
screened for STIs rather than the actual STI risk. Due to the nature of this study, we were unable
to deduce whether the higher number of sexual partners or an STI diagnosis was a cue to initiate
PrEP or whether those on PrEP were more likely to increase number of partners, which might
result in a higher likelihood of STIs.
In the final model, other individual-level variables significantly associated with PrEP use
include age and sexual identity. Participants between 30-39 years had higher odds of taking PrEP,
while participants who reported that they did not identify as gay had lower odds of taking PrEP.
MSM in this mid-age range of 30-39 may have increased knowledge of HIV- and HIV-risk and
improved access to healthcare and subsequently a prescription to PrEP as compared to those
participants who were younger.39,40 Similarly, participants who did not identify as gay may be less
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comfortable discussing their sexual behavior with a healthcare provider and/or may be less
integrated into the LGBTQ+ community, which may impact knowledge and access to PrEP. 39
Limitations
There are several limitations that should be mentioned. First, the data is from a crosssectional study where the exposures and outcome were simultaneously assessed and temporal
order for some associations cannot be determined. Another limitation is possible misclassification
of the outcome due to social desirability bias or misunderstanding of the outcome question. For
example, participants were asked if they were currently taking PrEP, but were not asked if they
had ever taken PrEP. Some participants may have discontinued use by the time of our survey,
therefore our measure may under-report lifetime PrEP use. Furthermore, some of our state-level
constructs do not have a generally accepted and validated measure, thus the measures used may
have reliability and validity issues, including construct validity and uncontrolled or residual
confounding. Although participants were recruited from all 50 states, recruitment methods may
not have resulted in a representative sample of MSM in the US and therefore findings may lack
eternal validity. Lastly, statistics used to quantify fitness (i.e. pseudo-R2) of a MLM with a
dichotomous outcome are often difficult to interpret.41

CONCLUSION
The findings suggests that individual-, social-, and state-level variables, and importantly,
the LGBTQ+ equality of the state of residence were associated with PrEP use among MSM of color.
MSM of color experience intersecting forms of stigma, including but not limited to racism and
homophobia, assessed in this paper, but also anti-immigrant sentiment, which we were unable to
evaluate. However, this may be an important factor based on our findings around individual
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race/ethnicity. In February 2019, the current administration announced, Ending the HIV Epidemic
in America, a new initiative which seeks to reduce all new HIV infections by 90% in the next 10
years. However, unless the complex set of socio-behavioral and structural factors, including
discrimination, stigma, and socioeconomical factors are considered, it is expected that HIV will
continue to disproportionately affect the same at-risk populations and those with dual minority
identity may be at an even higher risk. Although there has been much improvement regarding
LGBTQ+ and racial justice in the US, the equality landscape in the country varies greatly by state
and recent rollbacks in federal laws of sexual and reproductive health rights, and rights for LGBTQ+
and their families are cause for alarm.42,43 Our findings suggest that the policies that increase
inequality and stigma associated with minority statuses may hinder the administration’s new
initiative and/or limit the potential epidemiological impacts of PrEP and related determinants.
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TABLES AND FIGURES
Table 3 - 1. Description of Individual-, social-, and state-level characteristics overall and by PrEP
use
Characteristics

TOTAL

Individual level characteristics
Age
1465
Mean (SD)
Median (Range)
Age
1465
18-29
30-39
40-49
>50
Recruitment Website
1465
Sexual networking
website
General social
networking website
Street intercept
Geo-social sexual
networking phone app
Online Gay Porn sites
Panel study participants
US Region of residence
1465
South
North
Midwest
West
Race/ethnicity
1465
Native American /
Alaskan / Hawaiian / Pacific
Islander / Other
Black
Hispanic
Asian
Education
1465

Total
N (%)
1465 (100)

Non-PrEP users
N (%)
1266 (86.4%)

PrEP user
N (%)
199 (13.6%)

p-Value

32.9 (11.2)
30.0 (61.0)

32.8 (11.4)

33.9 (9.8)

0.1384

722 (49.3)
361 (24.6)
223 (15.2)
159 (10.9)

639 (88.5)
299 (82.8)
187 (83.9)
141 (88.7)

83 (11.5)
62 (17.2)
36 (16.1)
18 (11.3)

0.035

176 (12.0)

160 (90.9)

16 (9.1)

<0.001

137 (9.4)

121 (88.3)

16 (11.7)

137 (9.4)

101 (73.7)

36 (26.3)

666 (45.5)

581 (87.2)

85 (12.7)

116 (7.9)
233 (15.9)

100 (86.2)
203 (87.1)

16 (13.8)
30 (12.9)

487 (33.2)
370 (25.3)
179 (12.2)
429 (29.3)

440 (90.4)
299 (80.8)
156 (87.2)
371 (86.5)

47 (9.7)
71 (19.2)
23 (12.9)
58 (13.5)

<0.001

214 (14.6)

186 (86.9)

28 (13.1)

0.164

336 (22.9)
748 (51.1)
167 (11.4)

278 (82.7)
656 (87.7)
146 (87.4)

58 (17.3)
92 (12.3)
21 (12.6)

76

High School Diploma,
GED, or less
Some College, Associates
Degree, or currently
enrolled in college
4-Year College Degree or
more
Sexual Identity
Gay
Bisexual
Other
Social-level Characteristics
Main Partner Status
No Main Partner (MP)
MP is HIV-positive
MP HIV status unknown
or uncertain
MP HIV negative and on
PrEP
MP HIV negative and not
on PrEP
Number of partners in past
3 months
0
1
2-5
>5
Drug use in the last 3
months
No
Yes
STD in past 6 months
No
Yes
State-level Characteristics
Equality
HRC state Equality Index
Low equality
High Equality
Structural Racism
High state racism (<22)

232 (15.8)

212 (91.4)

20 (8.6)

<0.001

583 (39.8)

521 (89.4)

62 (10.6)

650 (44.4)

533 (82.0)

117 (18.0)

1190 (81.2)
237 (16.2)
38 (2.6)

1017 (85.5)
215 (90.7)
34 (89.5)

173(14.5)
22 (9.3)
4 (10.5)

0.837

935 (63.8)
39 (2.7)

800 (85.6)
22 (56.4)

135 (14.4)
17 (43.6)

<0.001

90 (6.1)

82 (91.1)

8 (8.9)

24 (1.6)

9 (37.5)

15 (62.5)

377 (25.7)

353 (93.3)

24 (6.4)

220 (15.0)
334 (22.8)
507 (34.6)
404 (27.6)

211 (95.9)
312 (93.4)
434 (85.6)
309 (76.5)

9 (4.1)
22 (6.6)
73 (14.4)
95 (23.5)

<0.001

474 (32.4)
991 (67.7)

428 (90.3)
838 (84.6)

46 (9.7)
153 (15.4)

0.003

1242 (84.8)
223 (15.2)

1104 (88.9)
162 (72.7)

138 (11.1)
61 (27.4)

<0.0001

739 (50.4)
726 (49.6)

666 (90.1)
600 (82.6)

73 (9.9)
126 (17.4)

<0.001

640 (43.7)

572 (89.4)

68 (10.6)

0.004

1486

1465

1465

1465

1465
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Low state racism (>=22)
Medicaid Expansion
No
Yes
Prevalence
Mean (SD)
Median (Range)
Poverty Rate
Mean (SD)
Median (Range)
Percent Uninsured
Mean (SD)
Median (Range)

825 (56.3)

694 (84.1 )

131 (15.9)

502 (34.3)
963 (65.7)

451 (89.8)
815 (84.6)

51 (10.2)
148 (15.4)

0.006

16.7 (7.6)
15.4 (60.9)

16.7 (7.5)

16.8 (8.5)

0.817

14.9 (2.0)
15.4 (13.8)

14.9 (2.0)

14.8 (1.9)

0.576

9.6 (3.6)
8.6 (14.3)

9.8 (3.7)

8.9 (3.2)

<0.001

1465

1465

1465

1465

*Wilcoxon

rank sum test p-value
Rights Campaign (HRC) state scorecard
2 Variable created from The Geography of Racial Stereotyping: Evidence and
Implications for VRA Preclearance After Shelby County
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population
1Human

78

Table 3 - 2. Multilevel Logistic Regression Models with Random Intercept with Variables Entered in Blocks by Level
Model Summary

Model1

Model 2

Model 3

Model 4

Model 5

Ʈ2 of random
effects
VPC or ICC
MOR
PCV

0.1434
4.2
1.44

0
0
1.00

0.09158
2.7
1.33

0.03005
0.91
1.18

0
0
1.00

PCV: proportional change of the variance, VPC: variance partition coefficient, ICC: intra class coefficient, MOR: median odds ratio
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Table 3 - 3. Five-level covariate-adjusted multilevel logistic regressions (OR, AOR, and 95% CI’s) between individual, social and state
level variables and PrEP use.
Bivariate (Crude
Variables
OR)
OR (CI)
P-value
Individual-level Characteristics
Age
18-29
REF
1.6 (1.084, 2.252)
30-39
0.017
1.5 (0.986, 2.349)
40-49
0.058
1.0 (0.589, 1.783)
>50
0.930
US Region of
residence
South
REF
2.2 (1.478, 3.344)
Northeast
0.0003
1.4 (0.799, 2.34)
Midwest
0.241
1.5 (0.961, 2.229)
West
0.075
Race/ethnicity
Black
REF
0.7 (0.475, 1.008)
Hispanic
0.055

Model1
ICC

Model 2
OR (CI)
P-value

Model 3
OR (CI)
P-value

Model 4
OR (CI)
P-value

Model 5
AOR (CI)
P-value

REF
1.3 (0.902, 1.903)
0.154
1.3 (0.827, 2.003)
0.260
0.9 (0.499, 1.535)
0.638

REF
1.5 (1.018, 2.312)
0.041
1.6 (0.966, 2.593)
0.068
1.2 (0.626, 2.165)
0.628

REF
2.1 (1.377, 3.168)
0.001
1.5 (0.841, 2.549)
0.173
1.6 (1.020, 2.426)
0.041

REF
1.8 (0.642, 5.194)
0.251
1.9 (0.712, 5.257)
0.189
1.4 (0.475, 4.371)
0.509

REF
0.7 (0.467, 0.996)
0.0477

REF
0.7 (0.428, 0.993)
0.046
80

0.7 (0.375, 1.144)
0.136

0.5 (0.286, 0.892)
0.019

0.5 (0.251, 0.883)
0.019

0.8 (0.463, 1.270)
0.30

0.7 (0.439, 1.211)
0.220

0.8 (0.430, 1.322)
0.321

REF

REF

REF

1.3 (0.723, 2.136)
0.426

1.3 (0.724, 2.145)
0.422

1.0 (0.559, 1.789)
1.00

2.3 (1.344, 3.754)
0.002

2.2 (1.303, 3.730)
0.004

1.7 (0.977, 3.016)
0.060

REF
0.6 (0.401, 0.993)
0.047
Social-level Characteristics
Main Partner
Status
No Main
Partner (MP)
REF

REF
0.7 (0.420, 1.051)
0.079

REF
0.5 (0.317, 0.850)
0.011

Asian
Other*
Education
High School
Diploma, GED,
or less
Some
College,
Associates
Degree, or
currently
enrolled in
college
4-Year
College
Degree or
more
Sexual
Identity
Gay
Did not
identify as gay

REF

REF
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MP is HIVpositive
MP HIV
status
unknown or
uncertain
MP HIV
negative and
on PrEP
MP HIV
negative and
not on PrEP
Number of
partners in
past 3 months
'0
'1
2-5
>5
Drug use in
the last 3
months
No
Yes
STD in past 6
months
No

4.6 (2.344, 9.194)
<0.001

4.0 (1.939, 8.315)
<0.001

3.6(1.704, 7.700)
0.001

0.5 (0.251, 1.163)
0.114

0.5 (0.213, 1.035)
0.061

0.5 (0.204, 1.024)
0.057

9.8 (4.043, 23.650)
<0.001

10.9 (4.355, 27.344)
<0.001

12.8 (4.888,
33.462) <0.001

0.4 (0.254, 0.638)
<0.001

0.4 (0.261, 0.709)
0.0012

0.4 (0.249, 0.691)
0.001

REF
1.6 (0.715, 3.594)
0.249
4.0 (1.916, 8.134)
<0.001
7.0 (3.419, 14.337)
<0.001

REF
2.1 (0.870, 4.825)
0.0998
3.8 (1.795, 7.842)
0.001
6.0 (2.900, 12.496)
<0.001

REF
2.0 (0.830, 4.714)
0.1225
3.9 (1.825, 8.137)
0.001
6.7 (3.199,
14.103) <0.001

REF
1.7 (1.171, 2.429)
0.006

REF
1.4 (0.964, 2.113)
0.0745

REF
1.9 (0.983, 2.215)
0.060

REF

REF

REF
82

Yes

2.9 (2.017, 4.158)
<0.001

2.6 (1.782, 3.886)
<0.001

2.6 (1.698, 3.825)
<0.001

State-level Characteristics
Equality
HRC State
Equality Index
Low equality
High
equality
State Racism
High racism
Low racism
Medicaid
Expansion
No

REF
1.8 (1.258, 2.702)
0.002

REF
1.9 (1.107, 3.350)
0.022

REF
2.0 (1.058, 3.720)
0.033

REF
1.3 (0.844, 2.112)
0.211

REF
1.2 (0.727, 1.875)
0.513

REF
1.2 (0.711,2.136)
0.447

REF
1.3 (0.781, 2.130)
0.313
1.0 (0.982, 1.030)
0.644
1.0 (0.880, 1.064)
0.489

REF
0.5 (0.218, 1.144)
0.098
1.0 (0.971, 1.040)
0.770
1.0 (0.913, 1.127)
0.787
Model 5

Model Summary

Model1

Model 2

Model 3

REF
0.8 (0.437, 1.554)
0.542
1.0 (0.980, 1.027)
0.808
1.0 (0.904, 1.095)
0.918
Model 4

Ʈ2

0.1434
4.2
1.44

0
0
1.00

0.09158
2.7
1.33

0.03005
0.91
1.18

0
0
1.00

1157.04

1142.30

1018.98

1159.40

1000.90

Yes
Prevalence
Poverty Rate

VPC or ICC
MOR
PCV
Fit Statistic
AICC
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1160.73
1166.10
1039.15
1171.87
1049.80
BIC
* Native American / Alaskan / Hawaiian / Pacific Islander / Other
1Human Rights Campaign (HRC) state scorecard
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population
*Estimated variance of random effect
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CHAPTER 4: EXPLORATION OF MULTILEVEL PREDICTORS OF PRIMARY
CARE PROVIDER TRUST AND ITS EFFECT ON PREP USE AMONG MEN
WHO HAVE SEX WITH MEN IN THE UNITED STATES
ABSTRACT
Background: PrEP is reaching only a small proportion of those who could benefit from the drug
and prescription rates among those eligible vary both by race/ethnicity and geographic region.
Primary providers (PCP) are gatekeepers to the provision of PrEP and in recent decades, trust with
PCP has been in decline. Individual-and structural-level factors have been shown to be associated
with mistrust, factors including race/ethnicity and the geographic region one resides in.
Furthermore, mistrust in PCP may be associated with a decreased willingness to take PrEP in
populations that need it the most.
Methods: Between May 2015-March 2016, a cross-sectional survey was conducted among a
geographically diverse sample of HIV-negative MSM. The participant survey data was linked to
publicly available state-level data based on participant’s residential zip code. Multivariable
multilevel logistic regression was used to explore the association between multilevel variables and
patient trust in physician (PTP) among a diverse sample of MSM. In addition, interaction analysis
was performed among state-level race/ethnicity and LGBTQ+ equality variables and the individuallevel variables, sexual identity and race/ethnicity.
Results: There were 2,750 HIV-negative participants who reported having a PCP. The results
showed very little variation in PTP scores between states. However, several individual- and
interpersonal-level factors including geographic region [Residents of the West β=-0.88, SE(0.27),
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p-value=0.002], sexual identity [non-gay identity β=-0.48, SE(0.15), p-value=0.003], individual drug
use [drug use β=-0.41, SE(0.13), p-value=0.004], and PrEP use [PrEP users β=0.75, SE(0.18), pvalue=0.0002] were associated with PTP. Interaction analysis suggests that a person’s racial
identity on PTP score varied depending on the racial equality of the state.
Conclusions: Trust is central to the patient-physician relationship. Understanding the potential
impact state policies and environments have on individual-level factors and its association with
patient-provider relationships may help us elucidate an individual’s decision to use PrEP.
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INTRODUCTION
In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir
disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis
(PrEP) in HIV-negative adults who are at high-risk of HIV infection.1 In 2016, the CDC estimated
that there were 1.1 million US adults who showed indications for PrEP use. This included
approximately 814,000 men who have sex with men (MSM), who disproportionately accounted
for a large majority of new HIV cases.2,3 Notwithstanding, only 7-8% of those eligible for PrEP were
prescribed the drug by the year 2015.3 What’s more is that PrEP uptake has been unequally
distributed by population subgroup and geographic region.4-6 Black individuals account for
approximately 40% of persons with indications for taking PrEP but white individuals are nearly six
times more likely to be prescribed the drug.3 PrEP has the potential to make a significant impact
on new diagnoses if provision could be delivered to the populations who need it the most.
Understanding the facilitators and barriers to its use, could guide future PrEP interventions.
As with any new biomedical intervention, primary care providers (PCP) are the gate
keepers, and a good doctor-patient relationship, is critical when disseminating information and
encouraging uptake of new medications.7 A trusting doctor-patient relationship allows patients to
be honest about their behaviors and needs, so that appropriate treatments can be discussed and
ultimately delivered. What’s more, is that a good relationship has also been shown to increase
patient self-efficacy and protective behaviors, as well as motivate patients to decrease high-risk
behaviors.8 However, trust in providers has been in decline in the US in recent decades. 9 If there
is mistrust, patients are less apt to communicate accurate information on behaviors and in
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consequence be less likely to receive information specific to their situation. At present, there is
documented research on medical mistrust among both racial/ethnic minorities and within sexual
minority communities.10,11 However, there is limited research which focuses on how mistrust by
sexual identity and race/ethnicity varies by geographic region and related to environmental
factors. 12
The disclosure of one’s sexual identity, their sexual behaviors, the feelings of perceived
judgement or homophobia, and concerns about confidentiality are just a few barriers that may
influence the relationship between MSM and their physicians.13-15 An overall distrust of providers
has been reported by MSM, and some MSM go as far as separating their sexual healthcare from
their primary healthcare due to this mistrust, fear of judgment, and/or embarrassment.16-18 Other
MSM have reported delays in seeking HIV/STI services due to such barriers.16,17,19,20 This type of
discrimination received or perceived is rooted in homophobia and can affect whether MSM seek
and are able to obtain appropriate, quality and relevant health care.21-23 Any type of delay in care
puts an already at risk population at even greater risk.
Medical mistrust has also been shown to be more prevalent among racial and ethnic
minority populations.24 Several studies have explored these populations and their distrust of
medical research, of the health care system, and distrust of health care providers. 24-26 In a study
exploring knowledge and willingness to use PrEP among Black MSM at a community event, onein-five participants reported that they did not trust doctors and healthcare workers, and the
variable mistrust was one of the strongest predictor of a willingness to use PrEP. 11 Furthermore,
studies have shown that racial and ethnic minority patients are more likely than white patients to
refuse treatment.27 Mistrust by African Americans has been said to stem from the history of racial
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discrimination and exploitation by the medical field, with studies including the Tuskegee
experiments and other harms of black patients by health professionals. These studies have come
to symbolize ethical misconduct and could be contributors to the mistrust and the disparities in
healthcare provision we see today.25,28 Although most of the research to date is centered on black
and African Americans in the US, it is not unforeseen that the mistrust and provider bias may be
more prevalent and apply to other racial and ethnic minorities.
Although there has been limited research, distrust of physicians in the US has been shown
to vary by race/ethnicity and according to where one lives, with minorities more often having a
higher distrust of physicians than whites.12 Depending on where one lives, state policies have the
potential to influence social norms around perception and behavior towards sexual and racial
minorities and people with fewer economic resources. In turn, these policies may affect how a
provider treats or serves a patient and if there is mistreatment or even perceived mistreatment,
this may increase mistrust. Understanding the potential impact state policies and environments
have on patient-provider relationships may help us understand an individual’s decision to use
PrEP. Acknowledging that PTP varies geographically and that LGBTQ+ and racial/ethnicity bias by
a PCP can lead to further mistrust is relevant, as this could suggest that structural-level factors
may impel mistrust.29
Lastly, mistrust may be further complicated when there are intersecting minority identities
(i.e. racial and sexual minority identity) and may be further impacted by context (the region that
one lives). For example, one might expect more mistrust among minorities living in regions with
higher levels of racism or anti-LGBTQ+ policies. Moreover, those with dual minority identities
(MSM of color) may have more barriers than those with a single minority identity (white MSM).
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These concerns are not unfounded, a recent study in MSM, indicated a potential for inequitable
provision of PrEP across racial groups due to provider bias. This study cited that black MSM were
rated as more likely than white MSM to engage in increased unprotected sex, reducing the
provider’s willingness to prescribe the medication.30 These interacting variables may discourage
and delay care seeking for those at highest risk.17,19,20 Therefore, the aim of this paper is to explore
PCP mistrust among a geographically diverse sample of MSM in the US and assess how mistrust
varies by individual-level sexual and race/ethnic identity and by state-level LBGT-equality and
racism.

METHODS
Study sample and data collection
The data for these analyses come from a cross-sectional survey of a geographically-diverse
sample of MSM in the US that was conducted from May 2015 to March 2016. The study methods
have been described elsewhere,31 but an abridge description is presented here. Participants were
eligible if they were age 18 years or older, cisgender male, and reported sex with other men in the
past 5 years. All participants who were HIV-positive were excluded from these analyses.
Participants were recruited via six different methods: (1) Online via a sexual networking
website, where a banner was hosted advertising the survey for 30 days; (2) Online via various gay
porn internet sites, where the same banner was used for a period of 39 days; (3) Mobile devices
via a geo-social sexual networking app popular with men-for-men connections, where we had a
pop-up message that was displayed to participants when they opened the app for the first time
during a given 12-hour window; (4) Online via a social networking site popular with the general
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public, where we ran an advertisement for 11 days; (5) Street intercept outside of locations in New
York City frequented by MSM; (6) An invitation to participants in a an ongoing panel study of 1,071
HIV-negative MSM identified by a marketing firm. All eligible participants completed a brief selfadministered survey that took approximately twenty minutes. Those recruited via street intercept
completed the survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software,
and all others did so online via a personal computer or phone app. The survey included questions
about demographic characteristics, including zip code of residence, HIV risk/protective behaviors,
including current PrEP use, questions about their primary care physician and trust in their
physician, and, lastly, questions on partner characteristics (e.g. main partner’s HIV status and PrEP
use). The participant survey data was then linked to publicly-available state-level data about statelevel economic and healthcare access indicators, HIV prevalence, as well as measures of LBGT
equality and racism, based on participant’s residential zip code.
Measures

Outcome
The outcome for these analyses was patient trust in physician (PTP). Those who reported
having a PCP (N=2750) were asked to complete a brief validated measure of PTP. The tool included
five questions: (1) Sometimes my doctor cares more about what is convenient for (him/her) than
about my medical needs, (2) My doctor is extremely thorough and careful, (3) I completely trust
my doctor’s decisions about which medical treatments are best for me, (4) My doctor is totally
honest in telling me about all of the different treatment options available for my condition and (5)
All in all, I have complete trust in my doctor. Responses options were in 5-point Likert scale from
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strongly agree to strongly disagree. Responses were summed (range 5–25), with higher scores
indicating more trust.32
Predictor variables
Individual- Level variables included demographics. Participant age was based on self-report
and was examined both as a continuous and a 4-category variable (18-29, 30-39, 40-49 and 50+
years), with categories based on the distribution of the data to ensure a sufficient number in each
category. Race and ethnicity were categorized into 4 distinct groups (white, black, Hispanic, Asian,
and other). The ‘other’ category included American Indian, Alaska native, native Hawaiian, Pacific
Islander and other, which were combined due to the small sample sizes in each of these groups.
Level of education was examined in 3 categories (High school diploma, GED or less; some college,
currently enrolled in college and/or associates degree; 4-year college degree or more). Sexual
identity was examined as three categories in the descriptive analysis (gay, bisexual, and other)
and, due to the small numbers, the variable was dichotomized into an indicator for gay identity
versus those who did not identify as gay, for the regression analysis.
Social-level factors
We defined social-level factors as behaviors or interactions that pertained or occurred
between persons. These factors included, sexual behaviors, drug use, and STIs, PrEP use, since it
requires communication with and a prescription from a physician, and main partner’s (MP) HIV
status.
Behavioral characteristics included the number of sex partners and drug use in the last
three months as well as diagnosis with any sexually transmitted infection (STI) in the last six
months. The number of sex partners was categorized into 4 groups (0 partners, 1 partner, 2-5
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partners and >5 partners) based on the distribution of the data. To assess drug and STI history,
participants were provided a list of recreational drugs (including non-prescription and
prescription) and STIs and were asked to indicate which they had used or been diagnosed with the
respective time period. Drug use and STIs were both dichotomized into an indicator for any versus
none.
All participants were asked about their current PrEP status. Responses were determined
using replies to the question: “What is your HIV status?“ Options were: (1) HIV-positive and
undetectable, (2) HIV-positive, but detectable, (3) HIV-negative, on PrEP, (4) HIV-negative, not on
PrEP, (5) Don’t know/unsure. Participants who reported don’t know/unsure of HIV status were
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP
versus not on PrEP.
Participants were asked if they had a main partner (MP) with whom they were in a
committed relationship and, if so, their knowledge of their MPs HIV and PrEP status. For these
analyses we included a five-category variable for MP status with the following categories: (1) no
MP, (2) MP is HIV+, (3) MP and I don't know their status, (4) MP and they are HIV-negative and on
PrEP (5) MP and they are HIV-negative and not on PrEP.
State-level Characteristics - All state-level measures used were from 2015.
The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) equality measure came
from the Human Rights Campaign (HRC) state scorecard. The HRC assigns a score based on
statewide laws and policies that affect LGBTQ people and their families.33 The HRC categorizes
these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building Equality, 3)
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Solidifying Equality and 4) Working Toward Innovative Equality. We dichotomized the variable into
low (categories 1 and 2) and high (categories 3 and 4) LGBTQ equality states.
To asses state-level racism, a measure was used that ranks states by the proportion of its
non-black residents who regard blacks more negatively than the national median.34 Elmendorf and
Spencer et al. created the variable using multilevel regression with post-stratification, a statistical
technique that has shown to yield estimates of state-level public opinion. Using their results, each
state was ranked from 1-50 with 1 representing the state with the highest proportion of nonblack
residents who are ‘prejudiced overall’.34 This measure was modeled as a numeric variable.
State HIV prevalence was ascertained from the CDC annual HIV Surveillance Report among
adults and adolescents. Using the rankings set by the CDC, rates of HIV diagnoses per 100,000
people were categorize into four categories: <10.0, 10.0-19.9, 20.0-29.9, and >/=30.35
State-level poverty was defined using the US Census Bureau's American Community Survey
Briefs for poverty in 2014-2015. The poverty rate measures the percentage of people whose
household income fell below their state’s assigned poverty threshold. Poverty thresholds are
assigned to individuals or families based on family size and composition.36 Both variables were
continuous variables in the model. Healthcare access was determined based on the percent
uninsured (via private or government insurance) in each state. Data was obtained from the Kaiser
Family Foundation and modeled as a continuous variable.37
Statistical analysis
Descriptive statistics (means, standard deviations, and percentages) were calculated to
describe the individual-, social-, and state-level characteristics of the sample overall and mean PTP
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scores were reported by characteristic. Wilcoxon Two-Sample Test and Kruskall Willis were used
to calculate p-values.
Crude and multivariable multilevel linear regression models were created with random
intercepts to estimate the variance explained by and the association of each independent variable
with PTP scores. The level-1 unit was the participant and the level-2 unit was the state.
Model 1 was an ‘empty’ model which assessed the extent that the variability in PTP scores
was due to state- vs. individual-level factors. Intraclass correlation coefficients (ICC) were
computed. Model 2 included individual-level demographic characteristics (age, race, education,
and sexual identity), Model 3 included interpersonal/social factors (number of partners, STIs, main
partner’s status). Models 2-3 allowed for the assessment of the association of the set of individualand interpersonal-level factors on PTP scores. Model 4 included all state-level characteristics to
examine the association of state-level characteristics and PTP score. Model 5 was extended to
include all variables into a final model.
The analysis was then extended to explore whether the intersection of individual sexual
and race/ethnic identity interacts with state-level LGBTQ+ and racial equality to shape PTP scores.
The initial analysis explored a 4-way interaction with all four variables by adding all possible
product terms, including all 2-way, 3-way and 4-way product terms for all possible combinations
of the 4 variables, to the adjusted model.38 This model was then compared to 3 other models: (1)
the main effects model, (2) model with only all 2-way interactions and (3) the model with 2- and
3-way interactions. The significance of interaction was assessed at alpha=0.10 due to the reduce
power when testing for interaction.39 Significant interaction will indicate that the impact of the
main exposure (individual’s sexual and/or racial identity) on PTP score varies depending on state95

level sexual minority and racial equality. Stratified analysis were conducted when a significant
interaction was present. Specifically, if we found evidence of interaction, we stratified on statelevel equality measures to determine how equality modifies the association between individualidentity and PTP score. All main effects were tested at alpha=0.05. Analyses were undertaken
using SAS 9.4 and PROC MIXED for binary outcomes (SAS, Cary, NC).

RESULTS
Description of the sample overall
There were 2,750 HIV-negative participants who reported having a PCP. Most of the
participants were between 18-29 years old (34.3%), followed >50 years of age (25.8%). The
average age was 38.6 years old (SD=13.9). More than half of the participants were white (64.4%),
identified as gay (78.8%), and reported having a college degree or more (51.1%). The greatest
percentage resided in the South (31.4%). (Table 1)
More than half of the participants reported that they were not taking PrEP at time of study
(84.2%), and did not have a MP (61.0%). Of those with a MP (39.0%), the majority reported having
a MP who was HIV-negative and not on PrEP (75.6%). In the past three months more than half of
participants reported having more than one sexual partner (87.6%) and using drugs (64.1%). Over
10% of the participants reported having been diagnosed with an STI within the last six months.
(Table 1)
Over half of the participants lived in states with the lowest LGBTQ+ equality (57.4%), the
highest racial equality (54.2%), and in the second to lowest HIV prevalence range of 10.0-19.9 per
100,000 (53.8%). The mean poverty rate of the states in which participants lived was 14.8%
(SD=2.2), just above the 2015 national average of 13.5%, and the mean state-level percent
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uninsured for participants was 9.0% (SD=3.4),36 which was similar to the national average in
2015.37
Mean PTP scores
The mean PTP score for all participants was 17.6 (SD=3.2) out of a possible maximum of
25. Participants residing in the Northeast had higher PTP scores (17.9, SE=3.3) at the time of the
study as compared to those from the South (17.6, SE=3.3), the Midwest (17.6, SE=2.9), and the
West (17.2, SE=3.3), (p=<0.001). Participants who identified as gay (17.7, SE=3.2) and reported
that they were taking PrEP at time of study (18.2, SE=2.9) had significantly higher scores that those
who did not identify as gay (17.1, SE=3.3, p<0.001) or who were not taking PrEP (18.2, SE=3.3,
p=<0.001), respectively. Participants who had a MP who was currently taking PrEP (18.6, SE=3.1)
had significantly higher PTP scores than those who had a MP who was HIV-positive (17.7, SE=3.6),
those who had no MP (17.6, SE=3.1), with a MP who was HIV-negative and not on PrEP (17.5,
SE=3.2), those who had a MP with an unknown/uncertain HIV status (17.4, SE=3.3; p=0.054).
Lastly, participants who reported using drugs in the last 3 months (17.8, SE3.3) had significantly
higher PTP scores than participants who reported no drug use (17.5, SE=3.2; p <0.001). (Table 1)
Logistic regression Modeling Results
Table 2 shows the assessment of variance for each model. Model 1 (empty model/ICC),
suggests that 0.5%, or less than 1% of the total variance in PTP scores is due to between state
differences whereas 99.5% is explained by individual differences. After adjusting for the respective
variables per model, each model had a ICC of less than 1%, suggesting that there was little variance
due to differences in characteristics between the states and that the remaining variance is due to
unmeasured differences between individual- and state -level characteristics. There was no ICC
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estimated for Models 5 as there was not enough variation in the response to attribute any
variation to state- or individual-level effects, controlling for all variables in the model.40
Crude Linear regression model results
Table 3 describes the association of independent variables with PTP scores. In the bivariate
models (Table 3, column 2), participants from the West [β=-0.39, SE(0.18), p-value=0.04] and those
who did not identify as gay [β=-0.55, SE(0.15), p-value<0.0001] had a significantly lower PTP score
as compared to those from the South and who identified as gay, respectively.
Participants who were taking PrEP [β=0.70, SE (0.17), p-value<0.0001] and those who had
a MP who was taking PrEP [β=1.0, SE (0.40), p-value=0.01] had significantly higher PTP scores
compared to those who were not taking PrEP or did not have a MP, respectively. Conversely,
participants who reported taking drugs in the last three months [β=-0.38, SE (0.13), p-value=0.004]
had a significantly lower PTP score compared to those who did not take drugs during the same
time period. There were no significant associations between state characteristics and PTP score.
Table 3 displays five models with covariate-adjusted multilevel linear regression results for
individual-, social-, and/or state- level predictors of PTP scores. In model 2 (Table 3, column 3), the
adjusted association of individual-level demographic characteristics with a participants PTP score
was explored. Similar to the univariate model, participants from the West [β=-0.38, SE (0.18), pvalue=0.04] and those who did not identify as gay [β=-0.57, SE(0.15), p-value<0.0001] had a
significantly lower PTP score compared to those from the South and who identified as gay,
respectively.
In model 3 (Table 3, column 4), the association of social-factors with PTP scores was
explored. Participants who were taking PrEP [β=0.81, SE(0.19), p-value<0.0001] had significantly
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higher PTP scores compared to those who were not taking PrEP, and participants who reported
taking drugs in the last three months [β=-0.40, SE(0.13), p-value=0.0028] had significantly lower
PTP scores compared to those who did not take drugs during the same time period. The
association with having a MP who was taking PrEP was no longer associated with the PTP score.
(Table 3). Similar to the univariate analysis, there were no significant associations between state
characteristics and PTP scores (Table 3, column 4).
Model 5 (Table 3, column 6) shows the results from the full model with all individual-,
social-, and state-level variables included.

All variables significant in the models 1-4 showed

similar associations in the final adjusted model.
Interaction Results
All possible four-, three-, and two-way, interactions were tested among state-level LGBT
equality, state-level racial equality, and both individual-level variables, sexual identity and
race/ethnicity. The 2-way interaction, (race/ethnicity * state’s racial equality), had a p-value =
0.057 which was <0.10 and deemed to be statistically significant. The significant interaction
suggests an association of a participant’s racial/ethnic identity on PTP score varied on the level of
the racial equality of the state.
After stratifying on the racial equality of the state, overall compared to whites, participants
who identified as ‘other’ and who lived in a high racial equality state had the highest PTP score
(β=0.73, p-value=0.05) and Asians who resided in states with low racial equality had the lowest
PTP scores (β=-0.87, p-value=0.14) compared to all groups. (Figure 1)
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When we stratified by race, with the exception of black participants, compared to white,
all other races had higher PTP scores in high racial equality states (less racism) than in low racial
equality states (more racism). Compared to white participants, black participants who lived in low
racial equality states had higher PTP scores than they did in high racial equality states (β=0.29, pvalue=0.34 vs. β=-0.19, p-value=0.40). Compared to white participants, Hispanics (β=-0.34, pvalue=0.18 vs. β=-0.30, p-value=0.16) and ‘others’ (β=-0.42, p-value=0.33 vs. β=0.73, pvalue=0.06), both had negative PTP scores (less than whites) in low racial equality state (and
positive PTP scores (higher than whites) in high racial equality states. Lastly, regardless of the
equality of the states, compared to whites, Asians had negative PTP scores, albeit, the PTP scores
were higher in states with high racial equality (β=-0.87, p-value=0.14 vs. β=-0.05, p-value=0.90).
(Figure 1)

DISCUSSION
Participants who were taking PrEP at the time of the study had significantly higher PTP
scores, suggesting that PrEP use may be associated with an individual’s trust in their physician.
Although anecdotally and not fully explored in the literature, PrEP use has been said to be
accompanied with additional monitoring, both before initiating the drug as well as during use. This
added interaction may result in increased communications within the healthcare system and
healthcare workers overall. One study suggested that PrEP use may be a gateway to primary care
for MSM, similar to how family planning clinics were and continue to be a gateway for women.41,42
Marcus and colleagues, further extended this to hypothesize that PrEP users may be more
motivated to care for their own health, and that this increasing engagement in healthcare either
may have led to a person using PrEP or was a result from the experience of using PrEP itself. 41
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However, if there is a lack of communication and trust between a patient and a physician, the
people who need PrEP the most may not be receiving the necessary information regarding PrEP.
MSM who lack trust in their providers, may be less likely to disclose their behavior and therefore
less likely to be prescribed the drug, and vice versa.43 Although increased contact within the
healthcare system for someone taking PrEP, may have allowed patients to cultivate relationships
and subsequently build trust with their physicians, further research should be conducted to better
understand the association between PCP trust and the provision of PrEP.
Another interesting finding of this study was the association or lack thereof between PTP
scores and a few individual- and social-level factors including sexual identity, individual drug use,
and race/ethnicity. Sexual identity and drug use are often associated with various types of stigma
and their significant association with PTP scores in this study, could suggest that individual-level
stigma is a barrier to the relationship between a patient and a physician. While there has been
improved measures regarding inclusive health care for sexual minorities, MSM, especially MSM of
color, are less likely to have access to health care and to culturally competent clinicians who are
knowledgeable in healthcare relevant to this population.44,45 The suboptimal access to healthcare
and HIV prevention services among MSM has been linked to distrust of providers, difficulty
disclosing MSM status, stigma/discrimination, poverty, and experienced and internalized
homophobia.17,19,20 These types of barriers could prevent patients from disclosing sexual identity
or discussing sexual behaviors with their PCPs or can potentially discourage and/or delay someone
from seeking healthcare at all. As compared to the participants who identified as gay, participants
who did not identify as gay had lower PTP scores. Our results are consistent with other studies
which have highlighted that mistrust of medical institutions, health care providers, and the health
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care system in general, is high among people of color and LGBTQ+ persons and could be a
significant barrier to accessing HIV services and interventions, including PrEP.12,14 Even more so,
MSM who do not identify as gay may be fearful of disclosing their same-sex behavior to a
provider.43 This reluctance to disclose may further create additional barriers to PrEP uptake.43 The
data presented here may suggest the need for specific targeted interventions for physicians on
how to interact and better understand this form of stigma.
Participants who reported drug use in the last three months had lower PTP scores than
those who reported no drug use. A study documents that substance use is more highly stigmatized
than many other health conditions and might explain this lower trust in providers among
substance users.46 Further studies suggest that drug-using patients and their physicians possess a
mutual uncertainty about how to interact with each other.47 While our study looked at any type
of drug use, much of the literature has focused on opiate abuse that began as pain treatment and
how that interaction spiraled into mistrust.48,49 One study noted that physicians often do not
acknowledge addiction as a medical disorder and that they may interpret drug-using behaviors as
dishonesty rather than as a side effect of a medical disorder.47 Furthermore, studies have reported
that those participating in particular types of drug use, such as injecting drug use or opioid abuse,
may frequent health care services intermittently and only after they become sick.47 Understanding
the stigma associated with drug use requires physicians to address any personal biases they may
have when working with this population.
The results discussed above, highlight the potential role stigma may play in trust in one’s
PCP. There has been much documented research regarding mistrust in racial and ethnic minority
populations, specifically in the black and African American populations. Recognizing the historical
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legacy of harm at the hands of the medical profession, including but not limited to the Tuskegee
syphilis experiment, we were surprised that we did not find a significant association between PTP
scores and race/ethnicity. However, the significance in our interaction analysis suggests that
structural-level variables may modify individual-level race/ethnicity. The interaction analysis found
that racial/ethnic identity was modified by the structural-level factor, racial equality of the state.
We have not seen other studies that look at this relationship specifically, however, we hypothesize
that state policies have the potential to influence social norms and may strengthen efforts to
counter structural/institutional racism in the health care system. A state with more equality may
have minority-friendly clinics, with a focus on vulnerable communities both for race/ethnicity and
for sexual minorities. These types of interventions could lead to both sexual and racial/ethnic
minorities to feel more comfortable discussing sexuality and behavior with a healthcare provider.
In the interaction analysis, regardless of the state’s equality, Asians had the lowest PTP scores
overall, although scores were slightly higher in the states with more equality. Our findings are
consistent with other studies that have suggested that Asian-Americans have the lowest
satisfaction with healthcare than of any ethnic or racial group.50,51 Lastly, we noted that in high
equality states, blacks have less provider trust than whites while possessing more trust than whites
in low equality states. Conversely, in low equality states Hispanics, Asians and those who identify
as ‘other’ have lower trust than whites but higher (or less low in the case of Asians) trust than
whites in high equality states. Further research is needed on race/ethnicity and its association with
trust in providers.
Lastly, our study showed very little variation in PTP scores between states; however, the
geographic region where someone lives was associated with PTP scores. The Northeast, the
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Midwest, and the West all had lower PTP scores as compared to the South, however, only the
West was shown to be statistically significant. There has been limited research on the geographic
variation of patient trust in healthcare or PCP. In one study, where the primary interest was
geographic variation in racial/ethnic differences in PTP, they documented that distrust varied
racially/ethnically across cities, but that, on average, minorities had a higher distrust of physicians
than did Whites. However, the study did show inconsistencies, where in some cities blacks
reported higher mean levels of distrust than whites while in others the results were reversed. The
study put forth that the variations could be due to the composition or environmental differences
of the region,12 highlighting the need to conduct further studies on the role that state
characteristics may play on PTP. As suggested from our interaction analysis, the impact that statelevel factors like equality may have on their residents may differ depending on their race/ethnicity
and sexual identity. It’s plausible that a state that has more LGBT protective laws may have more
LGBT-friendly clinics allowing MSM to feel more comfortable discussing sexuality and behavior
with a healthcare provider which, in turn, may lead to the provider prescribing PrEP.
Understanding the potential impact state policies and environments have on patient-provider
relationships may help us understand an individual’s decision to use PrEP.
Limitations
Study findings should be understood in light of their limitations. First, the data is from a
cross-sectional study precluding inferences about temporality or causality. Another limitation is
that we do not have data on why some participants had lower trust in physicians and the
healthcare system than others, meaning that trust may be a confounder for unknown or
unmeasured constructs. Furthermore, some state-level constructs do not have a generally
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accepted and validated measure, thus the measures we used may have reliability and validity
issues, including construct validity. While participants were recruited from all 50 states,
recruitment methods may not have resulted in a representative sample of MSM in the US and
therefore findings may lack eternal validity.

CONCLUSION
Trust is central to the patient-physician relationship. Understanding the potential impact
state policies and environments have on a patients trust in their provider and how that trust may
modify the association of individual-level factors with patient-provider relationships may help us
better understand the lower than desired PrEP uptake among some of the highest risk groups.
Further qualitative research could help us better understand how environment impacts trust in
physicians and what interventions could help PCPs address theses biases institutionalized through
unequal policies for sexual minorities and racism. In February 2019, the current administration
announced, Ending the HIV Epidemic in America, a new initiative which seeks to reduce all new
HIV infections by 90% in the next 10 years. Although there has been much improvement regarding
LGBTQ+ and racial justice in the US, the equality landscape in the country varies greatly by state
and recent rollbacks in federal laws of sexual and reproductive health rights, and rights for LGBTQ+
and their families are cause for alarm.52,53 Our findings suggest that the policies that increase
inequality and growing racism decrease PTP among some groups and this may hinder the
administration’s new initiation to end the HIV epidemic.
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TABLES AND FIGURES
Table 4 - 1. Description of individual-, social-, and state-level characteristics and PTP mean scores
PTP
score
Characteristics
TOTAL Total N (%)
P-Value*
Mean (SD)
Individual level characteristics
Age
2750
Mean (SD)
38.6 (13.9)
0.503
Median (Range)
36.0 (65.0)
Age
2750
18-29
944 (34.3)
17.5 (3.1)
0.835
30-39
597 (21.7)
17.5 (3.1)
40-49
500 (18.2)
17.7 (2.8)
>50
709 (25.8)
17.6 (3.6)
Recruitment Website
2750
Adam4Adam
599 (21.8)
17.5 (3.6)
0.001
Facebook
319 (11.6)
17.8 (3.1)
Field
239 (8.7)
18.0 (3.8)
Geospatial app (Grindr)
1269 (46.2)
17.4 (3.0)
Porn sites
324 (11.8)
17.9 (2.9)
US Region of residence
2750
Northeast
703 (25.6)
17.9 (3.3)
<0.001
Midwest
552 (20.1)
17.6 (2.9)
South
863 (31.4)
17.6 (3.3)
West
632 (23.0)
17.2 (3.3)
Race/ethnicity
2750
Native American / Alaskan /
138 (5.0)
17.8 (3.7)
0.177
Hawaiian / Pacific Islander / Other
Black
213 (7.8)
17.7 (3.6)
Hispanic
519 (18.9)
17.6 (3.3)
Asian
108 (3.9)
17.2 (3.2)
White
1772 (64.4)
17.6 (3.1)
Education
2750
High School Diploma, GED, or less
384 (14.0)
17.5 (3.2)
0.387
Some College, Associates Degree, or
961 (35.0)
17.6 (3.2)
currently enrolled in college
4-Year College Degree or more
1405 (51.1)
17.6 (3.2)
Sexual Identity
2750
Identify as gay
2168 (78.8)
17.7 (3.2)
<0.001*
Do not identify as gay
582 (21.1)
17.1 (3.4)
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Sexual Identity
Gay
Bisexual
Other
Interpersonal-level Characteristics
PCP knowledgable about sex with
men
No
Yes
PrEP use
No
Yes
Main Partner Status
No Main Partner (MP)
MP is HIV-positive
MP HIV status unknown or uncertain
MP HIV negative and on PrEP
MP HIV negative and not on PrEP
Number of partners in past 3 months
'0
'1
2-5
>5
Drug use in the last 3 months
No
Yes
STD in past 6 months
No
Yes
State-level Characteristics
Equality
HRC State Equality Index
0 - Low equality
1 - High equality
Racial equality
0 - Low equality
1 - High equality
Prevalence
<10.0
10.0-19.9

2750
2168 (78.8)
518 (18.8)
64 (2.3)

17.7 (3.2)
17.1 (3.4)
17.2 (3.0)

<0.001

872 (31.7)
1878 (68.3)

17.0 (3.2)
17.9 (3.2)

<0.001*

2316 (84.2)
434 (15.8)

17.5 (3.3)
18.2 (2.9)

<0.001*

1677 (61.0)
79 (2.9)
159 (5.8)
67 (2.4)
768 (27.9)

17.6 (3.1)
17.7 (3.6)
17.4 (3.7)
18.6 (3.1)
17.5 (3.2)

0.054

341 (12.4)
556 (20.2)
1017 (37.0)
836 (30.4)

17.5 (3.4)
17.7 (3.1)
17.7 (3.1)
17.4 (3.3)

0.406

987 (35.9)
1763 (64.1)

17.8 (3.3)
17.5 (3.2)

<0.001

2436 (88.6)
314 (11.4)

17.6 (3.2)
17.5 (3.1)

0.334*

1579 (57.4)
1171 (42.6)

17.5 (3.3)
17.7 (3.1)

0.923*

1260 (45.8)
1490 (54.2)

17.6 (3.3)
17.6 (3.2)

0.541*

719 (26.2)
1478 (53.8)

17.6 (3.0)
17.6 (3.3)

0.443

2750

2750

2750

2750

2750

2750

2750

2750
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20.0-29.9
>/=30
Medicaid
No
Yes
Prevalence
Mean (SD)
Median (Range)
Poverty Rate
Mean (SD)
Median (Range)
Percent Uninsured
Mean (SD)
Median (Range)

462 (16.8)
91 (3.3)

17.4 (3.5)
18.2 (2.4)

920 (33.5)
1830 (66.5)

17.6 (3.3)
17.6 (3.2)

2750
0.586

2750
15.3 (7.8)
15.4 (60.9)

0.504

14.8 (2.2)
15.3 (13.8)

0.117

9.0 (3.4)
8.6 (14.3)

0.261

2750

2750

* Wilcoxon Two-Sample Test, all others are Kruskall Willis
1 Human Rights Campaign (HRC) state scorecard
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population
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Table 4 - 2. Multilevel linear regression models with random intercept with variables entered in blocks by level
Model Summary

Model1

Model 2

Model 3

Model 4

Model 5

Ʈ2 of random effects
VPC or ICC

0.1434
4.2

0
0

0.09158
2.7

0.03005
0.91

0
0

VPC: variance partition coefficient, ICC: intra class coefficient,
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Table 4 - 3. Five-level covariate-adjusted multilevel linear regressions (Estimate, Standard Errors, and P-value) between individual,
social, and state level variables and PTP score
Bivariate
Variables
(Crude OR)
Model1
Model 2
Model 3
Model 4
Model 5
Estimate (SE)
Estimate (SE)
Estimate (SE)
Estimate (SE)
Estimate (SE)
ICC
P-value
P-value
P-value
P-value
P-value
Individual-level Characteristics
Age
18-29
REF
REF
REF
-0.02 (0.17)
-0.02 (0.17)
-0.06 (0.17)
30-39
0.893
0.913
0.740
0.22 (0.18)
0.27 (0.18)
0.21 (0.18)
40-49
0.226
0.144
0.2507
0.10 (0.16)
0.16 (0.17)
0.10 (0.17)
>50
0.547
0.325
0.570
US Region of
residence
South
REF
REF
REF
0.21 (0.17)
0.21 (0.18)
-0.15 (0.26)
Northeast
0.241
0.245
0.574
-0.04 (0.18)
-0.01 (0.18)
-0.24 (0.25)
Midwest
0.828
0.969
0.351
-0.39 (0.18)
-0.38 (0.18)
-0.88 (0.27)
West
0.035
0.044
0.002
Race/ethnicity
White
REF
REF
REF
0.04 (0.23)
0.10 (0.24)
0.01 (0.24)
Black
0.881
0.663
0.968
-0.001 (0.16)
0.07 (0.17)
0.08 (0.17)
Hispanic
0.994
0.980
0.660
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Asian

-0.35 (0.32)
0.278

-0.32(0.32)
0.320

-0.33 (0.33)
0.303

Other*

0.21 (0.28)
0.466

0.27 (0.29)
0.344

0.22 (0.29)
0.439

REF

REF

REF

0.15 (0.19)
0.443

0.13 (0.18)
0.511

0.14 (0.19)
0.489

0.10 (0.19)
0.576

0.08 (0.19)
0.693

0.01 (0.19)
0.960

Education
High School
Diploma, GED,
or less
Some
College,
Associates
Degree, or
currently
enrolled in
college
4-Year
College
Degree or
more
Sexual
Identity
Gay
Did not
identify as gay

PrEP User
No
Yes

REF
-0.55 (0.15)
<0.001

REF
0.70 (0.17)
<0.001

REF
-0.57 (0.15)
<0.001
Social-level Characteristics
REF
0.81 (0.19)
<0.001

REF
-0.48 (0.15)
0.003

REF
0.75 (0.19)
<0.001
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Main Partner
Status
No Main
Partner (MP)
MP is HIVpositive
MP HIV
status
unknown or
uncertain
MP HIV
negative and
on PrEP
MP HIV
negative and
not on PrEP
Number of
partners in
past 3 months
0
1
2-5
>5
Drug use in
the last 3
months
No

REF
0.06 (0.37)
0.869

REF
-0.23 (0.37)
0.984

REF
-0.25 (0.38)
0.513

-0.23 (0.27)
0.393

-0.10 (0.27)
0.466

-0.16 (0.27)
0.567

1.02 (0.40)
0.012

0.62 (0.41)
0.147

0.61 (0.41)
0.145

-0.58 (0.14)
0.679

-0.12 (0.15)
0.443

-0.09 (0.15)
0.550

REF
0.24 (0.22)
0.272
0.21 (0.20)
0.293
-0.06 (0.21)
0.791

REF
0.35 (0.24)
0.152
0.23 (0.21)
0.279
-0.12 (0.22)
0.585

REF
0.27 (0.24)
0.260
0.22 (0.21)
0.292
-0.10 (0.22)
0.636

REF

REF

REF
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Yes
STD in past 6
months
No
Yes

-0.38 (0.13)
0.005

-0.41 (0.13)
0.003

-0.41 (0.13)
0.004

REF
-0.13 (0.19)
0.510

REF
-0.24 (0.20)
0.239

REF
-0.21 (0.20)
0.308

State-level Characteristics
Equality
HRC
State
Equality Index
Low equality
High
equality
State Racism
High racism
Low racism
Prevalence
< 10.0
10.0-19.9

REF
0.20 (0.16)
0.231

REF
0.16 (0.21)
0.447

REF
0.33 (0.20)
0.102

REF
0.04 (0.15)
0.792

REF
-0.12 (0.19)
0.535

REF
0.17 (0.19)
0.392

REF
0.0003 (0.18)
0.999

REF
-0.20 (0.19)
0.922
-0.17 (0.31)
0.577
0.70 (0.43)
0.109
-0.05 (0.03)
0.158

REF
-0.20 (0.19)
0.302
-0.56 (0.31)
0.080
0.16 (0.42)
0.700
-0.05 (0.03)
0.133

20.0-29.9
≥ 30
Prevalence

-0.26 (0.24)
0.278
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0.58 (0.40)
-0.001 (0.04)
0.04 (0.04)
0.154
0.977
0.261
Model Summary
Model1
Model 2
Model 3
Model 4
Model 5
2
Ʈ =estimated
variance
of
0.04789
0.01004
0.04401
0.05676
0
random
effects
10.2766
10.2545
10.16
10.27
10.1438
VPC or ICC
0.464
0.097812469
0.492829492
0.549639965
0.003000292
MOR
PCV
Fit Statistic
14222
14199.3
14235.9
14200.9
AICC
14225.9
14203.1
14.239.8
14202.8
BIC
* Native American / Alaskan / Hawaiian / Pacific Islander / Other
1Human Rights Campaign (HRC) state scorecard
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County
3 2015 US Census Bureau's American Community Survey Briefs for poverty
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population
*Estimated variance of random effec
Poverty Rate
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Table 4 - 4. Two-way interaction exploring participant’s race/ethnicity stratified on state-level
LGBTQ+ equality measures (p=0.057).
Low Racial Equality States

High Racial Equality States

Race

Estimate

SE

P-value

Estimate

SE

P-value

White

REF

REF

REF

REF

REF

REF

Black

0.2889

0.3405

0.3995

-0.1874

0.3221

0.5626

Hispanic

-0.3446

0.2513

0.1754

0.3017

0.2127

0.1606

Asian

-0.871

0.5853

0.1419

-0.04866

0.3809

0.8987

Other

-0.4228

0.4308

0.3303

0.7335

0.376

0.0551
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Figure 4 - 1. PTP scores by race/ethnicity and states racial equality

Change in PTP scores by Race/Ethnicity and
States Racial Equality
1.00

0.73

0.80
0.60

PTP scores (β)

0.40

0.30

0.29

0.20
0.00

-0.05

-0.20
-0.40

-0.19
-0.34

-0.42

-0.60
-0.80
-1.00

Black

-0.87
Asian

Hispanic
Low Racial Equality States
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High Racial Equality States

Other

CHAPTER 5: CONCLUSION
INTRODUCTION
Men who have se with men (MSM) in the US are the most heavily affected by HIV. Although
MSM make up approximately 2–3% of the US population, in 2017, this group accounted for 70%
of the 38,739 new HIV diagnoses.1 MSM of color are further disproportionately represented and,
if current rates persist, the CDC reports that in their lifetime, one-in-two black and one-in-four
Latino MSM will be diagnosed with HIV, compared to one-in-eleven white MSM.2 At present, there
are more tools in our HIV toolbox than ever before to prevent HIV acquisition, with pre-exposure
prophylaxis (PrEP) being one of the newest.3 Despite its effectiveness, PrEP prescriptions are
reaching only a small proportion of those who could benefit from the drug and prescription rates
vary both by race and geographic region.4 The CDC reported that in 2016, among the estimated
1.1 million people nationwide who are potential candidates for PrEP, only 8% were taking PrEP. 5,6
More specifically, black and Latinos, who make up about two-thirds of the potential candidates for
PrEP, accounted for the smallest percentage of PrEP prescriptions to date and states in the South
of the United States (US), which had 52% of new HIV diagnoses, made up only 27% of PrEP users.7
In the last three decades, much of HIV research has focused on individual-level variables,
with insufficient attention to structural-level factors and how they may influence both individualand social-level variables. Initial PrEP studies focused largely on the acceptability and willingness
to use PrEP. Acceptability was generally high and, although demographic and behavioral factors,
including age,8,9 race/ethnicity,10-13 sexual behavior,8,12,14 and education,9,14 were found to be
associated with PrEP use, the associations were inconsistent across studies and no clear patterns
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emerged. The contradictions between studies could be due to the impact of higher-level
contextual factors working as confounders or modifiers of individual-level associations, factors
including stigma and/or the policies of the state where one resides.15,16 There has been an
increasing recognition of the multi-level nature of HIV and the need to study the impact of
social/structural drivers of the epidemic in addition to individual-level factors.8,17 However,
understanding the influence that structural-level factors have on the epidemic is more challenging
than solely examining the influence of individual-level variables alone. One of the major challenges
is the ‘complexity and “immensity” of structural factors,’ and exploring their definitions and how
they affect the individual.18 For example, in this dissertation there is not an accepted nor validated
measure for the racism of a state, we used a measure that we considered most closely represented
the construct of racism of a state, but, in fact, could instead be a causal marker for an unknown
factor and this may be a limitation to our study. Nonetheless, understanding the synergy of both
the individual- and the structural- level factors is critical to understanding why the epidemic is
more manageable in some populations than in others, and this dissertation is a start along that
path.
The social ecological model (SEM) contextualizes individuals’ behaviors using dimensions
made up of intrapersonal, interpersonal, community, and public policy to provide a framework for
describing the impact of factors at different levels and their interactions between each level.19 The
SEM recognizes that, although individuals are responsible for their own health, an individual’s
ability to assume this responsibility may be influenced by factors within and across each level.20
Using the SEM as a backdrop, this dissertation attempted to examine how factors working at and
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interacting across multiple levels of organization may explain why some groups are more likely to
use PrEP than other groups.

RESEARCH QUESTIONS
Data from a cross-sectional survey of MSM residing in all 50 US states was used to test a
series of hypotheses regarding PrEP use. Specifically, we explored if (a) variables at the individual(i.e. demographics, racial/ethnic and sexual identity), social- (main partner [MP] factors and social
behaviors), and state-levels (state LBGTQ+ equality, racism, HIV prevalence, socio-economic
factors) influenced the outcome (PrEP use and patient trust in provider [PTP] scores) among MSM
with a focus on state equality (LBGTQ+ and racism). We further extended this hypothesis to
examine if our state equality measures modified the association between individual racial/ethnic
and sexual identity and our outcomes (PrEP use or PTP scores), and (b) if the association of statelevel (LGBTQ+ and racism) and individual-level sexual and race/ethnic identity variables with PrEP
use was mediated through PTP. We examined these hypotheses among all participants, and
conducted a sub-analysis looking at the first hypothesis among only MSM of color, as this group
currently has the highest HIV incidence in the US and we felt warranted a closer look in an attempt
to tease out reasons for this high risk.21
The outcome for aims 1 and 2 was PrEP use. In aim 1, we looked at all participants,
irrespective of race/ethnicity, then, in aim 2, we focused on MSM of color only, excluding
participants who reported their race/ethnicity as non-Hispanic white. The outcome for aim 3 was
patient trust in physician (PTP) and all participants who reported they had a primary care physician
(PCP) were included in the analysis.
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SUMMARY OF FINDINGS
Aim 1 and Aim 2
Aim 1 included 4,165 HIV-negative MSM of whom 13.4% (N = 560) were taking PrEP at the
time of the survey. In Aim 2, there were 1,465 HIV-negative MSM of color, of whom 13.6% (N =
199) were taking PrEP. In both aims 1 and 2, our results suggested that both individual and
structural-level factors are important as main effects, as seen with the LGBTQ+ and the sexual
identity variables remaining significant even after controlling for all other variables. LGBTQ+
equality of a state may be a marker for multiple causal factors or even play a direct role in
influencing PrEP use among MSM. This is consistent with findings in other studies examining
equality and health outcomes, and suggests that LBGTQ+ inequality may impact the risk and
health-seeking behaviors of MSM and/or hinder access to appropriate healthcare.22-25 LGBTQ+
friendly states may also have a stronger LGBTQ+ community which can provide social support,
more awareness of HIV and prevention interventions, and more access to healthcare that focuses
on MSM-specific health needs.26 Similarly, in both aims, sexual identity was also shown to be
associated with PrEP use. Participants who did not identify as gay had significantly lower odds of
taking PrEP than those who identified as gay. Participants who did not identify as gay may be less
comfortable discussing their sexual behavior with a healthcare provider and/or may be less
integrated into the LGBTQ+ community, which may impact knowledge/access to PrEP.
Unlike the LGBTQ+ equality variable, in aims 1 and 2 our measure of state-level racism was
not associated with PrEP use. However, in aim 2 among MSM of color, race/ethnicity was
significantly associated with PrEP use. There has been a considerable amount of research showing
that MSM of color feel isolated from the broader LGBTQ+ community or have experienced
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racism/discrimination within that community,27 and therefore we had hypothesized that those
with dual minority identities, sexual and racial, might be more impacted by the co-occurrence of
LBGTQ+ and racial inequality. However, in both aims, exploration of interaction did not support
this hypothesis, and the racism and LBGTQ+ equality of the state were not found to be modifiers
of the association of individual-level identity in predicting PrEP use. Although in both aims, our
measure of state racism was not predictive, in Aim 2, there was evidence that PrEP use varied by
a participant’s race/ethnic identity. Participants who identified as either Latino or Asian had lower
odds of taking PrEP compared to black participants, suggesting that PrEP use is not only suboptimal
among MSM of color, but that it is differential by race/ethnicity among racial/ethnic minorities,
even after controlling for individual level factors. These results suggest that MSM of color are not
one panethnicity and that even within MSM communities of color, there is ethnic and racial
diversity which should be considered and addressed with specific culturally appropriate HIV
prevention strategies.
In both Aims 1 and 2, several social and behavioral variables were strongly associated with
PrEP use, specifically the MP variable. Participants with MP’s who were HIV-positive or were
currently taking PrEP had much higher odds of taking PrEP themselves, while, in both aims,
participants who had a negative MP who was not on PrEP had lower odds of taking PrEP. Only in
Aim 1, participants whose MP HIV status was unknown had lower odds of taking PrEP compared
to participants with no MP. In Aim 2, this category was not significant. The MP findings may be
related to HIV-specific social support and communication within couples and requires further
research. Similarly, participants with more sexual partners or a recent STI diagnosis also had higher
odds of taking PrEP. However, due to the nature of this study, we were unable to deduce whether
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the higher number of sexual partners or an STI diagnosis was a cue to initiate PrEP or whether
those on PrEP were more likely to have increased number of partners or a higher likelihood of
STIs. Age was also associated with higher odds of using PrEP, in both aims, participants between
30-39 years had higher odds of taking PrEP compared to the youngest group, while only in Aim 1,
participants between 40-49 were also shown to have higher odds of taking PrEP compared to the
youngest group.
Interestingly, in both aims, in model 2 of the logistic regression, the individual-level model,
both the Northeast and the West were associated with higher PrEP use, however in the final
adjusted model both variables lost significance. In addition, in aim 1, in model 2, we saw a reversal
in the significance of association of age. In the individual-level model, >50 years of age was
significantly associated with lower PrEP use, however, in the final adjusted model this
characteristic lost significance, but those who were younger, between 30-39 and 40-49 years,
became significantly associated with higher odds of using PrEP. Similarly, in aim 2, education lost
significance from model 2 to model 5. These changes suggest that the social- and/or structural level factors may have been confounding the associations in models looking only at the individuallevel and therefore the inconsistency we saw in previous research could have been due to not
adjusting for these larger multi-level variables.
Aim 3
In aim 3, we included 2,750 HIV-negative participants who reported having a primary care
provider (PCP). The average PTP score for all participants was 17.6 (Range = 5 - 25). Aim 3 showed
very little variation in PTP scores between states, however, after controlling for individual-, social, and structural-level factors, geographic region was associated with PTP. Overall, taking PrEP was
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associated with significantly higher PTP scores, while participants from states in the West (versus
the South), those who did not identify as gay (versus gay), and those who reported taking drugs in
the last three months had significantly lower PTP scores.
Although we did not see the individual racial/ethnic identity or the state LBGTQ+ equality
or racism variables to be associated with PTP scores, our interaction analysis did suggest that
racial/ethnic identity influenced PTP differently depending on the racism at the state-level. After
stratifying on the racial equality of the state, the results suggest that, with the exception of black
participants, all other races had higher PTP scores compared to whites in high racial equality states
(less racism) than in low racial equality states (more racism). In addition, compared to whites,
participants in the ‘other race’ category who lived in a high racial equality state had the highest
PTP score, while Asians who resided in states with low racial equality had the lowest PTP scores
compared to all groups. Lastly, in our final analysis in aim 3 we found that PTP was not a mediator
between individual identity, state level equality variables and PrEP use (see appendix A).
Overall, the findings from the analysis from Aim 1, 2, and 3 suggest that there is a
complicated relationship among and between the individual-, social-, and the structural-level
factors and how they impact for whom and where in the US PrEP is being used. In aims 1 and 2,
LGBTQ+ equality was significantly associated with PrEP use, while in aim 3, PTP scores are also
associated with PrEP. Although we concluded that PTP was not a mediator between individual
identities and the equality of the state and PrEP use, further exploration may be needed using
different measures of equality.
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POLICY IMPLICATIONS
This is one of the first studies that explored several multi-level predictors of PrEP use and,
given our large sample, it also offered a unique opportunity to examine the influence of state-level
factors on PrEP use as main effects, effect modifiers, and factors farther back on the causal
pathway working via mediators. The results of our work suggest that individual-, social-, and statelevel variables, specifically the LGBTQ+ equality of the state of residence, are associated with PrEP
use. In the last decade, there has been much improvement regarding LGBTQ+ and racial justice in
many states in the US; however, the equality landscape in the country varies greatly by state. In
February 2019, the current administration announced, Ending the HIV Epidemic in America, a new
initiative which seeks to reduce all new HIV infections by 90% in the next 10 years.28 Unfortunately,
there has been concerns over the approach of the current administration to HIV, both globally and
domestically, and specifically in their work towards undoing much of the equality progress that
has been made here in the US.29 In the last three years, there has been rollbacks in federal laws of
sexual and reproductive health rights, as well as the rights for LGBTQ+ and their families, 30,31 a
move away from harm reduction to a more punitive approach to drug use,32 and lastly, the many
steps this administration has taken to weaken the Affordable Care Act.33 The findings of this study
suggest that policies that increase inequality may have a detrimental impact on HIV prevention
interventions and may hinder the administration’s new initiation.

FUTURE RESEARCH
Our research identified a number of individual-, social-, and structural-level factors that
may be associated with PrEP use and can inform future studies as well strengthen the existing
literature. Below we lay out potential future research at the state and at the individual/social
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levels to better understand potential predictors of PrEP use and subsequently improved effective
PrEP interventions.
State-Level Characteristics
An important finding of this dissertation at the state level suggested that participants who
resided in states with more LGBTQ+ equality had a higher odds of using PrEP even after controlling
for individual-, social-, and structural-level factors. This could mean that states with more equality
may have the ability or the resources to reach this population and to provide more access to
culturally relevant healthcare, specifically healthcare that focuses on minority health. Other
studies suggest that state policies are a factor when assessing health in gender minority
populations.23,34 Hatzenbuehler and colleagues found in a number of studies that structural
discrimination led to increased risk of psychiatric disorders among LGBT populations. 23,34 In a
quasi-natural experiment conducted by Hatzenbuehler and colleagues, after gay marriage was
legalized in Massachusetts, hospital utilization, psychiatric visits, and overall healthcare
expenditures was significantly reduced among gay men.35 Future research is needed to fully
disentangle the role state LGBTQ+ equality has on LGBTQ+ people and what the driving factors are
when it comes to the health of this population. In aim 3, we did not see an association with the
LGBTQ+ equality of the state and PTP, nor did we see that PTP mediates the relationship between
LGBTQ+ equality and PrEP use, however, we did see that PTP scores were associated with PrEP
use. Therefore it would be important to see what at the state level impacts PrEP use, including but
not limited to the policies and resources that are provided to providers. The policies and resources
provided by the state may encourage more providers to prescribe PrEP or not. In addition, more
research should look at the role of the provider in states with both high and low LGBTQ+ equality.
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Moreover, future research should explore other forms of stigma at higher levels, including
stigma specifically associated with PrEP, state racism, and PCP stigma/discrimination. First, it
would be important to see how PrEP-stigma manifests in all populations in need of HIV prevention.
In both aims 1 and 2, we explored the association between state racism and PrEP use, and we
extended this analysis in aim 2, where we attempted to explore the intersectionality of multiple
minority identities interacting with multiple forms of inequality and subsequently its impact on
PrEP use. The findings in this dissertation did not find a significant association between PrEP use
and the state racism score, nor did we find any evidence of interaction among minority identities
and state-level equality measures. In future research, it would be important to further explore
the effects of racism on PrEP use, specifically racism experienced by MSM of color. The current
stigma research often focuses on the consequences of only one form of stigma. MSM of color
likely experience the stress of multiple minority stigmas which are often correlated and
interrelated and their combined effects may not just be additive.36 The statistics have shown that
MSM of color are not only disproportionately affected by HIV but also that this group at times feels
isolated from the broader LGBTQ+ communities and/or have experienced racism and
discrimination from within the gay community.27,37 We did not explore racism within the gay
community as the data we had did not include this information. Moving forward, exploring racism
experienced within the gay community and its association with PrEP would be important as it could
suggest that the racism experienced at the community-level is more important in the healthseeking behaviors of MSM of color than racism at the state-level as a whole.
Furthermore, state-level racism is difficult to measure and our variable may not have
captured this construct adequately. Although our measure of state racism was not predictive, we
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did find variation in the odds of PrEP use by individual race/ethnic identity. Among participants or
color in our study, those who identified as either Latino or Asian had lower odds of taking PrEP
compared to black participants, suggesting that PrEP use is both suboptimal among MSM of color
overall and differential by race/ethnicity, even after controlling for multi-level factors. MSM of
color should not be treated as a panethnicity, and each group, as well as other factors including
sexual identity and nativity, need to be considered and addressed with specific culturally
appropriate HIV prevention strategies.
Individual- and Social-Level Characteristics
With the understanding that the effectiveness of PrEP is associated with adherence, a
better understanding of the dynamics of non-adherence is crucial. In both aims 1 and 2, MP HIV
and PrEP use were strongly associated with participant PrEP use. Compared to those with no MP,
participants with a MP who was HIV-positive or who was taking PrEP at time of study were more
likely to be taking PrEP themselves while those who had a negative MP who was not on PrEP or
whose MP HIV status was unknown, had lower odds of taking PrEP. There have been many studies
using the theory of interdependency to better understand the health-enhancing behaviors
undertaken by those within a couple. One study looked at the motivations of HIV-negative couples
to use PrEP and suggested the importance of incorporating relationship dynamics into biomedical
strategies.38 Importantly, this should also be explored among MSM of color, as studies have cited
that most intervention research on black MSM have focused on individual-level barriers and
facilitators, rather than those at the couple-level.39 Therefore, research to understand how best
to provide appropriate and effective PrEP roll out to MSM in relationships could be a facilitator in
PrEP uptake.
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Lastly, both aim 1 and 2 showed that participants who did not identify as gay were less
likely to use PrEP. Those who do not identify as gay may not feel comfortable discussing their
sexual behavior with a healthcare provider and/or may be less integrated into the LGBTQ+
community, which may impact knowledge and access to PrEP. Therefore, understanding the
dynamics that sexual identity has on health-seeking behavior is important and could be beneficial
for the healthcare community.
Study design
Multilevel modeling (MLM) is a statistical approach that can be used in analyzing clustered
data or data collected at more than one level in order to demonstrate a relationship.40,41 Similar
to the data source used in this dissertation, of the studies that have conducted MLM and HIV
prevention, have been mostly of a cross-sectional design.42,43 Therefore a longitudinal MLM study
exploring both individual and structural level factors and its association with PrEP acceptability in
an MSM population would be very relevant to the literature.

LIMITATIONS
Overall
There are a number of potential limitations that should be mentioned. First, the data used
for each aim was from a cross-sectional survey not originally designed to answer the questions
posed in this dissertation. Analyses from cross-sectional studies, where the exposures and
outcome are simultaneously assessed, would preclude inferences about temporality or causality
for our variables of interest. For example, for aims 1 and 2, a participant could have lived in a state
with high equality and initiated PrEP and then moved to a state with low equality and continued
taking PrEP. Although we do not believe that this would have occurred often enough to get a
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reverse association, it is worth noting that not controlling for this type of migration could make a
causal relationship impossible to be determined or at least in this case it could have
underestimated the true association. Similarly, in aim 3, we did not have data on whether
participants had ever had a PCP or about their experiences with the healthcare system (i.e.
frequency, if they had a nurse practitioner vs a pcp). This could have led to misclassification of the
outcome as they would have been excluded from the analysis for not having a PCP.
Another limitation is that the study relied on self-reported data. Taking PrEP has been
associated with several types of stigma, including the stigma of being related to HIV, HIV risk, and
also the negative reputation of enabling promiscuity, inconsistent condom use, and unsafe sex. 44
Therefore, the sensitive nature of some of the social behavioral questions (i.e. drug use, partner
number, history of STI, or even the outcome, PrEP use) may have led to social desirability bias or
to some respondents to answer falsely. Although these questions were conducted either privately
online or on an ACASI, due to the nature of online surveys there is the potential for sampling bias,
potential false reporting due to social desirability bias, recall error, misunderstanding of the
questions, or error in entering the response may also have resulted in non-differential
misclassification. Another limitation is that some of the state-level constructs we used did not have
a generally accepted and validated measure, thus the measures used may have reliability and
validity issues, including construct validity. Generalizability should also be mentioned as a
limitation, although participants included residents from all 50 US states, recruitment, for the most
part was conducted online and may not have resulted in a representative sample of MSM in the
US, and therefore our findings may lack external validity. Lastly, the data we used for this
secondary analysis was collected in 2015-2016. As we’ve seen over the past five years, the
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landscape for PrEP is rapidly evolving and therefore, some of the information we present in this
dissertation may be outdated.
Finally, a limitation specific to aims 1 and 2 was our use of multilevel modeling (MLM) for
a dichotomous outcome, PrEP use. The statistics used to quantify fitness (i.e. pseudo-R2) of a MLM
with a dichotomous outcome are often difficult to interpret.45 Although there are other statistical
models which will account for clustering of data, our interest in this study was to identify how
much variation in PrEP use was due to state-level versus individual-level factors and not just
estimate population average effects for variables at these different levels. For this reason, we used
MLM as we considered this the best statistical method that could accomplish our aim, despite the
difficulty in interpreting some of the measures when the outcome is dichotomous.

FINAL CONCLUSION
Biomedical individualism is the view that the causes of disease can always be tracked to an
individual biological factor.46 Focusing only on individual-level factors of HIV conveys a myopic
focus of a virus that is so enwrapped in social determinants. This view excludes structural
conditions as factors that exert influence on the individual including the equality, discrimination,
and access/affordability that might be associated with where a person resides. The HIV epidemic
is complex, and understanding the environment certain groups at higher risk must be explored. To
do this, we need to conduct studies at multiple levels if we want a clear picture of facilitators and
barriers to PrEP. PrEP is one of the newest biomedical tools in our toolkit and a successful scaleup plan will require a biomedical, behavioral and social intervention to maximize its preventative
impact. In final, PrEP will not be the last preventative tool and establishing effective policies and
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the steps needed for successful roll out will further support the roll out of our next biomedical
tool.
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APPENDIX A: SENSITIVITY ANALYSIS FOR EQUALITY AND RACISM
VARIABLES
DESCRIPTION OF ANALYSIS
Sensitivity analysis to determine variables to be include in model as well as to determine
categorizations for main predictor variables. Variables to consider:
a. Main predictors: LGBT stigma variable (HRC) and Racism variable
b. Additional state characteristics:
i. HIV prevalence
ii. Income and income inequality
1. GINI
2. State median
3. Poverty level
iii. Healthcare Access
1. Medicaid
2. Percent uninsured

METHODS
1. Run Correlations between all continuous state variables (GINI, state median, poverty level,
percent uninsured)
2. Plot continuous variables that appear to correlate (See below)
3. Plot continuous variables with the LGBT categorical variable (See below)
4. Bivariate analysis of state variables
5. Multivariate analysis with main predictor categorizations
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Pearson Correlation Coefficients, N = 4165
Prob > |r| under H0: Rho=0
GINI
GINI

PovRate

1.00000

0.42864

PovRate Prevalence RacialStigma PercentUninsured
0.42864

0.61265

-0.14653

0.00354

0.20441

<.0001

<.0001

<.0001

0.8195

<.0001

1.00000

0.40227

-0.37601

0.43530

-0.64366

<.0001

<.0001

<.0001

<.0001

1.00000

-0.24075

0.33530

0.07797

<.0001

<.0001

<.0001

1.00000

-0.61292

0.52929

<.0001

<.0001

1.00000

-0.43450

<.0001
Prevalence

RacialStigma

PercentUnins
ured
StateMed

StateMed

0.61265

0.40227

<.0001

<.0001

-0.14653

-0.37601

-0.24075

<.0001

<.0001

<.0001

0.00354

0.43530

0.33530

-0.61292

0.8195

<.0001

<.0001

<.0001

0.20441

-0.64366

0.07797

0.52929

-0.43450

<.0001

<.0001

<.0001

<.0001

<.0001

<.0001
1.00000

CONCLUSION
Using information from the correlations, plots, bivariate, and multivariate analysis we conducted
a sensitivity analysis for state-level variables to be included in our analysis with a focus on the
LGBTQ+ and Racism variable.In addition, we explored the categorizations for our state-level
predictors. When we had four categories, for the LGBTQ+ equality variable, we saw no difference
in the results. For the racism variable, there was evidence of a dose response, however, none of
the four categories were significant. Our decision to collapse was based on parsimony and our
final adjusted model. In our final model, we did not have enough power to include multiple
categories, therefore we decided to collapse the variables. In final, the variables to be included in
the analysis are described below:
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Final Variable Analysis:

1. Removed GINI due to lack of variation. GINI a good measure of inequality between
countries not US states
2. Collapsed HRC and racism variable to a binary variable for parsimony
3. Additional state characteristics: Removed state median due to multicollinearity with many
of the variables as well as with the main HRC predictor
FINAL VARIABLES: MAIN PREDICTORS - Collapsed HRC, Racism OTHER-HIV Prevalence
(categorical), poverty rate (continuous) %uninsured (continuous), Medicaid for 2nd aim
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RESULTS
Correlations
Gini vs poverty rate
Pearson’s Correlation = 0.4286

Gini vs Prevalence
Pearson’s Correlation = 0.612

Poverty rate versus Prevalence
Pearson’s Correlation = 0.4023
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Poverty Rate vs Racial stigma
Pearson’s Correlation = -0.376

Poverty rate versus % uninsured
Pearson’s Correlation = 0.4353

Prevalence versus %uninsured
Pearson’s Correlation = 0.4353

Racial Stigma versus %uninsured
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Pearson’s Correlation = -0.613

Poverty rate versus State median
Pearson’s Correlation = -0.644

Racial stigma versus State median
Pearson’s Correlation = 0.5293

Percent uninsured versus State median
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Pearson’s Correlation = -0.434

Racial Stigma vs. LGBT stigma
Pearson’s Correlation = -0.553

Medicaid vs. LGBT stigma
Pearson’s Correlation = -0.618

Poverty Rate vs. LGBT stigma
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Pearson’s Correlation = 0.2402

Prevalence vs. LGBT stigma
Pearson’s Correlation = -0.01

State Median vs. LGBT stigma
Pearson’s Correlation = -0.704
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APPENDIX TABLES
Table A - 1. Bivariate Analysis of State-Level Characteristics
State-level Characteristics

Odds Ratio

Main predictors - Equality
HRC state Equality Index
Lowest equality
Low equality
High equality
1 - Highest equality
HRC (collapsed)
Lowest equal
Highest equal
Structural Racism (continuous)
Structural Racism (Collapsed)
High racism
Low racism
Structural Racism (Collapsed)
1-12 (High Racism)
13-21
22-29
30-50 (Low Racism)
Income and Income inequality
GINI (continuous)
US Census Gini coefficient by state
Less than 0.470
0.470-0.485
<0.485
State median (continuous)
US Median Household Income
Less than $50,000
$50,000 to $59,999
$60,000 or more
Poverty Rate
Healthcare Access
Participated in Medicaid Expansion
No
Yes
Percent Uninsured (continuous)
Other
HIV Prevalence (continuous)
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95% CI

REF
1.00
1.77
1.68

REF
0.684, 1.460
1.255, 2.493
1.282, 2.205

REF
1.71
1.014

REF
1.372,2.139
1.004, 1.0024

REF
1.441

REF
1.117, 1.860

REF
1.12
1.13
1.41

REF
0.757, 1.649
0.734, 1.742
0.969, 2.055

>999.999

30.787, >999.999

REF
0.932
1.419
1.00

REF
0.685, 1.268
1.032, 1.951
.

REF
1.333
1.89
0.991

REF
0.958, 1.854
1.354, 2.638
0.938, 1.047

REF
1.294
0.91137

REF
0.977, 1.714
0.93, 1.01

1.014

1.001, 1.028

Prevalence
<10.0
10.0-19.9
20.0-29.9
>/=30

REF
1.054
0.821
1.996
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REF
0.777, 1.43
0.54, 1.249
1.12, 3.558

Table A - 2. LGBTQ+ In 4 Categories for Bivariate, State, and Multivariate Model
Variables
Model 1
Model 2
Model 3
OR (CI)
OR (CI)
OR (CI)
P-value
P-value
P-value
Individual-level
Characteristics
Age
18-29
30-39

Model 4
OR (CI)
P-value

REF
1.18 (0.93, 1.50)
0.1779
1.09 (0.84, 1.43)
0.5079

REF
1.34 (1.02, 1.76)

0.77 (0.59, 1.00)
0.0499

0.94 (0.69, 1.28)

REF
1.41 (1.03, 1.94)
0.035
0.99 (0.72, 1.36)
0.940
1.38 (1.01, 1.86)
0.041

REF
1.52 (0.84, 2.77)

White

REF

REF

Black

1.41 (1.02, 1.94)
0.035
0.92 (0.71, 1.20)
0.537

1.42 (0.99, 2.05)

0.69 (0.42, 1.12)
0.127
1.01 (0.66, 1.54)
0.971

0.74 (0.44, 1.27)

REF

REF

1.23 (0.85, 1.77)
0.273

1.02 (0.69 ,1.52)

40-49
>50
US Region of
residence
South
Northeast
Midwest
West

1.36 (1.01, 1.84)

1.04 (0.65, 1.69)
0.97 (0.56, 1.67)

Race/ethnicity

Hispanic
Asian
Other

0.97 (0.72, 1.30)

1.08 (0.68, 1.73)

Education
High School
Diploma, GED,
or less
Some College
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4-Year College
Degree or more

2.29 (1.62, 3.24)
<0.01

1.76 (1.21, 2.56)

REF

REF

0.55 (0.41, 0.74)
<0.001

0.49 (0.36, 0.67 )

Sexual Identity
Gay
Other
Interpersonallevel
Characteristics
Main Partner
Status
No Main
Partner (MP)
MP is HIVpositive
MP HIV status
unknown or
uncertain
MP HIV
negative and on
PrEP
MP HIV
negative and not
on PrEP
Number of
partners in past
3 months
'0
'1
2-5
>5

REF

REF

4.63 (3.03, 7.09)
<0.001
0.34 (0.19, 0.61)
<0.001

4.46 (0.36, 0.67)

16.30 (9.65, 27.53)
<0.001

16.52 (9.67,
28.23)

0.46 (0.35, 0.61)
<0.001

0.47 (0.35, 0.62)

REF
1.301 (0.756, 2.240)
0.340
3.276 (2.083, 5.153)
<0.001

REF
1.16 (0.67, 2.01)

6.65 (4.26, 10.39)
<0.001

6.72 (4.28,
10.54)

REF
1.33 (1.04, 1.69)
0.022

REF
1.28 (0.99, 1.64)

REF

REF

0.34 (0.19, 0.62)

3.16 (2.00, 4.99)

Drug use in the
last 3 months
No
Yes
STD in past 6
months
No
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Yes

3.25 (2.55, 4.14)
<0.001

3.16 (2.46, 4.05)

State-level
Characteristics
Equality
HRC state
Equality Index
4- Lowest
equality
3- Low equality

REF

REF

0.88 (0.55 1.41)
0.573
1.76 (1.22, 2.54)
0.004

1.02 (0.59, 1.79)

1.45 (1.05, 2.00)
0.024
1.32 (0.99, 1.76)
0.060

1.70 (1.08, 2.68)

REF

REF

1=10.0-19.9

0.95 (0.724, 1.234 )
0.6736

0.71 (0.51, 0.99)

2=20.0-29.9

0.73 (0.41, 1.30)

2- high equality
1 - Highest
equality
Structural
Racism
Prevalence
0=<10.0

1.34 (0.75, 2.39)

1.10 (0.72, 1.67)

Model 2

Model 3

0.99 (0.65, 1.51)
0.958
1.80 (1.12, 2.91)
0.017
1.02 (0.96, 1.07)
0.582
1.01 (0.96, 1.06)
0.793
Model 4

0.01602

0.05931

0.004963

0

0.485

1.77

0.15

0

MOR

1.128

1.262

1.070

1

PCV

80.1

26.1

93.8

0

3192.54

2658.99

3255.27

2595.47

3=>/=30
Poverty Rate
Percent
Uninsured
Model Summary
Ʈ2 =estimated
variance of
random effects
VPC or ICC

1.33 (0.69, 2.57)
1.04 (0.98, 1.11)
1.03 (0.97, 1.10)
Model 5

Fit Statistic
AICC
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BIC

3223.76

2680.17
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3272.61

2652.97

Table A - 3. LGBTQ+ and Racism in 4 Categories for Bivariate, State, and Multivariate Model
Variables
Model 2
Model 3
Model 4
Model 5
OR (CI)
P-value

OR (CI)
P-value

OR (CI)
P-value

OR (CI)
P-value

Individuallevel
Characteristics
Age
18-29

REF

REF

30-39

1.18 (0.93, 1.50)
0.1779
1.09 (0.84, 1.43)
0.5079
0.77 (0.59, 1.00)
0.050

1.34 (1.03, 1.76)
0.003
1.36 (1.01, 1.84 )
0.047
0.94 (0.69, 1.28)
0.705

REF

REF

1.41 (1.03, 1.94)
0.035
0.99 (0.72, 1.36)
0.940
1.38 (1.01, 1.86)
0.041

1.48 (0.77, 2.84)
0.240
1.03 (0.60, 1.75)
0.917
1.08 ( 0.59, 1.96)
0.829

White

REF

REF

Black

1.41 (1.02, 1.94)
0.035
0.92 (0.71, 1.20)
0.537
0.69 (0.42, 1.12)
0.127
1.01 (0.66, 1.54)
0.971

1.42 (0.99, 2.05)
0.554
0.97 (0.73, 1.31)
0.859
0.74 (0.43, 1.27)
0.269
1.08 (0.67, 1.72)
0.740

40-49
>50
US Region of
residence
South
Northeast
Midwest
West
Race/ethnicity

Hispanic
Asian
Native
American /
Alaskan /
Hawaiian /
Pacific
Islander /
Other
Education
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High School
Diploma, GED,
or less
Some
College
4-Year
College
Degree or
more
Sexual Identity
Gay
Other

REF

REF

1.23 (0.85, 1.77)
0.2728

1.02 (0.69, 1.52)
0.920

2.29 (1.62, 3.24)
<0.001

1.76 (1.21, 2.56)
0.004

REF

REF

0.55 (0.41, 0.74)
0.001

0.49 (0.35, 0.67)
0.001

Social-level
Characteristics
Main Partner
Status
No Main
Partner (MP)
MP is HIVpositive
MP HIV
status
unknown or
uncertain
MP HIV
negative and
on PrEP
MP HIV
negative and
not on PrEP
Number of
partners in
past 3 months
0
1
2-5
>5

REF

REF

4.63 (3.03, 7.09)
<0.001
0.34 (0.19, 0.61)
<0.001

4.46 (2.89, 6.90)
<0.001
0.34 (0.19, 0.62)
<0.001

16.30 (9.65, 27.53)
<0.001

16.80 (9.82, 28.73)
<0.001

0.46 (0.35, 0.61)
<0.001

0.47 (0.35, 0.62)
<0.001

REF

REF

1.30 (0.76, 2.24)
0.340
3.28 (2.08, 5.15)
<0.001
6.65 (4.26, 10.39)
<0.001

1.16 (0.67, 2.02)
0.597
3.16 (2.00, 4.99)
<0.001
6.75 (4.30, 10.59)
<0.001

154

Drug use in
the last 3
months
No
Yes
STD in past 6
months
No
Yes

REF
1.33 (1.04, 1.69)
0.022

REF
1.27 (0.99, 1.64)
0.058

REF
3.25 (2.55, 4.14)
<0.001

REF
3.16 (2.46, 4.06)
<0.001

State-level
Characteristics
Equality
HRC state
Equality Index
Lowest
Low
High
Highest
Structural
Racism
≤13

REF
1.05 (0.66, 1.67)
2.07 (1.49, 2.87)
1.68 (1.22, 2.31)

REF
1.10 ( 0.65, 1.89)
1.42 (0.86, 2.36)
1.76 (1.10, 2.81)

REF

REF

13 - 22

1.10 (0.71, 1.71)

0.92 (0.55, 1.53)

23-30

1.09 (0.66, 1.80)

0.83 (0.44, 1.58)

>30

1.15 (0.71, 1.87)

0.88 (0.44, 1.78)

REF

REF

10.0-19.9

0.92 (0.69, 1.21)

0.72 (0.50, 1.03)

20.0-29.9
≥30
Poverty Rate

0.96 (0.62, 1.49)
1.71 (1.04, 2.82)
1.03 (0.98, 1.08)

0.73 (0.41,1.30)
1.32 (0.67, 2.56)
1.04 (0.97, 1.11)

Percent
Uninsured
Model
Summary
Ʈ2 =estimated
variance of
random
effects

1.01 (0.96, 1.06)

1.02 (0.94, 1.10)

Prevalence
<10.0

Model 1

Model 2

Model 3

Model 4

0.01602

0.05931

0

0
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VPC or ICC
MOR
PCV
Fit Statistic
AICC
BIC

0.485
1.13
80.1

1.77
1.26
26.1

0
1
0

0
1
0

3192.54

2658.99

3255.27

2602.83

3223.76

2680.17

3272.61

2667.93
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APPENDIX B: CHAPTER 3 MEDIATION ANALYSIS

Aim 3d: Explore Patient trust in physician (PTP) as a mediator of the association between
individual- and state-level factors and PrEP use.

METHODS
In Aim 3 we examined the relationship among individual-, social- and state-level factors
and patient trust in their physician (PTP). The fourth sub-aim of aim 3, (3d), was to explore PTP
as a mediator between individual-level sexual and race/ethnic identity and state-level LBGTQ+
equality and racism and PrEP use. However, in our analyses for aim 1, we found that individuallevel race/ethnicity was not associated with PrEP use and in the analyses for aim 3 our results
suggested that state-level LBGTQ+ equality and racism were not associated with PTP. These null
findings suggest that our mediation hypothesis is unlikely to be supported with our data.
However, in the interest of completing the analyses proposed for this dissertation, we conducted
a formal assessment of PTP as a mediator in the relationship between individual (sexual and racial
identity) and state-level factors (LGBTQ+ and racial equality) and PrEP use and present the results
here.

ANALYTIC APPROACH
Mediation analysis investigates the mechanisms that underlie an observed relationship
between an exposure variable and an outcome variable.

It examines whether a third

intermediate variable, the mediator, explains the relationship between the exposure and the
outcome variable.1 The traditional approach, the Barron / Kenny method, is based on using
standard regression models and adjusting for the mediator to estimate the difference between
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the total and direct effects.2 However, recent methodological papers have shown that there are
potential issues to this approach.1,3 One issue is that this approach doesn’t test the significance
of the indirect pathway, where the independent variable (IV) affects the dependent variable (DV)
through the pathway via the mediator which can fail to measure some or partial mediation
effects.1,4 However, the traditional approach is still considered useful, as it can be used as a
preliminary step to assess the potential for the proposed mediation process.
New advances in mediation analysis have been made by using the counterfactual
framework which has allowed for definitions of direct and indirect effects and for decomposition
of a total effect.5 The causal inference method extends past the traditional approach and can
address some of the issues of the Baron / Kenny approach. Furthermore, this approach provides
a better understanding of the causal structure of the variables involved in a model, where the
direct and indirect effects in a counterfactual framework are defined and alternative analytical
methods have been introduced to improve the validity and interpretation of mediation analysis.3
One methodological approach, one that can explain unseen or partial mediation, are the methods
described by Valeri and Vanderweele, where they aim to calculate the indirect effect.
In this mediation analysis we used both the Baron / Kenny and the causal inference
approach using the Valeri and Vanderweele SAS mediation macros to explore if PTP was a
mediator between state- and individual-level exposures and PrEP use. Due to the nature of the
data, we will conduct additional bootstrapping analysis in conjunction with the causal inference
approach. Bootstrapping is a non-parametric method based on resampling with replacement
which we will do 1000 times, however can be run up to 5000 times. 6 Bootstrapping is a popular
method of testing the indirect effect and is an alternative to the Delta method which calculates
an approximation of the SE.6 The Delta method uses the assumption of a normal approximation
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which will not hold with our analysis as we are using logistic regression and could lead to overly
conservative associations.6 Separate analyses were conducted for each exposure of interest.

MEDIATION MODEL
1. State equality (LGBTQ+
equality, racial equality)
2. Individual variables
(race/ethnicity and
sexual identity)

Patient Trust in
Provider (PTP)

PrEP use

Variables:
•

Outcome: PrEP use: Dichotomous indicator for yes the participant is taking PrEP vs. No

•

State-level exposures:
o State racial equality (racialstigma_binary): Dichotomous indicator for low racial
equality vs. high racial equality. This variable was a measure by Elmendorf and
Spencer et al., the variable ranks states by the proportion of its non-black residents
who regard blacks more negatively than the national median.7 Using their results,
each state was ranked from 1-50, with 1 representing the state with the highest
proportion of nonblack residents who are ‘prejudiced overall’.7 This measure was
then dichotomized at the median.
o State LGBTQ+ equality (hrc_lgbt_1): Dichotomous indicator for Low LGBTQ+ vs.
High LGBTQ+ equality. The LGBTQ+ equality measure came from the Human
Rights Campaign (HRC) state scorecard which assigns a score based on statewide
laws and policies that affect LGBTQ people and their families.8 The HRC categorizes
these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building
Equality, 3) Solidifying Equality, and 4) Working Toward Innovative Equality. We
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dichotomized the variable into low (categories 1 and 2) and high (categories 3 and
4) LGBTQ equality states.
•

Individual identity exposures:
o Individual race/ethnicity (race_reg): Dichotomous indicator for identifying as
other vs. white (Note: The original race/ethnicity variable used in other models in
this dissertation were polytomous (white, black, Hispanic, Asian, and other). This
variable was dichotomized due to lack of mediation analysis methodology for
polytomous exposure variables.)
o Sexual identity (sexident_reg): Dichotomous indicator for identifying as other vs.
identifying as gay.
o Mediator: Patient trust: pcp_score_binary Dichotomous indicator for ≤ 18 vs. >
18. Using responses from a 5-question validated survey where the response
options were in 5-point Likert scale from strongly agree to strongly disagree.
Responses were summed (range 5–25), with higher scores indicating more trust.9
The variable was dichotomized at the median.

Steps
Each exposure variable was examined separately.
1. Baron and Kenny approach to mediation analysis (using SAS proc freq):
1. Assessed the relationship between each exposure variable and PrEP use.
2. Conducted an analysis to determine whether PTP may be a potential mediator of
the relationship between exposure variables and PrEP use.
i. Assessed whether adjusting for the mediator (PTP score) reduces the
association between each exposure variable and the PrEP.
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3. Using the Causal Inference approach to mediation analysis (using the Valeri and
Vanderweele SAS mediation macros):
i. Assess the direct and indirect effects
ii. Assess using bootstrapping method to confirm results.

RESULTS
The step-by-step results for both the state and the individual-level exposures are reported
at the end of each section for each methodology, the Baron/Kenny approach and the Valeri and
Vanderweele methods. Overall the results using both methods yielded consistent results.
State-level variables
There was a strong association between state racial equality variable and PrEP use. The
analysis suggested that participants who lived in states with high racial equality had higher odds
(OR=1.5, 95% CI: 1.254, 1.914) of taking PrEP than those who lived in a low racial equality state.
PTP was associated with taking PrEP with those who had high PTP scores having an odds of taking
PrEP that is 1.3 times greater than those with low PTP scores (95%CI 1.051, 1.593). However, PTP
scores were not significantly associated with racism of the state (OR=1.4, 95% CI:0.997, 1.903),
suggesting that PTP is not a mediator between state racism and PrEP use according to the
Baron/Kenny approach.
The Causal Inference methodology showed a significant direct effect of a state’s racial
equality on odds of taking PrEP (OR=1.6, 95% CI: 1.26 – 1.91), however, there was not a significant
indirect effect of racial equality on the odds of PrEP use through the PTP score (OR=1.0, 95% CI:
0.99-1.01). The bootstrapping based method yielded the same results.
The LGBTQ+ equality variable showed similar results to the racial equality as an exposure
analysis. There was a strong relationship of the state LGBTQ+ equality and PrEP use. Participants
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who lived in states with high LGBTQ+ equality had higher odds (OR=1.8, 95% CI: 1.448, 2.188) of
taking PrEP than those who lived in a low LGBTQ+ equality states. LBGTQ+ equality was associated
with PrEP use (OR=1.3, 95%CI 1.050, 1.593), but, similar to the racial equality variable, LGBTQ+
equality was not significantly associated with PTP scores (OR=1.0, 95%CI 0.844, 1.153) and thus
our mediation hypothesis was not supported by the data.
Using the Causal Inference methodology, we found a significant direct effect of the state’s
LGBT+ equality on odds of taking PrEP (OR=1.8, 95% CI: 1.45, 2.19). However, there was not a
significant indirect effect on PrEP use through the PTP score (OR=1.00, 95% CI: 0.99, 1.01).
Bootstrapping provided similar results.
Overall, for both state equality variables, the controlled direct effects were equivalent to
the natural direct effects, indicating lack of mediation. In each case, there were significant direct
effects of the state-level equality variables (i.e. racial and LGBTQ+) on the odds of taking PrEP,
however, there was not a significant indirect effect through PTP score.
Individual-level variables
The association between individual race/ethnic identity and PrEP use was not significant
(OR=1.1, 95% CI: 0.875, 1.338). The association between race/ethnicity and PTP scores was also
not significant (OR=1.0, 95% CI: 0.860, 1.187), but PTP was significantly associated with PrEP use
(OR=1.3, 95%CI 1.050, 1.593). Thus the mediation hypothesis was not supported by the data
using the Baron/Kenny approach.
Similarly, using the Causal Inference methodology, showed there was no significant direct
effect of individual race/ethnic identity on the odds of taking PrEP (OR=1.1, 95% CI: 0.874, 1.34),
nor was there a significant indirect effect of race/ethnicity on the odds of using PrEP through PTP
(OR=1.0, 95% CI: 0.991, 1.01). The bootstrapping procedure produced the similar results.
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Using the Baron/Kenny approach, sexual identity was strongly associated with PrEP use
such that those who did not identify as gay had significantly lower odds of taking PrEP than those
who identify as gay (OR=0.4, 95% CI: 0.329, 0.609). Participants who did not identity as gay also
had significantly lower odds (OR=0.7, 95% CI: 0.593, 0.876) of having high PTP compared to
participants who identify as gay. And, as shown in all the analyses above, PrEP use was
significantly associated with PTP scores (OR=1.3, 95%CI 1.050, 1.593). Thus the criteria for
mediation are met, but when using the Valeri and Vanderwheele Causal Inference methodology
we found a significant direct effect of identity on odds of taking PrEP (OR=0.45, 95% CI: 0.334,
0.629), but there was not a significant indirect effect through PTP (OR=0.98, 95% CI: 0.962, 1.00).
The bootstrapping method gave similar conclusions that no meditation was occurring.
Thus we conclude that the impact of state level LBGT+ equality and racism and individual
sexual and racial/ethnic identity on PrEP use is not mediated through PTP. In all analyses, the
controlled direct effects were equivalent to the natural direct effects, signifying lack of mediation.
Limitations

These methods have a number of limitations that should be considered and are listed here.
1. Although there is clustering within states, we analyzed the data as if there were no
clustering. However, our findings regarding the associations from the main analyses in
aims 1 and 3 that did account for cluster suggest that mediation is unlikely.
2. According to the literature, in a multi-level modeling mediator analysis, it is recommended
that the dependent variable (DV) and the mediator variable (MV) be continuous variables,
while the independent variable (IV) can be either.10 The literature cites that the odds ratio
of a binary outcome that is common in nature may be a problem when conducting logistic
regression as this measure is “noncollapsible,”11 and the marginal and conditional odds
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ratios are not directly comparable. Therefore, the traditional approach to mediation even
if there is no X-M association will result in a non-interpretable estimate.10 In our case, our
data did not allow for the DV (PrEP use) to be a continuous variable. Therefore, we
conducted this analysis violating this rule. Currently there is no methodology that we
could find where the dependent variable was dichotomous.
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1. ICC of the mediator and the outcome
ICC of the mediator: PTP score
proc mixed data=aim3_data cl covtest noclprint;
class zip_state;
model pcp_score=/solution ddfm=bw;
random intercept/subject=zip_state;
run;
Covariance Parameter Estimates
Cov Parm Subject

Estimate Standard Z Value
Error

Intercept ZIP_STATE 0.04789 0.03397
Residual

10.2766

0.2780

Pr > Z Alpha

1.41 0.0793
36.97 <.0001

Lower

Upper

0.05 0.01715

0.3995

0.05

9.7528 10.8440

ICC of the outcome: PrEP use
*ICC of the outcome;
proc mixed data=aim3_data cl covtest noclprint;
class zip_state;
model prep_user=/solution ddfm=bw;
random intercept/subject=zip_state;
run;
Covariance Parameter Estimates
Cov Parm Subject

Estimate Standard Z Value
Error

Intercept ZIP_STATE 0.001668 0.000854
Residual

0.1310 0.003553

Pr > Z Alpha

1.95 0.0253
36.87 <.0001

Lower

Upper

0.05 0.000750 0.006375
0.05

0.1243

0.1383
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2. Baron and Kenny methodology

Racial Equality
1. Relationship of state racial equality variable and PrEP use:
proc sort data=aim3_data;
by descending racialstigma_binary descending prep_user;
run;
proc freq data=aim3_data order=data;
table racialstigma_binary*prep_user / relrisk chisq;
run;
Table of racialstigma_binary by prep_user
racialstigma_binary

prep_user(dichotmous variable for PrEP use)
Yes

High Equality

Low Equality

Total

No

Total

274

1216

1490

9.96

44.22

54.18

18.39

81.61

63.13

52.50

160

1100

1260

5.82

40.00

45.82

12.70

87.30

36.87

47.50

434

2316

2750

15.78

84.22

100.00

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.5491

1.2540

1.9138

Relative Risk (Column 1) 1.4482

1.2096

1.7338
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 2) 0.9348

0.9054

0.9652

Those who live in states with high racial equality have odds of not taking PrEP that are 1.5
greater than that of those who live in a low racial equality state. The 95% confidence interval
is (1.254, 1.914), which does not include the null value one, and, therefore this increased odds
is statistically significant at the 0.05 level.

2. Determine whether PTP score may be a potential mediator of the relationship between the
state’s racial equality variable and PrEP use.

a. Are PTP scores associated with living in more racially equal states (mediator to
exposure)?
proc sort data=aim3_data;
by descending racialstigma_binary descending pcp_score_binary;
run;
proc freq data=aim3_data order=data;
table racialstigma_binary*pcp_score_binary/relrisk chisq nopercent norow nocol;
run;
Table of racialstigma_binary by pcp_score_binary
racialstigma_binary

pcp_score_binary
High PTP score Low PTP score

Total

Total

High equality

557

933

1490

Low equality

479

781

1260

1036

1714

2750
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Odds Ratio

0.9734

0.8338

1.1363

Relative Risk (Column 1) 0.9833

0.8930

1.0828

Relative Risk (Column 2) 1.0102

0.9529

1.0710

Those who live in states with high racially equality, have odds of having high PTP scores that is 1.0
times greater than that of those who live in low equality states. The 95% confidence interval is
(0.834, 1.114), which includes the null value one, and, therefore this increased odds is not
statistically significant at the 0.05 level.
b. Are PTP scores associated with taking PrEP (mediator to outcome)?
proc sort data=aim3_data;
by descending pcp_score_binary descending prep_user;
run;
proc freq data=aim3_data order=data;
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol;
run;
Table of pcp_score_binary by prep_user
pcp_score_binary

prep_user(dichotmous variable for PrEP use)
Yes

No

Total

High PTP scores

186

850

1036

Low PTP scores

248

1466

1714

434

2316

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.2935

1.0506

1.5927

Relative Risk (Column 1) 1.2408

1.0429

1.4763
168

Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 2) 0.9593

0.9267

0.9929

Those who have higher PTP scores, have a higher odds of taking PrEP that is 1.3 greater times
than that of those with low PTP scores. The 95% confidence interval is (1.051, 1.593), which
does not include the null value, therefore, this increased odds is statistically significant at the
0.05 level.
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3. Valeri’s mediation macro
Macro Inputs:
data: name of your dataset
yvar: name of your outcome variable
avar: name of your exposure variable
mvar: name of your mediator variable
cvar: name of your other covariates (must be dummy variables, leave blank if none)
a0: baseline level of exposure
a1: new exposure level
m: level of the mediator at which the controlled direct effect is to be estimated
nc: number of covariates used (leave blank if none)
yreg: type of regression to be used to model outcome variable (linear, logistic)
mreg: type of regression to be used to model mediator variable (linear, logistic)
interaction: specify if exposure-mediator interaction is present (true, false)
output: reduced (leave blank) or full output (=full)*
c: level of covariates to calculate conditional effects (default is mean level if left blank)
casecontrol: use if using case-control data (leave blank, true)
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta
method (leave blank)
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect
Full output = also displays “pure” effects, effects conditional on covariates and the effects
evaluated at the mean level of covariates
Did not add confounders/covariates as it was not in proposal.
Racial equality mediation macros
**Question 6a for racial equality**;
title 'm=logistic y=logistic delta';
%mediation(data=data1,yvar=y,avar=x,mvar=m,cvar=,a0=0,a1=1,m=0,nc=0,yreg=logistic,mreg=lo
gistic,
interaction=false,casecontrol=,output=,c=,boot=);
quit;
Obs Effect

Estimate p_value _95__CI_lower _95__CI_upper

1

cde

1.55324 0.00005 1.25699

1.91932

2

nde

1.55324 0.00005 1.25699

1.91932

3

nie

0.99830 0.73526 0.98848

1.00821

4

marginal total effect 1.55060 0.00005 1.25459

1.91645
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There is a significant direct effect of a state’s racial equality on odds of taking PrEP (OR=1.6, 95%
CI: 1.26 – 1.91), however, there is not a significant indirect effect of a state’s equality on odds of
PrEP use through the PTP score (OR=1.00, 95% CI: 0.99-1.01). Lastly, the controlled direct effects
were equivalent to the natural direct effects, signifying lack of mediation.

Now running with bootstrapping using 100 samples.
title 'm=logistic y=logistic bootstrap=100';
%mediation(data=data1,yvar=y,avar=x,mvar=m,cvar=,a0=0,a1=1,m=0,nc=0,yreg=logistic,mreg=lo
gistic,
interaction=false,casecontrol=,output=,c=,boot=100);
quit;
m=logistic y=logistic bootstrap=100
Obs Effect

Estimate s_e_

_95__CI_lower _95__CI_upper

1

cde

1.55518 0.15874 1.27704

1.85276

2

nde

1.55518 0.15874 1.27704

1.85276

3

nie

0.99892 0.00567 0.98802

1.01019

4

marginal total effect 1.55349 0.15868 1.27489

1.85642

The same results are reached with bootstapping.
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1. Baron and Kenny methodology
LGBTQ+ equality
1. Relationship of state LGBTQ+ equality and PrEP use:
proc sort data=aim3_data;
by descending hrc_lgbt_1 descending prep_user;
run;
proc freq data=aim3_data order=data;
table hrc_lgbt_1*prep_user / relrisk chisq;
run;
Table of hrc_lgbt_1 by prep_user
hrc_lgbt_1

prep_user(dichotmous variable for PrEP use)
Yes

High Equality

Low Equality

Total

No

Total

237

934

1171

8.62

33.96

42.58

20.24

79.76

54.61

40.33

197

1382

1579

7.16

50.25

57.42

12.48

87.52

45.39

59.67

434

2316

2750

15.78

84.22

100.00

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.7801

1.4481

2.1882
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 1) 1.6222

1.3642

1.9290

Relative Risk (Column 2) 0.9113

0.8805

0.9431

Those who live in states with high LGBTQ+ equality have odds of taking PrEP that are 1.8
greater than that of those who live in a low LGBTQ+ equality state. The 95% confidence interval
is (1.4481, 2.1882), does not include the null value, and, therefore this increased odds is
statistically significant at the 0.05 level.
2. Determine whether PTP score may be a potential mediator of the relationship between state
equality variables and PrEP use.
a. Are PTP scores associated with living in more LGBTQ+ equal states (mediator to exposure)?
proc sort data=aim3_data;
by descending hrc_lgbt_1 descending pcp_score_binary;
run;
proc freq data=aim3_data order=data;
table hrc_lgbt_1*pcp_score_binary/relrisk chisq nopercent norow nocol;
run;
Table of hrc_lgbt_1 by pcp_score_binary
hrc_lgbt_1

pcp_score_binary
High PTP score Low PTP score

Total

High equality

439

732

1171

Low equality

597

982

1579

1036

1714

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
0.9865

0.8440

1.1531
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 1) 0.9916

0.8996

1.0929

Relative Risk (Column 2) 1.0051

0.9478

1.0659

Those who live in high LGBTQ+ equality states have odds of having high PTP scores that is 1.0
times greater than that of those who live in low LGBTQ+ equality states. The 95% confidence
interval is (0.440, 1.153), which includes the null value one. Therefore this increased odds is not
statistically significant at the 0.05 level.
b. Are PTP scores associated with taking PrEP (mediator to outcome)?
proc sort data=aim3_data;
by descending pcp_score_binary descending prep_user;
run;
proc freq data=aim3_data order=data;
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol;
run;
Table of pcp_score_binary by prep_user
pcp_score_binary prep_user (dichotmous variable for PrEP use)
Yes

No

Total

High PTP scores

186

850

1036

Low PTP scores

248

1466

1714

434

2316

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.2935

1.0506

1.5927

Relative Risk (Column 1) 1.2408

1.0429

1.4763

Relative Risk (Column 2) 0.9593

0.9267

0.9929
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Those who have higher PTP scores have an odds of taking PrEP that is 1.3 greater times than
that of those with low PTP scores. The 95% confidence interval is (1.050, 1.593), which does
not include the null value one. This increased odds is statistically significant at the 0.05 level.
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2. Valeri’s mediation macro
Macro Inputs:
data: name of your dataset
yvar: name of your outcome variable
avar: name of your exposure variable
mvar: name of your mediator variable
cvar: name of your other covariates (must be dummy variables, leave blank if none)
a0: baseline level of exposure
a1: new exposure level
m: level of the mediator at which the controlled direct effect is to be estimated
nc: number of covariates used (leave blank if none)
yreg: type of regression to be used to model outcome variable (linear, logistic)
mreg: type of regression to be used to model mediator variable (linear, logistic)
interaction: specify if exposure-mediator interaction is present (true, false)
output: reduced (leave blank) or full output (=full)*
c: level of covariates to calculate conditional effects (default is mean level if left blank)
casecontrol: use if using case-control data (leave blank, true)
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta
method (leave blank)
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect
Full output = also displays “pure” effects, effects conditional on covariates and the effects
evaluated at the mean level of covariates
Did not add confounders/covariates as it was not in proposal.
LGBTQ+ equality
**For LGBTQ equality**;
title 'm=logistic y=logistic delta';
%mediation(data=data,yvar=y,avar=x,mvar=m,cvar=,a0=0,a1=1,m=0,nc=0,yreg=logistic,mreg=log
istic,
interaction=false,casecontrol=,output=,c=,boot=);
quit;
Obs Effect

Estimate p_value _95__CI_lower _95__CI_upper

1 cde

1.78394 0.00000

1.45088

2.19346

2 nde

1.78394 0.00000

1.45088

2.19346

3 nie

0.99914 0.86463

0.98930

1.00907

4 marginal total effect 1.78241 0.00000

1.44930

2.19207
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There is a significant direct effect of a state’s LGBT equality on odds of taking PrEP (OR=1.8, 95%
CI: 1.45 - 2.19). However, there is not a significant indirect effect of a state’s equality on odds of
PrEP use through the PTP score (OR=1.00, 95% CI: 0.99-1.01). Lastly, the controlled direct effects
were equivalent to the natural direct effects, signifying lack of mediation.

Now running with bootstrapping using 100 samples.
title 'm=logistic y=logistic bootstrap=100';
%mediation(data=data,yvar=y,avar=x,mvar=m,cvar=,a0=0,a1=1,m=0,nc=0,yreg=logistic,mreg=log
istic,
interaction=false,casecontrol=,output=,c=,boot=100);
quit;

m=logistic y=logistic bootstrap=100
Obs Effect

Estimate s_e_

_95__CI_lower _95__CI_upper

1

cde

1.79489 0.20255 1.46425

2.20128

2

nde

1.79489 0.20255 1.46425

2.20128

3

nie

1.00066 0.00514 0.99053

1.01166

4

marginal total effect 1.79621 0.20415 1.46863

2.22000

Bootstrapping reaches the same results.
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3. ICC of the mediator and the outcome
ICC of the mediator
proc mixed data=aim3_data cl covtest noclprint;
class zip_state;
model pcp_score=/solution ddfm=bw;
random intercept/subject=zip_state;
run;
Covariance Parameter Estimates
Cov Parm Subject

Estimate Standard Z Value
Error

Intercept ZIP_STATE 0.04789 0.03397
Residual

10.2766

0.2780

Pr > Z Alpha

1.41 0.0793
36.97 <.0001

Lower

Upper

0.05 0.01715

0.3995

0.05

9.7528 10.8440

ICC of the outcome
*ICC of the outcome;
proc mixed data=aim3_data cl covtest noclprint;
class zip_state;
model prep_user=/solution ddfm=bw;
random intercept/subject=zip_state;
run;
Covariance Parameter Estimates
Cov Parm Subject

Estimate Standard Z Value
Error

Intercept ZIP_STATE 0.001668 0.000854
Residual

0.1310 0.003553

Pr > Z Alpha

1.95 0.0253
36.87 <.0001

Lower

Upper

0.05 0.000750 0.006375
0.05

0.1243

0.1383
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1. Baron and Kenny methodology

Race / Ethnicity
1. Relationship of identity variables and PrEP use:
*RACIAL/ETHNICTY IDENTITY;
proc sort data=aim3_data;
by descending race_reg descending prep_user;
run;
proc freq data=aim3_data order=data;
table race_reg*prep_user / relrisk chisq;
run;
The FREQ Procedure
Table of race_reg by prep_user
race_reg

Non-White

White

Total

prep_user(dichotmous variable for PrEP use)
Yes

No

Total

161

817

978

5.85

29.71

35.56

16.46

83.54

37.10

35.28

273

1499

1772

9.93

54.51

64.44

15.41

84.59

62.90

64.72

434

2316

2750

15.78

84.22

100.00

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.0820

0.8748

1.3384
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 1) 1.0685

0.8939

1.2773

Relative Risk (Column 2) 0.9875

0.9543

1.0219

Those who identify as non-white, have odds of taking PrEP that are 1.08 times greater than those
who identify as white. The 95% CI is (0.8748, 1.3384) which includes the null value and therefore
is not statistically signicant at the 0.5 level.
2. Use stratified analysis methods to determine whether having a high PTP score may be a potential
mediator of the relationship between state equality variables and PrEP use.
a. Are PTP scores associated with race (mediator to exposure)?
*RACE IDENTITY;
proc sort data=aim3_data;
by descending race_reg descending pcp_score_binary;
run;
proc freq data=aim3_data order=data;
table race_reg*pcp_score_binary/relrisk chisq nopercent norow nocol;
run;

Table of race_reg by pcp_score_binary
race_reg

pcp_score_binary
High PTP Score Low PTP score

Total

Non-White

370

608

978

White

666

1106

1772

1036

1714

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.0106

0.8603

1.1872
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Odds Ratio and Relative Risks
Statistic

Value 95% Confidence Limits

Relative Risk (Column 1) 1.0066

0.9106

1.1128

Relative Risk (Column 2) 0.9960

0.9373

1.0585

Sample Size = 2750
Participants who identity as non-white have odds of having high PTP scores that is 1.01 times
greater than that of white participants. The 95% Confidence Interval (0.860, 1.187) includes the
null value of one, therefore this increased odds is not statistically significant.

b. Are PTP scores associated with taking PrEP (mediator to outcome)?
proc sort data=aim3_data;
by descending pcp_score_binary descending prep_user;
run;
proc freq data=aim3_data order=data;
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol;
run;
Table of pcp_score_binary by prep_user
pcp_score_binary

prep_user(dichotmous variable for PrEP use)
Yes

No

Total

High PTP scores

186

850

1036

Low PTP scores

248

1466

1714

434

2316

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.2935

1.0506

1.5927

Relative Risk (Column 1) 1.2408

1.0429

1.4763

Relative Risk (Column 2) 0.9593

0.9267

0.9929
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Those who have higher PTP scores have odds of taking PrEP that is 1.3 greater times than that of
those with low PTP scores. The 95% confidence interval is (1.051, 1.593), which does not include
the null value one, and, therefore this increased odds is statistically significant at the 0.05 level.
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2. Valeri Macro’s
Macro Inputs:
data: name of your dataset
yvar: name of your outcome variable
avar: name of your exposure variable
mvar: name of your mediator variable
cvar: name of your other covariates (must be dummy variables, leave blank if none)
a0: baseline level of exposure
a1: new exposure level
m: level of the mediator at which the controlled direct effect is to be estimated
nc: number of covariates used (leave blank if none)
yreg: type of regression to be used to model outcome variable (linear, logistic)
mreg: type of regression to be used to model mediator variable (linear, logistic)
interaction: specify if exposure-mediator interaction is present (true, false)
output: reduced (leave blank) or full output (=full)*
c: level of covariates to calculate conditional effects (default is mean level if left blank)
casecontrol: use if using case-control data (leave blank, true)
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta
method (leave blank)
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect
Full output = also displays “pure” effects, effects conditional on covariates and the effects
evaluated at the mean level of covariates
Did not add confounders/covariates as it was not in proposal
Obs Effect

Estimate p_value _95__CI_lower _95__CI_upper

1 cde

1.08152 0.47047

0.87419

1.33803

2 nde

1.08152 0.47047

0.87419

1.33803

3 nie

1.00065 0.89785

0.99072

1.01068

4 marginal total effect 1.08223 0.46726

0.87456

1.33921

There is a not a significant effect of a person’s race on odds of taking PrEP (OR=1.1, 95% CI:
0.874, 1.34), nor is there a significant indirect effect of a person’s race on the odds of using PrEP
through PTP score PrEP (OR=1.0, 95% CI: 0.991, 1.01). Lastly, the controlled direct effects were
equivalent to the natural direct effects, signifying lack of mediation.
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m=logistic y=logistic bootstrap=100
Obs Effect

Estimate

s_e_ _95__CI_lower _95__CI_upper

1 cde

1.08381 0.10816

0.87598

1.30464

2 nde

1.08381 0.10816

0.87598

1.30464

3 nie

1.00140 0.00581

0.98937

1.01511

4 marginal total effect 1.08527 0.10789

0.87486

1.31205

We reach the same effects with bootstrapping.
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1. Baron and Kenny methodology
Sexual identity
*SEX IDENTITY;
proc sort data=aim3_data;
by descending sexident_reg1 descending prep_user;
run;
proc freq data=aim3_data order=data;
table sexident_reg1*prep_user / relrisk chisq;
run;
Table of sexident_reg1 by prep_user
sexident_reg1(identity collapsed prep_user(dichotmous variable for PrEP use)
into dichotomous variable)
Yes
No
Total
Do not identify as gay

Identify as gay

Total

51

531

582

1.85

19.31

21.16

8.76

91.24

11.75

22.93

383

1785

2168

13.93

64.91

78.84

17.67

82.33

88.25

77.07

434

2316

2750

15.78

84.22

100.00

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
0.4476

0.3290

0.6090

Relative Risk (Column 1) 0.4960

0.3758

0.6546

Relative Risk (Column 2) 1.1081

1.0734

1.1440
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Those who do not identify as gay have odds of taking PrEP that are 0.45 times lower than those
who identify as gay. The 95% CI is (0.3290, 0.6090) does not include the null value, and therefore
is statistically significant at the 0.5 level.
2. Use stratified analysis methods to determine whether having a high PTP score may be a potential
mediator of the relationship between state equality variables and PrEP use.
a. Are PTP scores associated with sexual identity (mediator to exposure)?
*SEXUAL IDENTITY;
proc sort data=aim3_data;
by descending sexident_reg1 descending pcp_score_binary;
run;
proc freq data=aim3_data order=data;
table sexident_reg1*pcp_score_binary/relrisk chisq nopercent norow nocol;
run;
Table of sexident_reg1 by pcp_score_binary
sexident_reg1(identity
collapsed into dichotomous
variable)

pcp_score_binary
High PTP Score Low PTP Score

Total

Do not identify as gay

185

397

582

Identify as gay

851

1317

2168

1036

1714

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
0.7212

0.5936

0.8761

Relative Risk (Column 1) 0.8098

0.7111

0.9222

Relative Risk (Column 2) 1.1229

1.0523

1.1983

Sample Size = 2750
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Participants who do not identity as gay have odds of having high PTP scores that are 0.72 times
lower than that of participants who identify as gay. The 95% Confidence Interval (0.711, 0.922)
does not include the null value, therefore this increased odds is statistically significant.

b. Are PTP scores associated with taking PrEP (mediator to outcome)?
proc sort data=aim3_data;
by descending pcp_score_binary descending prep_user;
run;
proc freq data=aim3_data order=data;
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol;
run;
Table of pcp_score_binary by prep_user
pcp_score_binary

prep_user(dichotmous variable for PrEP use)
Yes

No

Total

High PTP scores

186

850

1036

Low PTP scores

248

1466

1714

434

2316

2750

Total

Odds Ratio and Relative Risks
Statistic
Odds Ratio

Value 95% Confidence Limits
1.2935

1.0506

1.5927

Relative Risk (Column 1) 1.2408

1.0429

1.4763

Relative Risk (Column 2) 0.9593

0.9267

0.9929

Those who have higher PTP scores have an odds of taking PrEP that is 1.3 greater times than that
of those with low PTP scores. The 95% confidence interval is (1.051, 1.593), which does not
include the null value, and, therefore this increased odds is statistically significant at the 0.05
level.
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2. Valeri
Macro Inputs:
data: name of your dataset
yvar: name of your outcome variable
avar: name of your exposure variable
mvar: name of your mediator variable
cvar: name of your other covariates (must be dummy variables, leave blank if none)
a0: baseline level of exposure
a1: new exposure level
m: level of the mediator at which the controlled direct effect is to be estimated
nc: number of covariates used (leave blank if none)
yreg: type of regression to be used to model outcome variable (linear, logistic)
mreg: type of regression to be used to model mediator variable (linear, logistic)
interaction: specify if exposure-mediator interaction is present (true, false)
output: reduced (leave blank) or full output (=full)*
c: level of covariates to calculate conditional effects (default is mean level if left blank)
casecontrol: use if using case-control data (leave blank, true)
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta
method (leave blank)
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect
Full output = also displays “pure” effects, effects conditional on covariates and the effects
evaluated at the mean level of covariates
Did not add confounders/covariates as it was not in proposal

m=logistic y=logistic delta
Obs Effect

Estimate

p_value _95__CI_lower _95__CI_upper

1 cde

0.45490 0.000001

0.33421

0.61916

2 nde

0.45490 0.000001

0.33421

0.61916

3 nie

0.98199 0.078922

0.96228

1.00210

4 marginal total effect 0.44670 0.000000

0.32823

0.60793

There is a significant direct effect of a person’s sexual identity on odds of taking PrEP (OR=0.45,
95% CI: 0.334, 0.629), however, there is not a significant indirect effect of a person’s sexual
identity on the odds of using PrEP through PTP score PrEP (OR=0.98, 95% CI: 0.962, 1.00). Lastly,
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the controlled direct effects were equivalent to the natural direct effects, signifying lack of
mediation.

m=logistic y=logistic bootstrap=100
Obs Effect

Estimate

s_e_ _95__CI_lower _95__CI_upper

1 cde

0.45512 0.075597

0.33334

0.61876

2 nde

0.45512 0.075597

0.33334

0.61876

3 nie

0.98063 0.011964

0.95226

0.99765

4 marginal total effect 0.44629 0.074244

0.32578

0.60999

We see similar results in the bootstrapping.
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